• Author Index
• Abstract Index
• Search
• Journal Homepage
• ISTH Homepage
• Online Journal
• Privacy Policy
• 2003
• 2005
• 2007
• 2009

Author Index

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

 

L
l. Pfliegler on Behalf of the Hungarian Consensus Conference G.P.	-	ANTITHROMBOTIC PROPHYLAXIS AND THERAPY. THE HUNGARIAN CONSENSUS AND EXPERIENCE, 2007
La Spisa C.	-	SUBMASSIVE PULMONARY EMBOLISM: ROLE OF THROMBOLITIC THERAPY
Lab L.	-	CHALLENGES IN DEFINING TYPE 2M VON WILLEBRAND DISEASE: RESULTS FROM A CANADIAN COHORT STUDY
Labarere J.	-	IS THROMBO-EMBOLIC DISEASE AN HETEROGENEOUS DISEASE ?
Labarque V.	-	HYPERREACTIVE PLATELETS IN PATIENTS WITH GS DEFICIENCY
Labas V.	-	TYPE III COLLAGEN BINDING PROTEIN (TIIICBP) IS IDENTICAL TO KINDLIN-3, A PROTEIN BELONGING TO A NOVEL FAMILY OF FOCAL ADHESION PROTEINS
Labat C.	-	AGE-DEPENDENT INCREASED ARTERIAL STIFFNESS IS ASSOCIATED WITH COMPOSITE CHANGES IN PRO- AND ANTI-COAGULANT REACTIONS IN SUBCLINICAL ATHEROSCLEROSIS
Labbadia G.	-	RELATIONSHIP BETWEEN INFLAMMATORY INDEXES ON ADMISSION AND DIAGNOSIS OF ACUTE AORTIC DISSECTION
Labelle A.	-	IMMUNOGLOBULIN ISOTYPES AND FUNCTIONAL ANTI-FVIII ANTIBODIES IN RESPONSE TO FVIII TREATMENT IN TWO STRAINS OF HEMOPHILIA A MICE
	-	SAFE AND LONG-TERM EXPRESSION OF FVIII FOLLOWING SUBCUTANEOUS IMPLANTATION OF GENETICALLY-MODIFIED ENDOTHELIAL PROGENITORS IN HEMOPHILIA A MICE
	-	IMMUNE TOLERANCE INDUCTION TO FVIII IN HEMOPHILIA A MICE USING SUBCUTANEOUSLY IMPLANTED FVIII GENE-MODIFIED ENDOTHELIAL PROGENITOR CELLS
	-	PRECLINICAL PHARMACOLOGY OF AV513 INCLUDING ORAL EFFICACY IN SEVERE HEMOPHILIA A DOGS
	-	ENHANCED TOLEROGENIC PRESENTATION OF FVIII BY ANDROGRAPHOLIDE-TREATED IMMATURE DENDRITIC CELLS
	-	ANTI-CD3 IN COMBINATION WITH NASAL FVIII-A2 DOMAIN DECREASES FVIII INHIBITORS
Laborde E.	-	EFFECT OF ANTIINFLAMMATORY DRUGS ON HUMAN NEUTROPHILS IN ENDOTHELIAL CELL DAMAGE INDUCED BY SHIGA TOXIN-1
Labreuche J.	-	A ROLE FOR PLATELET ACTIVATION IN LACUNAR STROKE?
Labropoulos N.	-	BENIGN OUTCOME OF OBJECTIVELY PROVEN SPONTANEOUS RECANALIZATION OF INTERNAL CAROTID ARTERY OCCLUSION: LONG-TERM FOLLOW UP
Labuda M.	-	VARIEGIN, A NOVEL CLASS OF THROMBIN INHIBITOR FROM THE SALIVARY GLAND EXTRACT OF THE HARD TICK AMBLYOMMA VARIEGATUM
Lacolley P.	-	PLATELET ACTIVATION REINFORCES THE PROCOAGULANT PHENOTYPE INDUCED BY MURINE MONOCLONAL ANTI-PHOSPHOLIPID ANTIBODIES
	-	SIGNIFICANCE OF PLASMA SOLUBLE ENDOTHELIAL PROTEIN C RECEPTOR AND TISSUE FACTOR PATHWAY INHIBITOR IN PATIENTS WITH ANTIPHOSPHOLIPID ANTIBODIES
	-	AGE-DEPENDENT INCREASED ARTERIAL STIFFNESS IS ASSOCIATED WITH COMPOSITE CHANGES IN PRO- AND ANTI-COAGULANT REACTIONS IN SUBCLINICAL ATHEROSCLEROSIS
Lacombe D.	-	PLATELET ABNORMALITIES IN PATIENTS WITH CONSTITUTIONAL DEFECTS IN FILAMIN A
Lacroix-Desmazes S.	-	KINETICS OF HYDROLYSIS BY FVIII HYDROLYZING ANTIBODIES IN ACQUIRED HEMOPHILIA A
	-	IGG ANTIBODIES WITH HYDROLYTIC ACTIVITY TOWARDS ENDOGENOUS FVIII IN A FRENCH COHORT OF PATIENTS WITH ACQUIRED HEMOPHILIA
	-	IDENFICATION OF THE RECEPTORS IMPLICATED IN THE ENDOCYTOSIS OF FACTOR VIII BY HUMAN DENDRITIC CELLS
	-	COMPARISON OF THE IMMUNOGENICITY OF DIFFERENT THERAPEUTIC PREPARATIONS OF HUMAN FACTOR VIII IN THE MURINE MODEL OF HEMOPHILIA A
	-	EXPOSED MANNOSYLATION ON THERAPEUTIC FACTOR VIII MEDIATES ITS ENDOCYTOSIS BY HUMAN DENDRITIC CELLS LEADING TO ACTIVATION OF CD4+ T LYMPHOCYTES
	-	VWF INHIBITS OF THE ENDOCYTOSIS OF FACTOR VIII BY MURINE BONE MARROW-DERIVED DENDRITIC CELLS
Lacut K.	-	EFFECT OF TWO DOSES OF ORAL OESTROGEN REPLACEMENT THERAPY ON THE PROTEIN C SYSTEM IN POSTMENOPAUSAL WOMEN. A RANDOMISED DOUBLE BLIND PLACEBO-CONTROLLED STUDY
	-	BODY MASS INDEX, MILD HYPERHOMOCYSTEINEMIA AND VENOUS THROMBOEMBOLISM RISK
	-	VKORC1 GENETIC POLYMORPHISM IS ASSOCIATED TO VENOUS THROMBOEMBOLISM: RESULTS FROM THE EDITH STUDY
Laczkovics C.	-	RISK OF RECURRENCE AFTER A FIRST VENOUS THROMBOEMBOLIC EVENT IN YOUNG WOMEN
Ladenvall C.	-	FIBRINOGEN HAPLOTYPES AND PLASMA LEVELS SHOW INDEPENDENT ASSOCIATION TO ISCHEMIC STROKE
Ladner T.	-	CHARACTERIZATION OF A NEW METHOD TO ASSESS PLATELET ACTIVATION AND ERYTHROCYTE LYSIS DURING EXPOSURE TO PATHOPHYSIOLOGICAL SHEAR STRESS
Ladouzi A.	-	A PROSPECTIVE EFFICACY AND SAFETY STUDY OF A SOLVENT-DETERGENT TREATED AND 15-NM FILTERED FACTOR VIII ADMINISTERED BY CONTINUOUS INTRAVENOUS INFUSION IN SEVERE HAEMOPHILIA A PATIENTS UNDERGOING MAJOR SURGICAL PROCEDURES (PERFACT STUDY)
Lægreid I.	-	THE PREDICTIVE VALUE OF CRP, D-DIMER AND CLINICAL PROBABILITY TO EXCLUDE DVT IN PERSONS ADMITTED TO HOSPITAL FOR DVT
Laemmle B.	-	MEASUREMENT OF THROMBIN GENERATION IN PATIENTS AT RISK FOR ATHEROTHROMBOSIS
laffan M.A.	-	N-LINKED GLYCOSYLATION OF VWF MODULATES THE INTERACTION WITH ADAMTS13
Laffan M.	-	ATTEMPTED ERADICATION OF HIGH RESPONDING FVIII INHIBITOR BY ALLOGENEIC BONE MARROW TRANSPLANTATION
Lagarde M.	-	THE EFFECTS OF DOCOSAHEXAENOIC ACID IN PLATELETS (AN EX VIVO STUDY) AND IN MEGAKARYOCYTIC CELLS (AN IN VITRO STUDY)
Lagasse H.A.D.	-	DISCOVERY AND CHARACTERIZATION OF A POTENT NEUTRALIZING ANTI-VWF A1 DOMAIN SPECIFIC APTAMER
Lagasse H.	-	INHIBITION OF PLATELET FUNCTION BY THE ANTI-VON WILLEBRAND FACTOR APTAMER, ARC1779
Lages P.	-	SUCCESSFUL INHIBITOR-ELIMINATION W ITH RITUXIMAB IN ONE PATIENT WITH A CARRIER STATE FOR HEMOPHILIA A AND 4 PATIENTS WITH ACQUIRED HEMOPHILIA A
Lages G.F.G.	-	HEMOSTATIC PROFILE IN PATIENTS WITH PERIPHERAL ARTERIAL OBSTRUCTIVE DISEASE (PAOD): ASSOCIATION TO ANKLE-BRACHIAL INDEX (ABI)
Lages P.	-	SEVEN NOVEL MISSENSE MUTATIONS IN THE VITAMIN K EPOXIDE REDUCTASE COMPLEX SUBUNIT 1 (VKORC1) CAUSE HEREDITARY COUMARIN RESISTANCE
Lago A.	-	EARLY TISSUE FACTOR-INDUCED THROMBIN GENERATION IN PLATELETS: INFLUENCE OF ASPIRIN AND ASPIRIN PLUS CLOPIDOGREL
	-	DUAL ANTIPLATELET THERAPY WITH CLOPIDOGREL AND ASPIRIN ATTENUATES PLATELET REACTIVITY AND PROTHROMBOTIC EFFECT OF ERYTHROCYTES IN PATIENTS AFTER CAROTID STENTING
Laguna M.S.	-	INVOLVEMENT OF THE TPO/MPL PATHWAY IN THE PATHOGENESIS OF INHERITED THROMBOCYTOPENIAS
Laguna P.	-	BLOOD BORNE VIRUS INFECTIONS IN YOUNG HAEMOPHILIACS IN POLAND
	-	EVALUATION OF EFFICACY OF RADIOACTIVE SYNOVECTOMY IN RECURRENT JOINT BLEEDING IN HAEMOPHILIA
	-	LOW INCIDENCE OF INHIBITOR DEVELOPMENT IN PREVIOUSLY UNTREATED PATIENTS WITH HAEMOPHILIA A
	-	EFFICACY AND SAFETY OF A HIGHLY PURIFIED FACTOR IX CONCENTRATE IN PAEDIATRIC PATIENTS WITH HAEMOPHILIA B - RESULTS OF A CLINICAL TRIAL AND A POST MARKETING SURVEILLANCE STUDY
	-	HAEMOTHORAX IN A BOY WITH SEVERE HAEMOPHILIA AND FACTOR VIII INHIBITOR
Laharie D.	-	TREATMENT OF GASTROINTESTINAL BLEEDING AND ANGIODYSPLASIA IN GLANZMANN THROMBASTHENIA WITH OCTREOTIDE
Lahav J.	-	A NOVEL FUNCTION OF THE PLASMA TRANSGLUTAMINASE - COAGULATION FACTOR XIII: PROTEIN DISULFIDE ISOMERASE (PDI)
	-	MULTIPLE REDOX SYSTEMS OPERATE IN EXTRACELLULAR REGULATION OF INTEGRIN-MEDIATED PLATELET ADHESION
	-	SPECIFIC CYSTEINE RESIDUES IN BETA3 ARE ESSENTIAL FOR DISULFIDE BOND EXCHANGE- DEPENDENT OR -INDEPENDENT PATHWAYS OF ALPHAIIBBETA3 ACTIVATION
	-	ANTI-CD 20 MONOCLONAL ANTIBODY (RITUXIMAB) AS AN OPTIONAL TREATMENT FOR INTRACTABLE ACQUIRED GLANZMANN THROMBASTHENIA
Lahoz C.	-	LABORATORY DIAGNOSIS OF HEPARIN INDUCED THROMBOCYTOPENIA: HELP OR HINDRANCE?
	-	CLINICAL DIAGNOSIS OF HEPARIN-INDUCED THROMBOCYTOPENIA
Lahr B.D.	-	IMPACT OF VENOUS THROMBOEMBOLISM, VENOUS STASIS SYNDROME, VENOUS OUTFLOW OBSTRUCTION AND VENOUS VALVULAR INCOMPETENCE ON QUALITY OF LIFE AND ACTIVITIES OF DAILY LIVING: A POPULATION-BASED CASE-CONTROL STUDY
Lai C.	-	REFERENCE RANGE OF PLATELET FUNCTION ANALYZER-100 CLOSURE TIMES IN HEALTHY CHINESE
Lai Kuen R.	-	PLATELET FACTOR 4 (PF4/CXCL4) SEALS BLOOD CLOTS BY ALTERING THE STRUCTURE OF FIBRIN
Lail A.E.	-	ASSOCIATION BETWEEN A HISTORY OF INHIBITORS AND DELAYS IN SKELETAL MATURATION IN ADOLESCENTS WITH HEMOPHILIA
Lail A.	-	HFE GENE MUTATIONS DO NOT SHOW ASSOCIATIONS WITH HEMOPHILIC ARTHROPATHY
Laiou E.	-	CONTRIBUTION OF ROTATION THROMBOELASTOGRAPHY (RT) IN PERIOPERATIVE MANAGEMENT OF PATIENTS WITH GLAZMANN'S THROMBASTHENIA (GT)
	-	PRELIMINARY RESULTS ON EFFECTIVENESS AND SAFETY OF COMBINED ANTICOAGULANT AND ANTIPLATELET THERAPY
	-	DOES ADMINISTRATION OF LANSOPRAZOLE AFFECT ASA ANTIPLATELET FUNCTION IN HIGH RISK CARDIOVASCULAR PATIENTS? PRELIMINARY RESULTS
Laird J.	-	ANTICARDIOLIPIN ANTIBODIES AND OUTCOME OF PREGNANCY A RETROSPECTIVE 3 YEAR STUDY
Laivuori H.	-	BLOOD GROUP AB AND FV LEIDEN AS RISK FACTORS FOR PRE-ECLAMPSIA
Lajus S.	-	ABCIXIMAB-DEPENDENT THROMBOCYTOPENIA IN PATIENTS WITH ACUTE CORONARY SYNDROMES CAN OCCUR BY DIFFERENT MECHANISMS
Lak M.	-	THE CLINICAL RESULTS OF P32 RADIOSYNOVECTOMY IN HEMOPHILIC PATIENTS WITH CHRONIC SYNOVITIS
	-	DATABASE ON RARE BLEEDING DISORDER (RBDS): PHENOTYPE AND GENOTYPE ANALYSIS ON 400 AFFECTED PATIENTS
	-	EVALUATION OF THE USE OF RECOMBINANT FVIIA, NOVOSEVEN IN 28 GLANZMANN'S THROMBASTHENIA PATIENTS
Lale A.	-	DENGUE FEVER AND THROMBOCYTOPENIA: A DEADLY DUO
Lale S.	-	DENGUE FEVER AND THROMBOCYTOPENIA: A DEADLY DUO
Lally C.	-	THE ALPHA FIBRINOGEN THR312ALA POLYMORPHISM AND VENOUS THROMBOEMBOLISM IN AMERICAN CAUCASIANS AND AFRICAN AMERICANS: THE GATE STUDY
	-	POLYMORPHISMS IN THE 3'-END OF THE FIBRINOGEN GAMMA GENE AND RISK OF VENOUS THROMBOEMBOLISM IN THE AFRICAN-AMERICAN AND CAUCASIAN POPULATION
	-	PULMONARY EMBOLISM, OBESITY, DIABETES, AND HYPERTENSION AMONG AMERICAN CAUCASIANS IN THE GATE STUDY
	-	VENOUS THROMBOEMBOLISM, FACTOR V LEIDEN, AND PROTHROMBIN 20210 AMONG AMERICAN CAUCASIANS IN THE GATE STUDY
Lam P.Y.S.	-	POTENT ANTITHROMBOTIC ACTIVITY OF APIXABAN, A DIRECT FACTOR XA INHIBITOR, WITH MINIMUM BLEEDING TIME EFFECT IN RABBIT MODELS OF ARTERIAL THROMBOSIS AND HEMOSTASIS
Lam S.C.T.	-	TALIN HEAD-ROD INTERACTION MODULATES INTEGRIN BINDING TO THE TALIN HEAD DOMAIN
Lam J.K.	-	FURTHER CHARACTERISATION OF ADAMTS13 INACTIVATION BY THROMBIN
Lambert C.M.	-	CURRENT PRACTICE IN THROMBOSIS AND HAEMOSTASIS: A SINGLE-CENTER RETROSPECTIVE STUDY
Lambert C.	-	MONITORING AND DOSAGE MODULATION OF ENOXAPARIN DURING PREGNANCY
	-	DETERMINATION OF VKORC1 AND CYP2C9 GENOTYPES IS OF LIMITED VALUE DURING CHRONIC ANTICOAGULATION WITH ACENOCOUMAROL
	-	EVALUATION OF THE EFFECTS OF A SINGLE INFUSION OF FACTOR VIII ON WHOLE BLOOD COAGULATION THROMBOELASTOGRAPHY IN PATIENTS WITH SEVERE HAEMOPHILIA
Lambert T.	-	PRIMARY KNEE ARTHOPLASTY USING RECOMBINANT FACTOR VIIA (RFVIIA) AS FIRST-LINE THERAPY IN HAEMOPHILIA PATIENTS WITH HIGH RESPONDING INHIBITORS
Lambert C.	-	EVALUATION OF THROMBOPHILIA SCREENING IN WOMEN WITH OBSTETRICAL COMPLICATIONS: A "REAL WORLD" EXPERIENCE
Lambert C.M.	-	REPLACEMENT THERAPY WITH FIBRINOGEN CONCENTRATE: INDICATIONS AND ADEQUACY OF USE
Lambert J.	-	MANAGING PERI-DELIVERY ANTICOAGULATION IN WOMEN ON THERAPEUTIC DOSE LOW-MOLECULAR WEIGHT HEPARIN: A ROLE FOR UNFRACTIONATED HEPARIN
Lambert C.	-	ACUTE CORONARY STENT THROMBOSIS IN A PATIENT WITH SEVERE HAEMOPHILIA ON DUAL ANTIPLATELET THERAPY
Lambert M.P.	-	ENDOGENOUS PLATELET FACTOR 4 INCREASES ACTIVATED PROTEIN C GENERATION AND IMPROVES SURVIVAL AFTER LIPOPOLYSACCHARIDE CHALLENGE
Lambert T.	-	REFORMULATED RECOMBINANT FACTOR IX: EFFICACY AND SAFETY IN PREVIOUSLY TREATED PATIENTS WITH MODERATELY SEVERE TO SEVERE HEMOPHILIA B
Lambert M.P.	-	PLATELET FACTOR 4 EXERTS A NEGATIVE PARACRINE EFFECT ON MEGAKARYOPOIESIS THROUGH LIPOPROTEIN RELATED PROTEIN RECEPTOR-1 ON MEGAKARYOCYTIC PRECURSORS
Lami D.	-	ASSESSMENT OF CLOT LYSIS TIME TISSUE FACTOR-INDUCED BY EXOGENOUS T-PA IN HEALTHY SUBJECTS BY USING A MICROPLATE READER
Lämmle B.	-	DOSING LEPIRUDIN IN PATIENTS WITH HEPARIN-INDUCED THROMBOCYTOPENIA AND VARIOUS DEGREES OF RENAL FUNCTION IMPAIRMENT
	-	IGG SUBCLASS DISTRIBUTION OF ANTIBODIES AGAINST ADAMTS13 IN PATIENTS WITH THROMBOTIC THROMBOCYTOPENIC PURPURA
	-	VON WILLEBRAND FACTOR RELATED PARAMETERS IN SEVERE SEPSIS AND SEPTIC SHOCK
	-	A ROLE OF THE ADAMTS13 GENE IN ACUTE ACQUIRED THROMBOTIC THROMBOCYTOPENIC PURPURA (TTP)
Lamoril J.	-	FACTOR V LEIDEN (G1691A) AND PROTHROMBIN (G20210A) GENOTYPING BY HIGH-RESOLUTION MELT ANALYSIS (HRM) AND SYTO 9 FLUORESCENT DYE ON THE ROTOR-GENE 6000 HRM
Lamprecht S.	-	THE HUMANIZED ANTI-GPIB MONOCLONAL ANTIBODY 6B4-FAB ABOLISHES THROMBUS FORMATION IN A MODIFIED FOLTS' MODEL IN BABOONS
	-	A NOVEL COMPLETE HIGH SHEAR RATE ARTERIAL THROMBOSIS AND BLEEDING MODEL IN BABOONS
	-	CORONARY ARTERY IN-STENT STENOSIS PERSISTS DESPITE INHIBITION OF THE VON WILLEBRAND FACTOR-COLLAGEN INTERACTION IN BABOONS
Lamy E.	-	PRETERM BIRTH AND FETAL GROWTH RESTRICTION HAVE AN IMPACT ON ELASTIC AND COLLAGENIC STRUCTURES OF HUMAN UMBILICAL ARTERIES
Lanari A.	-	A MULTICENTER STUDY ON EARLY HEMORRHAGIC TRANSFORMATION IN ISCHEMIC STROKE: PRELIMINARY RESULTS
Landau M.	-	IS BETA3-ARG261 RESPONSIBLE FOR THE EXCLUSIVE BINDING OF ALPHAIIB TO BETA3?
	-	SPECIFIC CYSTEINE RESIDUES IN BETA3 ARE ESSENTIAL FOR DISULFIDE BOND EXCHANGE- DEPENDENT OR -INDEPENDENT PATHWAYS OF ALPHAIIBBETA3 ACTIVATION
	-	THREE RESIDUES (L284, I290, Y329) IN THE APPLE 4 DOMAIN OF FACTOR XI (FXI) ARE ESSENTIAL FOR COVALENT DIMERIZATION OF FXI SUBUNITS
Landgraf H.	-	LOW MOLECULAR WEIGHT HEPARIN IN PREGNANCY - INFLUENCE ON BIRTH WEIGHT AND DURATION OF PREGNANCY IN WOMEN WITH THROMBOPHILIA
	-	INFLUENCE OF THROMBOPHILIA ON VASCULAR ACCESS SURVIVAL IN CHRONIC HEMODIALYSIS PATIENTS
Landini G.	-	APPLICABILITY OF D-DIMER IN RULING OUT VENOUS THROMBOEMBOLISM (VTE) IN ELDERLY MEDICAL PATIENTS: COMPARISON BETWEEN IMMUNOTURBIDIMETRIC AND ELISA (ELFA) METHODS
	-	HIGH SENSITIVITY C-REACTIVE PROTEIN (HS-CRP) AND THE RISK OF FIRST EVER ISCHEMIC STROKE IN HEALTHY PEOPLE
Landolfi R.	-	SURGICAL BLEEDING AFTER PREOPERATIVE UNFRACTIONATED HEPARIN AND LOW MOLECULAR WEIGHT HEPARIN AT CORONARY BYPASS SURGERY
Landoni V.I.	-	EFFECT OF ANTIINFLAMMATORY DRUGS ON HUMAN NEUTROPHILS IN ENDOTHELIAL CELL DAMAGE INDUCED BY SHIGA TOXIN-1
	-	DIFFERENTIATION OF CD34+ CELLS MEDIATED BY THROMBOPOIETIN AND MONOCYTES/MACROPHAGES
Landry S.	-	THE IMPORTANCE OF THE PROPEPTIDE FOR CARBOXYLATION OF THE VITAMIN K DEPENDENT CLOTTING FACTORS: STUDIES WITH FACTOR IX
Landskroner K.A.	-	EVALUATION OF PEG-FVIII MOLECULES WITH PROLONGED HALF-LIVES IN A MURINE FVIII-DEPENDENT BLEEDING MODEL
Landskroner K.	-	SITE-SPECIFIC PEGYLATION OF RFVIII RESULTS IN PROLONGED IN VIVO EFFICACY
Landskroner K.A.	-	COMPARISON OF HUMAN RFVIII AND MURINE RFVIII IN A STANDARDIZED FVIII DEPENDENT BLEED MODEL IN FVIII -/- MICE
Lane G.	-	UFH PHARMACOLOGY IN CHILDREN
Lane D.A.	-	EVIDENCE FOR TWO FUNCTIONAL CALCIUM-BINDING SITES ON ADAMTS13
	-	SIX ADULT ONSET TTP PATIENTS WITH SEVERAL ADAMTS13 POLYMORPHISMS AND A MISSENSE MUTATION (R1060W) THAT EXHIBITS DEFECTIVE SECRETION IN VITRO
	-	EVIDENCE FOR A HIGH AFFINITY ADAMTS13 BINDING SITE DISTAL TO THE VWF A DOMAINS
	-	VWF A2 DOMAIN SEQUENCE 1533-1553: ITS ROLE IN CONTROLLING ADAMTS13 ACCESS TO THE Y1605-M1606 SCISSILE BOND
	-	NON-CONSERVED/VARIABLE REGIONS IN THE ADAMTS13 METALLOPROTEINASE DOMAIN ARE DETERMINANTS OF SUBSTRATE SPECIFICITY
Lane G.	-	UNFRACTIONATED HEPARIN (UFH) PHARMACOKINETICS IN CHILDREN
Lane D.A.	-	LOW ADAMTS13 LEVELS INCREASE THE RISK OF MYOCARDIAL INFARCTION (MI) INDEPENDENTLY OF VON WILLEBRAND FACTOR: GLASGOW MI STUDY
Lane C.	-	THE CENTRAL ROLE OF THROMBIN IN HAEMOSTASIS
Lane D.A.	-	THE CENTRAL ROLE OF THROMBIN IN HAEMOSTASIS
	-	FURTHER CHARACTERISATION OF ADAMTS13 INACTIVATION BY THROMBIN
Lang T.	-	AN EVALUATION OF SINGLE PORTION REAGENT VIALS FOR ROTEM ANALYSIS
Lang U.	-	THROMBIN GENERATION IN NORMAL UNCOMPLICATED PREGNANCY
Lang S.	-	HEAT SHOCK PROTEIN 70 (HSP 70) LEVELS AS PROGNOSTIC MARKER OF SEPTIC PATIENTS
Lang T.H.	-	EFFECTS OF FIBRINOGEN LEVELS AND CLOT STRENGTH IN THE PRESENCE OF THROMBOCYTOPENIA
Langdown J.V.	-	BIOCHEMICAL CHARACTERISATION OF ANTITHROMBIN BUDAPEST 3 (L99F)
Langdown J.	-	POSSIBLE PLACEMENT OF THE ELUSIVE TAIL OF HEPARIN COFACTOR II REVEALED BY A CRYSTAL STRUCTURE AT LOW IONIC STRENGTH
Lange J.	-	EARLY F. XIII APPLICATION MAINTAINS CLOT FIRMNESS AND REDUCES BLOOD LOSS IN PATIENTS AT HIGH RISK FOR INCREASED INTRAOPERATIVE BLEEDING - EVIDENCE FROM A DOUBLE BLIND, PLACEBO CONTROLLED TRIAL
Lange U.	-	COMBINING RIVAROXABAN WITH ACETYLSALICYLIC ACID INCREASES ANTITHROMBOTIC POTENCY WITHOUT AFFECTING BLEEDING TIMES IN ANIMAL MODELS
	-	RIVAROXABAN A NOVEL, ORAL, DIRECT FACTOR XA INHIBITOR ENHANCED THE ANTITHROMBOTIC EFFECTS OF CLOPIDOGREL IN RATS
	-	RIVAROXABAN AN ORAL, DIRECT FACTOR XA INHIBITOR INHIBITS TISSUE FACTOR-MEDIATED PLATELET AGGREGATION
Lange A.M.	-	SUCCESSFUL LONG TERM EXPRESSION OF FVIII AFTER GENE DELIVERY OF NOVEL ADENO-ASSOCIATED VIRAL VECTOR SEROTYPES IN HEMOPHILIA A DOGS
Lange U.	-	AN IN VIVO RISK/BENEFIT COMPARISON OF THE EFFECTS OF RIVAROXABAN AN ORAL, DIRECT FACTOR XA INHIBITOR WITH THROMBIN INHIBITORS, WARFARIN AND CLOPIDOGREL
Langer M.	-	SUCCESSFUL PREGNANCY OUTCOME IN A WOMAN WITH HOMOZYGOUS ANTITHROMBIN DEFICIENCY (99 LEUPHE MUTATION)
Langer F.	-	BLOOD-BORNE BUT NOT ENDOTHELIAL CD40 PROMOTES EXPERIMENTAL LUNG METASTASIS
Langer C.	-	ROLE OF ELEVATED ALPHA2-MACROGLOBULIN REVISITED: RESULTS OF A CASE-CONTROL STUDY IN CHILDREN WITH SYMPTOMATIC THROMBOEMBOLISM
Langer F.	-	THERAPEUTIC ANTIBODIES AGAINST CD40 LIGAND, TNF-ALPHA AND VEGF SHARE MECHANISTIC FEATURES IN COMMON WITH PLATELET ACTIVATING ANTIBODIES IN HEPARIN-INDUCED THROMBOCYTOPENIA (HIT)
Langer C.	-	INFLUENCE OF HERITABILITY AND HOUSEHOLD COMPONENTS ON LIPID CONCENTRATIONS AND CLOTTING FACTOR LEVELS IN 282 PEDIATRIC STROKE FAMILIES
Langer F.	-	HYPERCOAGULABILITY IN OVARIAN CANCER REVISITED: A PROSPECTIVE ANALYSIS OF COAGULATION AND PLATELET ACTIVATION MARKERS
Langford C.F.	-	DIFFERENCES IN PLATELET RESPONSE TO ADP AND CRP ARE CORRELATED WITH VARIATION IN THE RESTING PLATELET TRANSCRIPTOME
	-	MONOCYTE RESPONSE TO ACTIVATED PLATELETS: A TRANSCRIPTIONAL STUDY
Langley K.	-	LABORATORY DIAGNOSIS OF HEPARIN INDUCED THROMBOCYTOPENIA: HELP OR HINDRANCE?
	-	CLINICAL DIAGNOSIS OF HEPARIN-INDUCED THROMBOCYTOPENIA
Langlois N.	-	VERY LOW FREQUENCY OF HEPARIN INDUCED THROMBOCYTOPENIA (HIT) IN A TERTIARY CARE HOSPITAL
	-	A PILOT STUDY TO ASSESS THE FEASIBILITY OF A MULTICENTER TRIAL FOR THE MANAGEMENT OF ASYMPTOMATIC PERSONS WITH A THROMBOPHILIA
	-	PSYCHOLOGICAL IMPACTS OF GENETIC TESTING FOR THROMBOPHILIA ON FIRST DEGREE RELATIVES OF PATIENTS WITH VENOUS THROMBOEMBOLISM AND A THROMBOPHILIA A PILOT STUDY
Langrova E.	-	LOW MOLECULAR WEIGHT HEPARINS ARE EFFECTIVE AND SAFE IN THROMBOPROPHYLAXIS IN NEWLY DIAGNOSED MYELOMA PATIENTS DURING THE INDUCTION THERAPY
Långström S.	-	FRESH FROZEN PLASMA DOES NOT ATTENUATE COAGULATION ACTIVATION AFTER NEONATAL CARDIOPULMONARY BYPASS
Lanir N.	-	EFFECT OF FIBRIN MATRICES ON INCREASED PROLIFERATION AND SPREADING OF EARLY TERM TROPHOBLASTS AND PLACENTAL VILLI. MODULATION OF COAGULATION AND ANGIOGENESIS FUNCTIONS
Lannoy N.	-	PROPOSITION FOR A MULTI-STEP MUTATION DETECTION IN HAEMOPHILIA A
Lanquetot H.	-	INCIDENCE OF ANTITHROMBIN LEVEL ON "HEMOFILTER CIRCUIT" THROMBOSIS DURING EARLY CONTINUOUS VENOVENOUS HEMOFILTRATION IN POST CARDIOPULMONARY BYPASS PATIENTS
Lanza F.	-	ABNORMAL MEGAKARYOCYTE MATURATION WITH IMPAIRED PROPLATELET FORMATION IN A MOUSE MODEL OF BERNARD-SOULIER SYNDROME
	-	VASCULAR WALL ALTERATIONS AND MATRIX EXPOSURE FOLLOWING LASER-INDUCED INJURY OF MOUSE MESENTERIC ARTERIOLES
	-	MEGAKARYOCYTE-RESTRICTED MYH9 INACTIVATION DRAMATICALLY AFFECTS HAEMOSTASIS WHILE PRESERVING PLATELET AGGREGATION AND SECRETION RESPONSES
	-	A NEW LEU123 TO PRO MUTATION IN THE FIFTH LEUCINE-RICH REPEAT OF GLYCOPROTEIN IBALPHA IN A BERNARD-SOULIER PATIENT INDUCES DEFECTIVE SHEAR-DEPENDENT CELL ADHESION ON VON WILLEBRAND FACTOR
	-	A MONOCLONAL ANTIBODY AGAINST PLATELET GPIBBETA INHIBITS GPIB-V-IX-DEPENDENT SIGNALLING, PROCOAGULANT ACTIVITY AND THROMBUS FORMATION UNDER FLOW PERFUSION
	-	MEGAKARYOCYTE-RESTRICTED MHY9 INACTIVATION LEADS TO MEGAKARYOCYTE AND PLATELET ULTRASTRUCTURAL ABNORMALITIES
	-	THE GPIB-V-IX COMPLEX FACILITATES PLATELET PROCOAGULANT ACTIVITY INDEPENDENTLY OF THE GPIB ALPHA NH2 TERMINAL DOMAIN
Lap P.	-	THE DUAL ROLE OF INTRINSIC GENERATED PLASMIN IN THE REGULATION OF THE HEMOSTATIC BALANCE
	-	THE NIJMEGEN HAEMOSTASIS ASSAY (NHA) IN THE VITRO-STUDY: RELATION WITH HOMOCYSTEINE, B-VITAMIN TREATMENT AND RECURRENCE RISK
Lap P.A.J.	-	THE ROLE OF THE LOW-DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN (LRP) AND MEGALIN RECEPTOR IN THE CLEARANCE OF FACTOR VIII IN HUMANS
Lapecorella M.	-	SUCCESSFUL MANAGEMENT OF BLEEDING WITH A PASTEURIZED FVIII/VWF CONCENTRATE IN A WOMAN AFFECTED BY TYPE 2A VON WILLEBRAND DISEASE UNDERGOING UTERINE CERVIX CONIZATION
	-	VITAMIN K-INDUCED VARIATION OF COAGULATION PHENOTYPE IN VKORC1 HOMOZYGOUS DEFICIENCY
Lapetina D.L.	-	AMBLYOMIN-X IN CULTURED CANCER CELLS: CITOTOXICITY AND CELL CYCLE EFFECTS
Lapini I.	-	GENE EXPRESSION PROFILE INDUCED BY PHYSICAL EXERCISE IN RATS
	-	ABDOMINAL AORTIC ANEURYSM AND CAROTID ARTERY DISEASE: GENE EXPRESSION PROFILING OF TWO ATHEROSCLEROTIC DISEASES
	-	ROLE OF INFLAMMATION IN MODULATING GRAFT TOLERANCE INDUCED BY MESENCHIMAL STEM CELLS
	-	HOMOCYSTINURIA AND CARDIOVASCULAR MANIFESTATIONS: 5 ITALIAN CASES
	-	HIGH-THROUGHPUT MULTIPLEX SINGLE-NUCLEOTIDE POLYMORPHISM (SNP) ANALYSIS IN GENES INVOLVED IN METHIONINE METABOLISM
Laporte S.	-	RETRIEVABLE VENA CAVA FILTERS FOR SECONDARY PREVENTION OF PULMONARY EMBOLISM IN ORTHOPAEDIC SURGERY
	-	RENAL IMPAIRMENT ESTIMATES TO PREDICT THE HAEMORRHAGE RISK IN 2170 PATIENTS TREATED BY HEPARIN. COCKCROFT-GAULT OR SIMPLIFIED MDRD?
	-	DOES TRANEXAMIC ACID DECREASE ERYTHROCYTE TRANSFUSION IN PATIENTS UNDERGOING HIP FRACTURE SURGERY WITH FONDAPARINUX FOR PREVENTION OF VENOUS THROMBOEMBOLISM ?
	-	EVOLUTION OF D-DIMERS LEVELS DURING HEPARIN THERAPY OF PATIENTS WITH CEREBRAL VENOUS THROMBOSIS
	-	THROMBOPROPHYLAXIS IN ACUTELLY ILL MEDICAL PATIENTS: WHO, WHEN AND HOW
	-	LOW MOLECULAR WEIGHT HEPARIN (LMWH) AND CANCER SURVIVAL. A META-ANALYSIS OF RANDOMIZED CLINICAL TRIALS IN PATIENTS WITH AND WITHOUT VTE
Lara R.	-	EXPRESSION PATTERN OF PROTEIN S AND GAS6 IN THE RETINA
Largiadèr C.R.	-	A ROLE OF THE ADAMTS13 GENE IN ACUTE ACQUIRED THROMBOTIC THROMBOCYTOPENIC PURPURA (TTP)
Larin S.S.	-	INHIBITION OF PLASMINOGEN/PLASMINOGEN ACTIVATOR SYSTEM BY ANGIOSTATIN-LIKE PLASMINOGEN FRAGMENTS IS INVOLVED IN MECHANISM OF ANTIANGIOGENESIS
Larina L.E.	-	MASSIVE BLEEDINGS IN GIRLS DURING AND AFTER TERATOMAS EXCISION
Larionov A.A.	-	HYPERHOMOCYSTEINEMIA AND FACTOR V LEIDEN ACT SYNERGISTICALLY INCREASING RISK OF VEIN THROMBOSIS IN NORTH-WESTERN RUSSIA
Larkin D.	-	SUB-CELLULAR LOCALIZATION REGULATES THE INTERACTION BETWEEN THE PLATELET INTEGRIN IIB3 AND ICLN
Larocca L.M.	-	MARKED EMPERIPOLESIS AND INCREASED P-SELECTIN EXPRESSION ON MEGAKARYOCYTES IN A NOVEL CASE OF GRAY PLATELET SYNDROME
Laroche J.	-	SYMPTOMATIC THROMBOSIS COMPLICATIONS IN VENOUS MALFORMATION
	-	CLINICAL RISK FACTORS AND 3 MONTHS OUTCOMES OF SYMPTOMATIC CALF VEIN THROMBOSIS: FINDINGS FROM THE OPTIMEV COHORT
Larramendy-Gozalo C.	-	VKORC1 GENETIC POLYMORPHISM IS ASSOCIATED TO VENOUS THROMBOEMBOLISM: RESULTS FROM THE EDITH STUDY
Larrucea S.	-	CORRELATION BETWEEN SCD40L LEVELS AND METALLOPROTEINASE EXPRESSION WITH THE PLATELET FUNCTIONAL RESPONSE IN IMMUNOLOGICAL DISEASES
Larsen L.F.	-	A WHOLE BLOOD CLOTTING METHOD MEASURING EX VIVO EFFECTS OF RFVIIA AND FVIII IN HAEMOPHILIA BLOOD
Larsen K.S.	-	COAGULATION FACTOR VIIA VARIANTS WITH REDUCED SUSCEPTIBILITY TO INHIBITION BY ANTITHROMBIN III
Larsen M.R.	-	STRATEGIES FOR CHARACTERIZING THE PHOSPHO- AND GLYCOPROTEOMES OF MICROPARTICLES DERIVED FROM INTERLEUKIN-1BETA STIMULATED PANCREATIC BETA-CELLS
Larsen O.	-	EVALUATION OF COAGULATION KINETICS USING THROMBELASTOGRAPHY
Larsson R.	-	A NOVEL HIGHLY PROMISING POINT-OF-CARE METHOD FOR HIV MONITORING
Larsson P.M.	-	IL-1BETA-INDUCED TISSUE-TYPE PLASMINOGEN ACTIVATOR SUPPRESSION IN VASCULAR ENDOTHELIAL CELLS IS MEDIATED BY NF-KAPPAB SIGNALING
Laskowitz D.T.	-	ANTIDOTE REVERSAL OF A NOVEL ANTICOAGULANT DECREASES MORTALITY AND IMPROVES NEUROLOGICAL FUNCTION IN A MURINE MODEL OF SUBARACHNOID HEMORRHAGE
Lasmar M.C.	-	TISSUE FACTOR AND TOTAL TISSUE FACTOR PATHWAY INHIBITOR LEVELS IN CORONARY ARTERY DISEASE: CORRELATION WITH THE SEVERITY OF ATHEROMATOSIS
Lasne D.	-	ORGARAN CROSS REACTIVITY WITH HEPARIN INDUCED THROMBOCYTOPENIA ANTIBODIES: REPORT OF 12 CASES
	-	EFFECT OF HIGH-DOSE APROTININ ON PLATELET FUNCTION AFTER NORMOTHERMIC CARDIOPULMONARY BYPASS IN CHILDREN CARDIAC SURGERY
Lassen M.R.	-	A PHASE II DOUBLE-BLIND PLACEBO-CONTROLLED PARALLEL-GROUP RANDOMIZED STUDY OF EXTENDED PROPHYLAXIS WITH ODIPARCIL FOLLOWING TOTAL HIP ARTHROPLASTY (THA)
Lassen M.	-	DEVELOPMENT OF A NOVEL ONE STEP LATERAL FLOW DEVISE FOR QUALITATIVE DETECTION OF PROTHROMBIN FRAGMENT F1+2 IN URINE
Lassen M.R.	-	PREVENTION OF VENOUS THROMBOEMBOLISM VIA PARTIAL FACTOR IXA INHIBITION
	-	LATE BREAKING CLINICAL TRIAL: RIVAROXABAN AN ORAL, DIRECT FACTOR XA INHIBITOR FOR THE PREVENTION OF VENOUS THROMBOEMBOLISM IN TOTAL KNEE REPLACEMENT SURGERY: RESULTS OF THE RECORD 3 STUDY - LATE BREAKING
	-	LACK OF EFFECT ON MARKERS OF THROMBIN GENERATION AND FIBRINOLYSIS BY PARTIAL FACTOR IXA INHIBITION FOLLOWING HIP FRACTURE SURGERY
Lassila R.	-	SIGNIFICANT DISTINCTION BETWEEN PLASMA- AND PLATELET-DEPENDENT COAGULATION ACTIVITY IN HEMOPHILIA A PATIENTS
	-	PLATELET INTEGRIN ALPHA2BETA1 INTERACTION WITH TYPE I COLLAGEN IS INHIBITED BY A NOVEL SYNTHETIC MOLECULE BTT-3016
	-	PERSISTENT PLATELET MICROPARTICLE FORMATION IN THE PRESENCE OF BLOCKERS OF GP IBALPHA, GPIIB/IIIA, CALCIUM CHELATORS AND ADP SCAVENGERS UNDER HIGH SHEAR STRESS
László Á.	-	HIGH NOREPINEPHRINE LEVEL IS ASSOCIATED WITH SIGNIFICANT PLATELET HYPERREACTIVITY DEMONSTRATED BY INCREASED PLATELET P-SELECTIN POSITIVITY, ADENOSIN DIPHOSPHATE AND COLLAGEN INDUCED AGGREGATIONS IN STABLE CORONARY HEART DISEASE PATIENTS ON DUAL ANTIPLATEL
Latella M.	-	INTERLEUKIN-1B GENE HAPLOTYPES AND INFLAMMATORY/PROCOAGULANT RESPONSE OF HUMAN MONONUCLEAR CELLS
Latella R.	-	SUBMASSIVE PULMONARY EMBOLISM: ROLE OF THROMBOLITIC THERAPY
Latella M.	-	EFFICACY AND SAFETY OF HIGHLY PURIFIED VWF/FVIII CONCENTRATES IN THE TREATMENT OF INHERITED VON WILLEBRAND DISEASE: RESULTS FROM THE RETROSPECTIVE ITALIAN STUDY ON 103 CASES
	-	TISSUE FACTOR GENE TAG-SNPS AND HAPLOTYPES AND THE RISK OF MYOCARDIAL INFARCTION
Latella C.	-	IMMUNE TOLERANCE INDUCTION (ITI) IN PATIENTS WITH HEMOPHILIA A AND INHIBITORS: THE ITALIAN RETROSPECTIVE-PROSPECTIVE REGISTRY - THE PROFIT STUDY
Lathia A.	-	EPIDEMIOLOGY OF THROMBOEMBOLISM (TE) IN CHILDREN WITH CANCER
Lattanzio S.	-	OXIDATIVE STRESS AND PLATELET ACTIVATION IN SUBJECTS WITH MODERATE HYPERHOMOCYSTEINEMIA DUE TO MTHFR 677 C-T POLYMORPHISM
	-	DETERMINANTS OF PLATELET ACTIVATION IN HEART FAILURE
Lau K.	-	NEONATAL RENAL VEIN THROMBOSIS - 15 YEARS OF LITERATURE
Lau L.M.	-	IMPAIRED 'OUTSIDE-IN' INTEGRIN ALPHAIIBBETA3 SIGNALING AND THROMBUS STABILITY IN CD151 AND TSSC6-DEFICIENT MICE
Lau W.	-	THE EFFICACY AND SAFETY OF ANTITHROMBIN CONCENTRATE IN CHILDREN RECEIVING HEPARIN INFUSIONS
Laughlin S.	-	HEMORRHAGIC TRANSFORMATION OF ARTERIAL ISCHEMIC STROKE IN CHILDREN
Laumonnier Y.	-	THROMBIN INDUCES ACTIVATION OF MATURED DENDRITIC CELLS VIA RHO/ERK PATHWAYS
	-	PLASMIN INDUCES PROINFLAMMATORY STIMULATION OF HUMAN MACROPHAGES VIA THE ANNEXIN A2 HETEROTETRAMER
	-	THROMBIN STIMULATION AMPLIFIES MONOCYTIC/ENDOTHELIAL CELL CROSS-TALK AND SUBSEQUENT MCP-1 RELEASE THROUGH FRACTALKINE BINDING
Launay J.	-	ABNORMALITIES IN THE SEROTONIN METABOLISM: A PATHOGENIC HYPOTHESIS FOR CENTRAL RETINAL VEIN OCCLUSION (CRVO)
Laurendeau I.	-	EX VIVO PRIMING OF EPC WITH SDF-1 BEFORE TRANSPLANTATION COULD INCREASE THEIR PROANGIOGENIC POTENTIAL
Laurent N.	-	OPTIMIZATION OF COAGULATION FACTOR ASSAYS FOR IMPROVED ACCURACY OVER AN EXTENDED LINEAR RANGE
Laurent S.	-	LACK OF ENDOTHELIAL DYSFUNCTION IN THROMBOANGIITIS OBLITERANS
Laurenti L.	-	PLASMA EXCHANGE AND ASPIRIN PLUS HIGH VERSUS STANDARD DOSE STEROIDS IN IDIOPATHIC THROMBOCYTOPENIC PURPURA (TTP): A PROSPECTIVE, RANDOMIZED STUDY BY THE ITALIAN GROUP FOR PTT
Lauretani F.	-	HOMOCYSTEINE AS INDICATOR OF OSTEOPOROSIS. THE INCHIANTI STUDY
	-	ASSOCIATION BETWEEN METHYLENETETRAHYDROFOLATE REDUCTASE AND INFLAMMATORY MARKERS IN THE INCHIANTI STUDY
Laurian Y.D.	-	PRIMARY KNEE ARTHOPLASTY USING RECOMBINANT FACTOR VIIA (RFVIIA) AS FIRST-LINE THERAPY IN HAEMOPHILIA PATIENTS WITH HIGH RESPONDING INHIBITORS
Laurini R.	-	FACTOR V LEIDEN AND PLACENTAL PATHOLOGY
Lauritzen B.	-	EFFECT OF RFVIIA ON BLEEDING IN HES HEMODILUTED RABBITS
Lautrup-Larsen I.	-	FXIII VARIANTS WITH ALTERED THROMBIN ACTIVATION RATES
Lauw M.N.	-	JAK2-V617F IS A RISK FACTOR FOR VENOUS THROMBOEMBOLISM
Lauzon M.	-	COMPARISON OF THE ASSERACHROM VON WILLEBRAND FACTOR ANTIGEN ASSAY AND THE LIATEST VWF ASSAY AUTOMATED ON THE AMAX 200 COAGULATION ANALYZER IN HUMAN AND CANINE PLASMA SAMPLES
	-	COMPARISON OF TWO ASSAYS FOR THE MEASUREMENT OF URINARY 11-DEHYDRO THROMBOXANE B2
Lavagni M.G.	-	FALSE UNCOAGULABLE PT-INR RESULTS
Lavallée P.	-	A ROLE FOR PLATELET ACTIVATION IN LACUNAR STROKE?
Lavend'homme R.	-	ACTIVATION OF HUMAN LUNG ENDOTHELIAL CELLS INDUCES THE RELEASE OF A FVIII STORAGE POOL
Lavergne J.	-	IDENTIFICATION OF FACTOR VIII GENE MUTATIONS IN 120 HAEMOPHILIA A PATIENTS: DETECTION OF 26 NOVEL MUTATIONS AND CORRELATION WITH FVIII INHIBITOR DEVELOPMENT
Lavergne J.M.	-	THE RISK OF INHIBITOR DEVELOPMENT IN 1104 PATIENTS WITH HEMOPHILIA A ACCORDING TO FACTOR VIII GENOTYPE
Lavielle G.	-	ANTITHROMBOTIC ACTIVITY OF THE TP-RECEPTOR ANTAGONIST TERUTROBAN ON FOLTS-LIKE AND FECL3 INDUCED RAT MODELS OF THROMBOSIS
Laville M.	-	THE EFFECTS OF DOCOSAHEXAENOIC ACID IN PLATELETS (AN EX VIVO STUDY) AND IN MEGAKARYOCYTIC CELLS (AN IN VITRO STUDY)
Lavin J.	-	PREGNANCY ASSOCIATED ALTERATIONS OF THE INFLAMMATORY MEDIATORS, TISSUE FACTOR PATHWAY INHIBITOR AND PROTEIN Z
Lavitrano M.L.	-	ABDOMINAL AORTIC ANEURYSM AND CAROTID ARTERY DISEASE: GENE EXPRESSION PROFILING OF TWO ATHEROSCLEROTIC DISEASES
Lavoretano S.	-	DETERMINATION OF ANTI-ADAMTS13 AUTOANTIBODIES IN THROMBOTIC TROMBOCITOPENIC PURPURA (TTP) PATIENTS: COMPARISON OF TWO DIFFERENT METHODS
	-	PLATELET ADAMTS13 AND IN VITRO EXPRESSION STUDY OF A PATIENT AFFECTED BY CONGENITAL TTP
Lavrova E.	-	RELATIONSHIP BETWEEN CIRCULATING THROMBOMODULIN LEVELS AND LATENT PROGRESSION OF ATHEROSCLEROSIS IN TYPE 2 DIABETIC PATIENTS
	-	RELATIONSHIP BETWEEN ENDOTHELIAL HAEMOSTATIC MARKERS IN TYPE 2 DIABETIC PATIENTS
Lawal L.	-	SYNERGISTIC EFFECT OF SMOKING ON PLATELET RESPONSIVENESS TO CLOPIDOGREL
Lawall H.	-	INCIDENCE OF DEEP VEIN THROMBOSIS (DVT) IN NON-SURGICAL PATIENTS AT HOSPITAL ADMISSION
Lawler J.	-	THROMBOSPONDIN1 GENE DEFICIENCY MODULATES VASCULAR MEDIAL SMOOTH MUSCLE CELL ACTIVATION AND NEOINTIMA FORMATION
	-	THROMBOSPONDIN1 GENE DEFICIENCY ATTENUATES ATHEROSCLEROTIC PLAQUE BURDEN BUT ACCENTUATES INFLAMMATORY CELL PLAQUE CONTENT IN APOE-DEFICIENT MICE
Lawler E.	-	SF-12 PHYSICAL COMPONENT SCORE IS AN INDEPENDENT PREDICTOR OF MAJOR HEMORRHAGE IN A COHORT OF ELDERLY PATIENTS ANTICOAGULATED FOR ATRIAL FIBRILLATION
Lawrence R.G.	-	MULTIMODALITY INTRAOPERATIVE IMAGING OF THROMBI IN THICK-WALLED BLOOD VESSELS OF LARGE ANIMALS USING NEAR INFRARED FLUORESCENCE
Lawrence D.A.	-	REGULATION OF PLASMINOGEN ACTIVATOR ACTIVITY IN THE CENTRAL NERVOUS SYSTEM
Lawrie D.	-	MONOCYTE PLATELET COMPLEXES: A POTENTIAL FLOW CYTOMETRIC ASSAY FOR SCREENING PRE-THROMBOTIC EVENTS IN HIV POSITIVE PATIENTS
Lawrie A.S.	-	QUALITY MONITORING OF FRESH-FROZEN PLASMA (FFP) AND THE EFFECT OF WHOLE BLOOD STORAGE AT 4C OVERNIGHT
Lawrie A.	-	FXI/ADAMTS13 COMPLEX IN PLASMA
Lawrie A.S.	-	A COMPARATIVE EVALUATION OF THE CS-2000I COAGULATION ANALYSER USING CLOTTING, AMIDOLYTIC AND IMMUNO-TURBIDOMETRIC ASSAYS
Lawrie A.	-	DECREASED ADAMTS13 AND ANTI-ADAMTS13 IN THE ANTIPHOSPHOLIPID SYNDROME (APS)
	-	ADAMTS 13 IN NON-THROMBOTIC THROMBOCYTOPENIC PURPURA CONDITIONS
Laws H.J.	-	COMBINED FACTOR V AND FACTOR VIII DEFICIENCY: MUTATION ANALYSIS AND ETHNICAL BACKGROUND OF FIVE PATIENTS
Laws H.	-	DIAGNOSIS AND THERAPY OF CHILDREN WITH INHERITED DEFECTS OF PLATELET FUNCTION IN GERMAN SPEAKING COUNTRIES: QUALITY PROJECT THROMKID
Lawson H.	-	HEPARIN-INDUCED PLATELET AGGREGATION DOES NOT PREDICT THE PRESENCE OF ANTI-HEPARIN ANTIBODIES
	-	A NEW ADAMTS13 ACTIVITY ASSAY USED WITH ANTIGEN ASSAY PROVIDES DIAGNOSTIC INFORMATION IN TTP, BLEEDING OR THROMBOSIS
Lay A.J.	-	THE PROTECTIVE ROLE OF PROTEIN C IN ENDOTOXIN-INDUCED SHOCK
Layzer J.	-	DEVELOPING ANTIDOTE CONTROLLED ANTIPLATELET THERAPIES BY TARGETING THE VWF - GP IB-IX-V INTERACTION
Lazaropoulou C.	-	LONGITUDINAL COURSE AND CLINICAL SIGNIFICANCE OF TGF-B1, SL- AND SE-SELECTINS AND SICAM-1 LEVELS DURING SEVERE ACUTE STRESS IN CHILDREN
Lazo-Langner A.	-	DEFINING BENEFIT-RISK TRADEOFF VALUES FOR VENOUS THROMBOEMBOLISM (VTE) PROPHYLAXIS AFTER ORTHOPEDIC SURGERY (OS)
	-	SECULAR TRENDS IN STUDIES EVALUATING VENOUS THROMBOEMBOLISM (VTE) PROPHYLAXIS AFTER ORTHOPEDIC SURGERY (OS)
	-	A COMPARISON OF ANTICOAGULANTS (AC) FOR VENOUS THROMBOEMBOLISM (VTE) PROPHYLAXIS (PROPH) AFTER ORTHOPEDIC SURGERY (OS) USING A CLINICAL COST-EFFECTIVENESS ANALYSIS (CEA) APPROACH
Lazzari M.	-	IS THERE ANY CORRELATION BETWEEN FIBRINOLYTIC ACTIVITY AND BLEEDING SCORE IN TYPE 1 AND POSSIBLE TYPE 1 VON WILLEBRAND DISEASE?
Lazzari M.A.	-	POISONING WITH SUPERWARFARIN
Lazzari M.	-	VWF-CLEAVING SERINE PROTEASES ISOLATION DIFFERENT FROM ADAMTS13
Lazzari M.A.	-	EFFECT OF NYTROXYL AND NITRIC OXIDE ON HUMAN PLATELET ARACHIDONATE METABOLISM
	-	D-DIMER VALUE AND ECHOCARDIOGRAPHIC CHANGES AS PREDICTORS OF THROMBOEMBOLIC COMPLICATIONS AFTER THE FONTAN OPERATION
	-	ANTITHROMBIN (AT): A CONFORMATIONAL VARIANT?
	-	TESTOSTERONE INDUCES PHOSPHORYLATION OF P38 AND JNK IN HUVEC
	-	ROLE OF PPAR-GAMMA ACTIVATION IN MEGAKARYOCYTOPOIESIS
	-	THROMBOPHILIA TESTING IN A DEVELOPING COUNTRY REFERRAL CENTER: A 3-YEAR OBSERVATIONAL STUDY
Lazzari M.	-	THREE NEW POLYMORPHISMS LOCATED IN THE INTRON 2 OF THE ADAMTS13 GENE
Lazzari M.A.	-	BIOLOGICAL AND CLINICAL RESPONSE TO DESMOPRESSIN IN CHILDREN WITH VON WILLEBRAND DISEASE
	-	HEMOSTATIC MARKERS AS PROGNOSTIC FACTORS IN ATRIAL FIBRILLATION. PRELIMINARY RESULTS OF A PROSPECTIVE STUDY
	-	LOW MOLECULAR THIOLS, PRO-COAGULANT STATE AND NATURAL ANTIOXIDANT SYSTEM IN HEMODIALYSIS PATIENTS
	-	FACTOR XIII DEFICIENCY: SYMPTOMS, DIAGNOSIS AND LONG-TERM REPLACEMENT THERAPY
	-	EVALUATION OF VON WILLEBRAND FACTOR IN A MURINE MODEL UNDER STEROID HORMONE TREATMENT
Lazzari M.	-	AN ASSOCIATION OF VICENZA AND NORMANDY VARIANTS VON WILLEBRAND DISEASE (VWD)
Lazzari M.A.	-	DIAGNOSIS AND FOLLOW UP OF FACTOR XIII DEFICIENCY: COMPARISON OF DIFFERENT CLOT-SOLUBILITY TESTS
	-	EFFECT OF NYTROXYL (HNO) AND NITRIC OXIDE (NO) ON PROTEIN KINASE ACTIVATION PATHWAY IN HUMAN PLATELET
	-	MANAGEMENT OF SERIOUS HEMATOMAS IN PATIENTS ON CHRONIC ORAL ANTICOAGULATION: BALANCE BETWEEN IMMEDIATE AND LONG-TERM RISKS
Lazzeri C.	-	HYPERVISCOSITY AS A POSSIBLE DETERMINANT OF INFARCT SIZE IN PATIENTS WITH ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION
Lazzerini G.	-	HIGH GLUCOSE INHIBITS NITRIC OXIDE PRODUCTION THROUGH AN HYPEROSMOLAR EFFECT, WITHOUT INDUCING ENDOTHELIAL CELL ADHESION SURFACE EXPRESSION IN HUMAN ENDOTHELIAL CELLS
Le Blanc K.	-	ACTIVATION OF BLOOD COAGULATION IN AB0-COMPATIBLE BLOOD BY MULTIPOTENT MESENCHYMAL STROMAL CELLS
Le Bonniec B.F.	-	PLATELET FACTOR 4 (PF4/CXCL4) SEALS BLOOD CLOTS BY ALTERING THE STRUCTURE OF FIBRIN
	-	THROMBIN ADSORBED TO A FIBRIN CLOT CONFERS ANGIOGENIC AND HEMOSTATIC PROPERTIES ON ENDOTHELIAL PROGENITOR CELLS
Le Bonniec B.	-	THE THROMBIN ENDOTHELIAL RECEPTORS, THROMBOMODULIN AND PAR-1, ACTIVATE EGF RECEPTOR THROUGH DISTINCT SIGNALLING
Le Cam-Duchez V.	-	PROTEIN Z LEVEL AND GENE POLYMORPHISMS IN MYOCARDIAL INFARCTION IN THE YOUNG
	-	RISK FACTOR FOR ORAL ANTICOAGULANT TREATMENT OVERDOSE: A CASE CONTROL STUDY IN AN EMERGENCY UNIT
le Courvoisier-Flaujac C.	-	EVALUATION OF A NEW FUNCTIONAL CLOTTING ASSAY FOR THE MONITORING OF HEPARIN AND HEPARINOID ANTICOAGULANTS BASED ON THROMBIN AND/OR FACTOR XA INHIBITION WITH CLINICAL PATIENT PLASMAS AT THREE UNIVERSITY MEDICAL CENTERS
Le Flem L.	-	THREE DIFFERENT PATTERNS OF CALIBRATED AUTOMATED THROMBOGRAM OBTAINED WITH HIRUDIN, MELAGATRAN, DABIGATRAN, ARGATROBAN, FONDAPARINUX AND DANAPAROD
Le Gal G.	-	BODY MASS INDEX, MILD HYPERHOMOCYSTEINEMIA AND VENOUS THROMBOEMBOLISM RISK
	-	PULMONARY EMBOLISM FAILURE RATE IN PATIENTS IN WHOM PULMONARY EMBOLISM WAS RULED OUT BY LOW AND INTERMEDIATE PROBABILITY BY THE REVISED GENEVA SCORE AND A NORMAL QUANTITATIVE D-DIMER TEST RESULT
	-	VKORC1 GENETIC POLYMORPHISM IS ASSOCIATED TO VENOUS THROMBOEMBOLISM: RESULTS FROM THE EDITH STUDY
	-	USEFULNESS OF MULTIDETECTOR COMPUTED TOMOGRAPHY IN PATIENTS WITH SYMPTOMS SUGGESTING PULMONARY EMBOLISM
	-	INFLUENCE OF AGE ON THE COST EFFECTIVENESS OF DIAGNOSTIC STRATEGIES FOR SUSPECTED PULMONARY EMBOLISM
	-	MULTI-DETECTOR SPIRAL COMPUTED TOMOGRAPHY ALONE VERSUS COMBINED WITH LOWER LIMB COMPRESSION ULTRASONOGRAPHY IN OUTPATIENTS SUSPECTED OF PULMONARY EMBOLISM: A RANDOMISED NON-INFERIORITY TRIAL
	-	COMPARISON OF THE REVISED GENEVA RULE WITH WELLS RULE FOR ASSESSING CLINICAL PROBABILITY OF PULMONARY EMBOLISM
Le Gall C.	-	A DECISION SUPPORT TOOL ON HANDELD COMPUTERS TO IMPROVE DIAGNOSTIC STRATEGIES OF PULMONARY EMBOLISM IN EMERGENCY DEPARTMENTS (SPEED STUDY)
Le Guillou J.	-	MISUSE OF THE D-DIMER TEST IN HOSPITALISED PATIENTS
Le Lez M.	-	ASSOCIATION BETWEEN THE HOMOZYGOUS STATUS FOR THE 807T ALLELE OF ITGA2 AND RETINAL ARTERY OCCLUSION
Le Querrec A.	-	A NOVEL P.ASP344VAL SUBSTITUTION IN THE FIBRINOGEN GAMMA-CHAIN CAUSES DYSFIBRINOGENEMIA ASSOCIATED WITH THROMBOSIS
	-	COMPONENTS OF VARIABILITY OF D DIMER MEASUREMENT CLOSE TO THE CUT-OFF VALUE
	-	IDENTIFICATION OF FACTOR VIII GENE MUTATIONS IN 120 HAEMOPHILIA A PATIENTS: DETECTION OF 26 NOVEL MUTATIONS AND CORRELATION WITH FVIII INHIBITOR DEVELOPMENT
Le Strat N.	-	OVER-ANTICOAGULATION ASSOCIATED WITH COMBINED USE OF COUMARIN ANTICOAGULANTS AND TOPICAL ECONAZOLE OR BIFONAZOLE IN ELDERLY PATIENTS
Le Vankim C.	-	INCREASED ADHESION TO ENDOTHELIAL CELLS OF ERYTHROCYTES FROM PATIENTS WITH POLYCYTHEMIA VERA IS MEDIATED BY LAMININ ALPHA5 CHAIN AND LU/BCAM
Leal S.	-	SPANISH CONSENSUS STATEMENT ON PHARMACOLOGIC ALTERNATIVES TO ALLOGENEIC BLOOD TRANSFUSIONS: THE SEVILLE'S DOCUMENT*
Leal G.N.	-	NEONATAL THROMBOSIS: A SERIES OF 18 CASES FROM A BRAZILIAN PEDIATRIC CENTER
Leane D.	-	S-NITROSYLATION OF THE PLATELET INTEGRIN ALPHA IIB BETA 3
Lecchi A.	-	GENETIC CHARACTERIZATION OF PATIENTS WITH BERNARD-SOULIER SYNDROME AND THEIR RELATIVES FROM SOUTHERN IRAN
Lechat P.	-	THE ABCB1 (MDR1) C3435T POLYMORPHISM DOES NOT INFLUENCE PHARMACODYNAMIC RESPONSE TO CLOPIDOGREL IN HEALTHY SUBJECTS
Lechler R.I.	-	THROMBIN PROMOTES ANOMALOUS DIFFERENTIATION OF VASCULAR PROGENITOR CELLS DURING NEOINTIMAL HYPERPLASIA AFTER WIRE-INDUCED INJURY
	-	NK CELL AND MACROPHAGE INFILTRATION INTO ORGAN XENOGRAFTS IS DEPENDENT ON THROMBIN-MEDIATED PRODUCTION OF MONOCYTE CHEMOTACTIC PROTEIN-1(MCP-1) THROUGH PAR-1
	-	NEOINTIMAL CELLS IN WIRE-INJURED ARTERIES HAVE A MIXED ENDOTHELIAL CELL (EC)/VASCULAR SMOOTH MUSCLE CELL (VSMC) PHENOTYPE WHICH IS THROMBIN-DEPENDENT
Lechner K.	-	RISK OF RECURRENCE AFTER A FIRST VENOUS THROMBOEMBOLIC EVENT IN YOUNG WOMEN
Lechner D.	-	SPONTANEOUS DEEP VEIN THROMBOSIS OF THE UPPER EXTREMITIES: RISK FACTORS AND LONG TERM FOLLOW UP
	-	CISPLATIN INDUCES IN VITRO THROMBIN GENERATION VIA FORMATION OF PROCOAGULANT ENDOTHELIAL MICROPARTICLES
Lecompte T.	-	INFLUENCE OF INJECTION SITE ON PROPHYLACTIC DOSE ENOXAPARIN BIOAVAILABILITY IN OBESE PATIENTS
	-	PLATELET ACTIVATION REINFORCES THE PROCOAGULANT PHENOTYPE INDUCED BY MURINE MONOCLONAL ANTI-PHOSPHOLIPID ANTIBODIES
	-	CAN THROMBIN GENERATION BE HELPFUL TO EVALUATE THE BLEEDING PHENOTYPE IN MILD HEMOPHILIA A WITH FACTOR VIII ASSAY DISCREPANCY?
	-	SIGNIFICANCE OF PLASMA SOLUBLE ENDOTHELIAL PROTEIN C RECEPTOR AND TISSUE FACTOR PATHWAY INHIBITOR IN PATIENTS WITH ANTIPHOSPHOLIPID ANTIBODIES
	-	INFLUENCE OF PHOSPHOLIPID SURFACE AND CONCENTRATION IN THROMBOGRAPHY
	-	AGE-DEPENDENT INCREASED ARTERIAL STIFFNESS IS ASSOCIATED WITH COMPOSITE CHANGES IN PRO- AND ANTI-COAGULANT REACTIONS IN SUBCLINICAL ATHEROSCLEROSIS
Lecumberri R.	-	D-DIMER LEVELS CORRELATE WITH MORTALITY IN PATIENTS WITH ACUTE PULMONARY EMBOLISM: FINDINGS FROM THE RIETE REGISTRY
	-	ANTITHROMBIN CAMBRIDGE II (A384S): AN UNDERESTIMATED GENETIC RISK FACTOR FOR VENOUS THROMBOSIS
	-	PROGNOSTIC FACTORS OF SHORT-TERM SURVIVAL IN PATIENTS WITH DEEP VEIN THROMBOSIS: FINDINGS FROM A PROSPECTIVE REGISTRY (RIETE)
	-	CLINICAL, GENETIC, FUNCTIONAL AND CONFORMATIONAL HETEROGENEITY OF CONGENITAL ANTITHROMBIN DEFICIENCY. RESULTS FROM 27 UNRELATED CASES
Lecut C.	-	P2X1 RECEPTORS AS NEW REGULATORS OF NEUTROPHIL LIFE SPAN
	-	ATP VIA P2X7 MODULATES THE TLR-DEPENDENT EXPRESSION AND ACTIVITY OF HUMAN NEUTROPHIL INFLAMMASOME
LeDieu R.	-	MAJOR OBSTETRIC HAEMORRGHAGE IN LATE TERMINATION OF PREGNANCY
	-	MAJOR OBSTETRIC HAEMORRHAGE IN LATE TERMINATION OF PREGNANCY
Lee S.	-	THE RELATIONSHIP OF P2Y1 ADP RECEPTOR POLYMORPHISMS AND ISCHEMIC VASCULAR DISEASE
Lee S.S.J.	-	EARLY DIAGNOSIS OF SEPTIC DISSEMINATED INTRAVASCULAR COAGULOPATHY
Lee D.S.	-	DIFFERENTIAL DOSING OF ENOXAPARIN (ENOX) IN TERM AND PRETERM NEONATES
Lee J.	-	ANTIPLATELET ACTIVITY OF EPIGALLOCATECHIN GALLATE IS MEDIATED BY THE INHIBITION OF PLCGAMMA2 PHOSPHORYLATION, ELEVATION OF PGD2 PRODUCTION AND MAINTENANCE OF CALCIUM-ATPASE PUMP
Lee T.	-	THE INHIBITORY ACTIVITY AND MECHANISM OF BUD-030, A NOVEL INHIBITOR OF VASCULAR SMOOTH MUSCLE CELLS
Lee C.A.	-	POSTPARTUM LOCHIAL LOSS IN WOMEN WITH INHERITED BLEEDING DISORDERS
Lee Y.K.	-	THE TISSUE FACTOR CYTOPLASMIC DOMAIN REGULATES PROCOAGULANT RESPONSES IN MACROPHAGES
Lee L.H.	-	LONG TERM OUTCOMES OF DEEP-VEIN THROMBOSIS IN ASIA AFTER MAJOR ORTHOPEDIC SURGERY: THE AIDA EXTENSION STUDY
Lee W.C.	-	LONG TERM OUTCOMES OF DEEP-VEIN THROMBOSIS IN ASIA AFTER MAJOR ORTHOPEDIC SURGERY: THE AIDA EXTENSION STUDY
Lee D.	-	ASSESSMENT OF THROMBOTIC ADVERSE EVENTS (TAES) WITH ACTIVATED PROTHROMBIN COMPLEX CONCENTRATES (APCCS): 17 YEAR EXPERIENCE
Lee A.	-	EXPLORING ADULT PATIENT POPULATIONS AT RISK FOR DEVELOPING HIT
Lee K.	-	A CASE OF EWING'S SARCOMA WITH A CONGENITAL FACTOR VII DEFICIENCY
Lee J.	-	A CASE OF EWING'S SARCOMA WITH A CONGENITAL FACTOR VII DEFICIENCY
	-	POTENT INHIBITION OF PDGF-BB-STIMULATED RESPONSES IN VASCULAR SMOOTH MUSCLE CELL PROLIFERATION BY CUDRATRICUSXANTHONE A ISOLATED FROM THE ROOT BARK OF CUDRANIA TRICUSPIDATA
Lee Y.	-	MONITORING OF PLATELET FUNCTION AFTER CLOPIDOGREL TREATMENT
Lee I.	-	PROGNOSTIC SIGNIFICANCE OF THE POLYMORPHISMS IN METHYLENETETRAHYDROFOLATE REDUCTASE (MTHFR C677T) AND THYMIDYLATE SYNTHASE ENHANCER REGION (TSER) GENE IN EPILEPSY
Lee S.	-	OBOVATOL INHIBITS VASCULAR SMOOTH MUSCLE CELL PROLIFERATION AND NEOINTIMAL FORMATION AFTER CAROTID INJURY IN RATS
Lee A.	-	COMPARISON OF PRE-TEST PROBABILITY SCORES TO COMMERCIAL ASSAYS FOR MEASURING ANTIBODIES ASSOCIATED WITH HEPARIN-INDUCED THROMBOCYTOPENIA
Lee S.	-	ANTITHROMBOTIC EFFECT OF RECOMBINANT DISINTEGRIN IN A MOUSE THROMBOSIS MODEL
Lee C.A.	-	REPORT OF THE SC-VWF WORKING PARTY ON VWF ASSAYS IN VWD DIAGNOSES
Lee J.	-	ANTIPLATELET ACTIVITY OF FENOFIBRATE, A PPARALPHA AGONIST, WAS MEDIATED BY BLOCKING OF CYTOSOLIC CALCIUM MOBILIZATION AND THROMBOXANE A2 RECEPTOR
Lee M.	-	ANTIPLATELET ACTIVITY OF FENOFIBRATE, A PPARALPHA AGONIST, WAS MEDIATED BY BLOCKING OF CYTOSOLIC CALCIUM MOBILIZATION AND THROMBOXANE A2 RECEPTOR
Lee J.	-	ANTIPLATELET ACTIVITY OF FENOFIBRATE, A PPARALPHA AGONIST, WAS MEDIATED BY BLOCKING OF CYTOSOLIC CALCIUM MOBILIZATION AND THROMBOXANE A2 RECEPTOR
Lee A.Y.	-	A SYSTEMATIC REVIEW OF THE INCIDENCE OF VENOUS THROMBOEMBOLISM (VTE) AND EFFECTIVENESS OF PROPHYLAXIS IN PATIENTS WITH MULTIPLE MYELOMA (MM) RECEIVING THALIDOMIDE
Lee J.	-	VERY LOW FREQUENCY OF HEPARIN INDUCED THROMBOCYTOPENIA (HIT) IN A TERTIARY CARE HOSPITAL
	-	EMODIN INHIBITS PDGF-BB-STIMULATED VASCULAR SMOOTH MUSCLE CELL PROLIFERATION BY BLOCKING OF PDGF BETA-RECEPTOR PHOSPHORYLATION
Lee C.	-	LONG TERM FOLLOW-UP OF LEVONORGESTREL-RELEASING INTRAUTERINE SYSTEM IN THE MANAGEMENT OF MENORRHAGIA IN WOMEN WITH INHERITED BLEEDING DISORDERS
Lee S.P.	-	EVALUATION OF ORTHOSTATIC BALANCE AT GROUND AND SLOPE LEVELS IN ADULT PATIENTS WITH HAEMOPHILIA
Lee C.A.	-	A MULTIDISCIPLINARY CLINIC FOR WOMEN WITH INHERITED BLEEDING DISORDERS
Lee C.	-	MECHANISMS OF INDUCTION OF ENDOTHELIAL CELL E-SELECTIN EXPRESSION BY SMOOTH MUSCLE CELLS AND ITS INHIBITION BY SHEAR STRESS
Lee P.	-	MECHANISMS OF INDUCTION OF ENDOTHELIAL CELL E-SELECTIN EXPRESSION BY SMOOTH MUSCLE CELLS AND ITS INHIBITION BY SHEAR STRESS
Lee S.	-	PLASMA LEVELS OF PROTHROMBIN FRAGMENT F1+2, D-DIMER, AND PROTHROMBIN TIME IN GASTRIC CANCER PATIENTS CORRELATE WITH CLINICAL STAGE AND LYMPH NODE METASTASIS
Lee C.A.	-	FINAL ANALYSIS OF A PROSPECTIVE-MULTICENTRE STUDY TO EVALUATE EFFICACY AND SAFETY OF A TRIPLE-SECURED VON WILLEBRAND FACTOR (VWF)
Lee S.S.J.	-	CHANGES OF THE PLASMA LEVELS OF PLATELET AND ENDOTHELIAL MICROPARTICLES IN PATIENTS WITH VENOUS THROMBOEMBOLISM AND ANTIHOSPHOLIPID SYNDROME
Lee Y.Y.G.	-	CHANGES OF THE PLASMA LEVELS OF PLATELET AND ENDOTHELIAL MICROPARTICLES IN PATIENTS WITH VENOUS THROMBOEMBOLISM AND ANTIHOSPHOLIPID SYNDROME
Lee K.	-	KNOWLEDGE AND BEHAVIORS REGARDING COMPLICATION AND PREVENTION OF PATIENTS WITH HEMOPHILA IN KOREA
Lee J.	-	INTRACRANIAL HEMORRHAGE IN AN ACUTE ITP PATIENT WITH MODERATE THROMBOCYTOPENIA
Lee K.	-	INTRACRANIAL HEMORRHAGE IN AN ACUTE ITP PATIENT WITH MODERATE THROMBOCYTOPENIA
Lee S.	-	CORRELATION OF PF4 ELISA (PF4) OPTICAL DENSITY RESULTS AND CLINICAL FINDINGS TO ACCURATELY DIAGNOSE HEPARIN INDUCED THROMBOCYTOPENIA (HIT)
Lee J.M.	-	CLINICAL EXPERIENCE WITH A HIGH PURITY FACTOR IX CONCENTRATE IN YOUNG CHILDREN
	-	USE OF A HIGH PURITY FACTOR IX (FIX) CONCENTRATE IN SURGERY
Lee V.	-	MANAGEMENT OF ORTHOPAEDIC SURGICAL PROCEDURES IN PATIENTS WITH HAEMOPHILIA A RETROSPECTIVE COMPARISON BETWEEN INTERMITTENT BOLUS FACTOR INFUSIONS VS. CONTINUOUS FACTOR INFUSION FROM A TERTIARY CENTRE IN INDIA
Lee A.	-	ACCURACY AND USEFULNESS OF A CLINICAL PREDICTION RULE AND D-DIMER TESTING IN EXCLUDING DEEP VEIN THROMBOSIS (DVT) IN CANCER PATIENTS
Leebeek F.W.G.	-	EFFECTS OF PARTICULATE MATTER AIR POLLUTION ON INFLAMMATION AND HAEMOSTASIS
	-	PLATELET RECEPTOR P2Y12 HAPLOTYPES PREDICT RESTENOSIS AFTER PERCUTANEOUS CORONARY INTERVENTIONS
	-	ADAMTS13 AND VWF IN PEDIATRIC PATIENTS WITH SEVERE MENINGOCOCCAL SEPSIS
	-	HEART-TYPE FATTY ACID BINDING PROTEIN IS PREDICTIVE FOR MORTALITY IN PATIENTS WITH ACUTE PULMONARY EMBOLISM
	-	CLINICALLY SUSPECTED ACUTE RECURRENT PULMONARY EMBOLISM: A DIAGNOSTIC CHALLENGE
	-	ADAMTS13 LEVELS ARE ASSOCIATED WITH THE RISK OF ARTERIAL THROMBOSIS IN YOUNG SUBJECTS
	-	ALPHA-1-ANTITRYPSIN IS THE MOST ABUNDANT PROTEIN NON-COVALENTLY BOUND TO THE FIBRIN MATRIX OF A PLASMA CLOT
	-	HIGH D-DIMER LEVEL INCREASES THE LIKELIHOOD OF PULMONARY EMBOLISM IN A HIGH-RISK POPULATION
Leenders P.	-	ACTIVE SITE INHIBITED FACTOR VIIA REDUCES MYOCARDIAL INFARCT SIZE AFTER ISCHEMIA/REPERFUSION INJURY IN MICE VIA TISSUE FACTOR/NFKAPPAB-MEDIATED MECHANISMS
	-	ACTIVE SITE INHIBITED FACTOR VIIA HAS A PROTECTIVE ROLE IN RENAL ISCHEMIA/REPERFUSION INJURY VIA ANTI-INFLAMMATORY MECHANISMS
Leesar M.A.	-	TISSUE FACTOR/FACTOR VIIA INHIBITOR REDUCES ISCHEMIA IN PATIENTS WITH NSTE-ACS: FINAL RESULTS OF THE ANTHEM-TIMI 32 TRIAL
Leese P.T.	-	INITIAL INTRAVENOUS EXPERIENCE WITH PRT060128 (PRT128), AN ORALLY-AVAILABLE, DIRECT-ACTING, AND REVERSIBLE P2Y12 INHIBITOR
Lefebvre J.	-	ABCIXIMAB-DEPENDENT THROMBOCYTOPENIA IN PATIENTS WITH ACUTE CORONARY SYNDROMES CAN OCCUR BY DIFFERENT MECHANISMS
Lefrancois A.	-	SUCCESSFUL TREATMENT OF HIGH TITRE FACTOR VIII (FVIII) INHIBITOR IN TWO PATIENTS WITH MILD AND MODERATE HAEMOPHILIA A WITH RITUXIMAB ALONE
Lefrant J.Y.	-	SIMPLE COAGULATION TESTS IMPROVE EARLY MORTALITY PREDICTION IN ICU PATIENTS WITH SEPTIC SHOCK
	-	PROSPECTIVE EVALUATION OF A SIMPLIFIED SCORE FOR THE PREDICTION OF DISSEMINATED INTRAVASCULAR COAGULATION IN SEPSIS
Legendre P.	-	DECREASED ADAMTS-13 IS ASSOCIATED WITH A POOR PROGNOSIS IN SEPSIS-INDUCED ORGAN FAILURE
	-	EXPRESSION AND CHARACTERISATION OF 4 ADAMTS13 MUTATIONS IDENTIFIED IN PATIENTS WITH TTP (UPSHAW-SCHULMAN SYNDROME)
Leggett D.	-	AN ASSESSMENT OF THE EFFECTIVENESS OF INFERIOR VENA CAVA FILTERS IN PREVENTION OF PULMONARY EMBOLISM BASED UPON DEMONSTRATION OF TRAPPED EMBOLUS AT THE TIME OF FILTER RETRIEVAL
	-	AN AUSTRALIAN EXPERIENCE OF RETRIEVABLE INFERIOR VENA CAVA FILTERS IN PATIENTS WITH INCREASED RISK OF THROMBOEMBOLIC DISEASE
Leggo J.	-	PLATELET TYPE VON WILLEBRAND DISEASE: AN UNDERDIAGNOSED CAUSE OF EXCESSIVE MUCOCUTANEOUS BLEEDING
Legnani C.	-	D-DIMER TESTING AND RECURRENT VENOUS THROMBOEMBOLISM AFTER UNPROVOKED PULMONARY EMBOLISM
	-	NO INCREASED SIGNS OF ATHEROSCLEROTIC ALTERATIONS IN CARRIERS OF INHERITED THROMBOPHILIA WITH OR WITHOUT PREVIOUS VENOUS THROMBOSIS
	-	COAGULATION FACTOR XI LEVELS AND THE LDL RECEPTOR-RELATED PROTEIN (LRP) GENOTYPE
	-	THE COURSE OF D-DIMER AND FACTOR VIII LEVELS DURING THE ACUTE PHASE OF LEG DEEP VENOUS THROMBOSIS AND RELATIONSHIP WITH THE THROMBOTIC BURDEN
	-	DIFFERENT CUT-OFF VALUES OF THREE D-DIMER (DD) TESTS TO ESTABLISH DURATION OF ORAL ANTICOAGULATION TREATMENT (OAT) AFTER A VENOUS THROMBOEMBOLISM (VTE)
	-	HIGHER FIBRIN MONOMERS (FM) LEVELS AFTER ORAL ANTICOAGULATION (OAT) WITHDRAWAL ARE ASSOCIATED WITH INCREASED RISK OF VENOUS THROMBOEMBOLISM (VTE) RECURRENCE
	-	INNOVANCE D-DIMER ASSAY TO ASSESS THE INDIVIDUAL RISK OF VENOUS THROMBOEMBOLISM (VTE) RECURRENCE AFTER ANTICOAGULATION (OAT) WITHDRAWAL
	-	CLINICAL EVALUATION OF A NEW QUANTITATIVE HIGHLY SENSITIVE D-DIMER ASSAY FOR EXCLUSION OF DEEP VEIN THROMBOSIS AND PULMONARY EMBOLISM
	-	EFFECTS OF AGE AND DIFFERENT CUT-OFF VALUES ON USE OF D-DIMER (DD) TESTING TO ESTABLISH DURATION OF ORAL ANTICOAGULATION TREATMENT (OAT) AFTER VENOUS THROMBOEMBOLISM (VTE)
	-	PLASMA FIBRINOLYTIC POTENTIAL AND THE RISK OF VENOUS THROMBOEMBOLISM (VTE) RECURRENCE
	-	G20210A PROTHROMBIN MUTATION IS MORE FREQUENT IN PATIENTS WITH ADVANCED STAGES OF PERIPHERAL ARTERIAL DISEASE (PAD)
	-	THE NATURAL HISTORY OF D-DIMER LEVELS IN SUBJECTS WITH NEGATIVE D-DIMER AFTER SUSPENSION OF ORAL ANTICOAGULATION FOR A FIRST EPISODE OF VENOUS THROMBOEMBOLISM: THE PROSPECTIVE OBSERVATIONAL PROLONG II STUDY
	-	RESIDUAL VENOUS OBSTRUCTION AND D-DIMER AS RISK FACTORS FOR RECURRENCE AFTER ANTICOAGULATION WITHDRAWAL FOR A FIRST IDIOPATHIC DEEP VEIN THROMBOSIS IN THE PROLONG STUDY
	-	THE ROLE OF D-DIMER AS A RISK FACTOR FOR OCCULT CANCER AND CARDIOVASCULAR EVENTS AFTER ANTICOAGULATION WITHDRAWAL FOR A FIRST IDIOPATHIC DEEP VEIN THROMBOSIS IN THE PROLONG STUDY
Legrand C.	-	THE KOGEOGPK PEPTIDE FROM TYPE III COLLAGEN INHIBITS BREAST ADENOCARCINOMA CELL ADHESION TO TYPE III COLLAGEN AND HUVEC MATRIX IN WHOLE BLOOD AND UNDER FLOW CONDITIONS
Legrand C.M.	-	SYNDECAN-4 CONTRIBUTES TO ENDOTHELIAL TUBULOGENESIS THROUGH INTERACTIONS WITH TWO MOTIFS INSIDE THE PRO-ANGIOGENIC N-TERMINAL DOMAIN OF THROMBOSPONDIN-1
Legrand C.	-	A NOVEL RECOMBINANT RGD-DISINTEGRIN FROM BOTHROPS ALTERNATUS (DISBA-01) ANTAGONIZES ALPHAIIB-BETA3 AND INHIBITS THROMBOSIS
Leguet P.	-	CONVENIENCE OF THE NEW LONG-ACTING ANTICOAGULANT IDRAPARINUX (IDRA) VERSUS VITAMIN K ANTAGONIST (VKA) IN PATIENTS WITH DEEP VENOUS THROMBOSIS (DVT)
	-	MULTINATIONAL DEVELOPMENT OF A QUESTIONNAIRE ASSESSING PATIENT SATISFACTION WITH ANTI-COAGULANT TREATMENT
Lehanka F.	-	LOW MOLECULAR WEIGHT HEPARINS ARE EFFECTIVE AND SAFE IN THROMBOPROPHYLAXIS IN NEWLY DIAGNOSED MYELOMA PATIENTS DURING THE INDUCTION THERAPY
Lehtisalo J.	-	PLATELET INTEGRIN ALPHA2BETA1 INTERACTION WITH TYPE I COLLAGEN IS INHIBITED BY A NOVEL SYNTHETIC MOLECULE BTT-3016
Leighton F.	-	TISSUE FACTOR-DEPENDENT COAGULANT ACTIVITY OF PLATELET-MONOCYTE COMPLEXES IN CHRONIC RENAL FAILURE (CRF). ASSOCIATION WITH HEMOSTATIC ACTIVITY, INFLAMMATION, OXIDATIVE DAMAGE AND ENDOTHELIAL DYSFUNCTION
Leis L.A.	-	TISSUE FACTOR PROCOAGULANT ACTIVITY LEVELS IN HUMAN BLOOD ARE ELEVATED BY WARFARIN
	-	INCREASED CELL ASSOCIATED TISSUE FACTOR ACTIVITY FOLLOWING TOTAL KNEE ARTHROPLASTY
	-	THE CRITICAL ROLE OF MYOSIN IIA IN PLATELET INTERNAL CONTRACTION
Leissinger C.A.	-	VON WILLEBRAND FACTOR/FACTOR VIII CONCENTRATE EFFECTIVELY PREVENTS EXCESSIVE BLEEDING IN PATEINTS WITH VERY LOW VWF:RCO PLASMA LEVELS
	-	THE ROLE OF RACE AND ETHNICITY IN THE CLINICAL OUTCOMES OF SEVERE HEMOPHILIA A PATIENTS WITH INHIBITORS
	-	SAFETY AND EFFICACY OF VON WILLEBRAND FACTOR/FACTOR VIII CONCENTRATE FOR PROPHYLAXIS DURING ELECTIVE SURGERY IN SUBJECTS WITH VON WILLEBRAND DISEASE
Leissinger C.	-	RITUXIMAB IN THE TREATMENT OF FVIII INHIBITORS
Leitienne P.	-	MONITORING OF LOW MOLECULAR WEIGHT HEPARIN NADROPARIN DURING HEMODIALYSIS
Leitner J.M.	-	THE EFFECT OF BIBT 986, A NOVEL SMALL MOLECULE DUAL INHIBITOR OF THROMBIN AND FACTOR XA, ON COAGULATION IN A MODEL OF ENDOTOXIN INDUCED, TISSUE FACTOR TRIGGERED COAGULATION ACTIVATION IN HUMANS
	-	EFFECTS OF LOW DOSE ENDOTOXEMIA ON ENDOTHELIAL PROGENITOR CELLS IN HUMANS
	-	ETHNIC DIFFERENCES IN A HUMAN MODEL OF TISSUE FACTOR- TRIGGERED COAGULATION
	-	EFFECTS OF SHORT TERM STATIN PRE-TREATMENT AND SUBSEQUENT LOW DOSE ENDOTOXEMIA ON CIRCULATING ENDOTHELIAL PROGENITOR CELLS IN HEALTHY VOLUNTEERS
Leizorovicz A.	-	IRIS AN ONGOING, INTERNATIONAL, MULTICENTRE, OPEN, CENTRALLY RANDOMISED, PARALLEL GROUP STUDY WITH TINZAPARIN OR UNFRACTIONATED HEPARIN (UFH) ADMINISTERED SUBCUTANEOUSLY (SC) TO PATIENTS WITH DEEP VEIN THROMBOSIS (DVT) OR PULMUNARY EMBOLISM (PE). THE IRI
	-	RISK FACTORS FOR CONCOMITANT VENOUS THROMBOEMBOLISM (VTE) IN PATIENTS WITH SUPERFICIAL THROMBOPHLEBITIS (ST): PRELIMINARY RESULTS OF THE POST STUDY
	-	THREE-MONTH INCIDENCE OF VENOUS THROMBOEMBOLISM (VTE) IN PATIENTS WITH ISOLATED SUPERFICIAL THROMBOPHLEBITIS (ST): PRELIMINARY RESULTS OF THE POST STUDY
	-	RISK MANAGEMENT IN THE DEVELOPMENT OF NEW ANTITHROMBOTIC DRUGS
	-	FONDAPARINUX IN THE TREATMENT OF SYMPTOMATIC, ISOLATED SUPERFICIAL THROMBOPHLEBITIS (ST): THE CALISTO TRIAL
Lejeune C.	-	ROTEM THROMBOELASTOMETRY IN OBSTETRIC: NEAR PATIENT-TEST AS AN EARLY PREDICTOR OF POST-PARTUM HEMORRHAGE (PPH)
Lejniece S.	-	DNR ANALYSIS RESULTS IN THROMBOSES PATIENTS: THE FIRST DATA IN LATVIA
	-	NATURAL CLEARANCE OF HEPATITIS C VIRUS INFECTION AND HUMAN LEUKOCYTE ANTIGEN CLASS II ALLELES IN CHILDREN WITH HAEMOPHILIA
Lejnieks A.	-	DNR ANALYSIS RESULTS IN THROMBOSES PATIENTS: THE FIRST DATA IN LATVIA
Lelakowski J.	-	THROMBIN GENERATION IN CHRONICALLY ANTICOAGULATED PATIENTS
Lelazari S.	-	COMPARISON OF PEGYLATED LIPOSOMAL FVIII INFUSION RATES IN HEMOPHILIA A
Lemm G.	-	INHIBITOR DEVELOPMENT IN PATIENTS WITH HEMOPHILIA A TREATED WITH SUCROSE-FORMULATED RECOMBINANT FACTOR VIII
Lemmerhirt H.L.	-	REGULATION OF PLASMA VON WILLEBRAND FACTOR (VWF) BY MODIFIER GENES
Lemponen M.	-	SIGNIFICANT DISTINCTION BETWEEN PLASMA- AND PLATELET-DEPENDENT COAGULATION ACTIVITY IN HEMOPHILIA A PATIENTS
Lenain N.	-	DEFICIENCY OF SRC HOMOLOGY 2 DOMAIN-CONTAINING INOSITOL 5-PHOSPHATASE 1 (SHIP1) AFFECTS PLATELET RESPONSES AND THROMBUS GROWTH
Leng B.	-	ENHANCED HEPARIN BINDING AFFINITIES INCREASE THE EFFICIENCIES AT WHICH THE BETA-ANTITHROMBIN III ISOFORM AND A RECOMBINANT ATIII VARIANT LOAD ONTO PENTASACCHARIDE-BEARING SURFACES UNDER FLOW
Lenicek-Krleza J.	-	INHERITED PROTHROMBOTIC RISK FACTORS IN CHILDREN WITH CEREBROVASCULAR DISORDERS
Lenk H.	-	LONG-TERM PHARMACOVIGILANCE UPDATE WITH A RECOMBINANT FVIII CONCENTRATE FOR THE TREATMENT OF HEMOPHILIA A
Lenoir S.	-	MISUSE OF THE D-DIMER TEST IN HOSPITALISED PATIENTS
Lenormand B.	-	MONOCYTE PARAMETERS TO DISCRIMINATE ESSENTIAL FROM REACTIVE THROMBOCYTOSIS
Lensing A.W.A.	-	PREVENTION OF RECURRENT THROMBOEMBOLISM BY ADJUSTING THE DURATION OF ANTICOAGULATION ACCORDING TO RESIDUAL VEIN THROMBOSIS. A RANDOMIZED STUDY
Lenta R.E.	-	ACTIVATED PROTEIN C LEADS TO CELL SURFACE ACCUMULATION OF CLEAVED PAR1 AND SUPPORTS PROTECTIVE SIGNALING EVEN IN THE PRESENCE OF THROMBIN
Lenti M.	-	CHANGES OF INFLAMMATORY MARKERS DURING FOLLOW-UP OF PATIENTS WITH HEART FAILURE UNDERGOING CARDIAC RESYNCHRONIZATION THERAPY
	-	THROMBOPHILIA IS FREQUENT IN SUPERFICIAL VEIN THROMBOSIS AND IS ASSOCIATED WITH RECURRENCE
	-	HOMOCYSTINURIA AND CARDIOVASCULAR MANIFESTATIONS: 5 ITALIAN CASES
Lenti L.	-	OXIDATIVE STRESS-MEDIATED PLATELET CD40 LIGAND UPREGULATION IN PATIENTS WITH HYPERCHOLESTEROLEMIA. EFFECT OF ATORVASTATIN
Lenti M.	-	FISH INTAKE AND LPA 93CT POLYMORPHISM: GENE-ENVIRONMENT INTERACTION IN MODULATING LIPOPROTEIN (A) CONCENTRATIONS
	-	HEMORHEOLOGICAL PROFILE IN RETINAL VEIN OCCLUSION
	-	DO HIGH SENSITIVITY C-REACTIVE PROTEIN AND CYSTATIN-C SERUM LEVELS PREDICT TOTAL MORTALITY IN HEART FAILURE PATIENTS?
Lenti L.	-	LDL ARE OXIDATIVELY MODIFIED BY PLATELETS VIA GP91PHOX
Lenting P.J.	-	LIVER AND SPLEEN MACROPHAGES CONTRIBUTE TO THE CLEARANCE OF VON WILLEBRAND FACTOR AND ITS COMPLEX WITH FACTOR VIII
	-	ACTIVE CONFORMATION OF VON WILLEBRAND FACTOR IN TTP IS NOT RESTRICTED TO ULTRA-LARGE MULTIMERS
	-	DIMERIC 2-GPI BINDS TO LDL-BINDING DOMAIN 1 OF APOER2. PLATELETS EXPRESS THREE 3 DIFFERENT SPLICE VARIANTS OF APOER2 OF WHICH APOER24-5 IS THE MOST ABUNDANT
	-	PSGL1 AND LDL-RECEPTORS MEDIATE ADHESION OF LEUKOCYTES TO BETA2-GLYCOPROTEIN-I
	-	CHARACTERIZATION OF THE INTERACTION BETWEEN VON WILLEBRAND FACTOR AND OSTEOPROTEGERIN
Lenting P.	-	THE EFFECT OF EXERCISE ON INDIVIDUALS WITH TYPE 1 AND TYPE 2B VON WILLEBRAND DISEASE (VWD)
Lenting P.J.	-	EVIDENCE FOR A HIGH AFFINITY ADAMTS13 BINDING SITE DISTAL TO THE VWF A DOMAINS
	-	THE OUTER-SURFACES OF SCHISTOSOMA MANSONI DURING THE LIFE-CYCLE DEMONSTRATE DIFFERENTIAL PROPERTIES TOWARDS PLATELET ADHESION
	-	ROLE OF GLYCOPROTEIN IBA MOBILITY IN PLATELET DESTRUCTION AND FUNCTION
	-	A MURINE MODEL TO ASSESS VON WILLEBRAND FACTOR FUNCTION IN VIVO
Lentz S.R.	-	CRITICAL ROLE FOR CYCLOPHILIN D (CYPD) AND THE MITOCHONDRIAL PERMEABILITY TRANSITION PORE (MPTP) IN THE REGULATION OF PLATELET ACTIVATION AND THROMBOSIS
	-	REVERSAL OF HYPERCHOLESTEROLEMIA PROTECTS AGAINST ARTERIAL THROMBOSIS IN ATHEROSCLEROTIC MICE
Leo L.	-	REVERSAL OF HYPERCHOLESTEROLEMIA PROTECTS AGAINST ARTERIAL THROMBOSIS IN ATHEROSCLEROTIC MICE
	-	CRITICAL ROLE FOR CYCLOPHILIN D (CYPD) AND THE MITOCHONDRIAL PERMEABILITY TRANSITION PORE (MPTP) IN THE REGULATION OF PLATELET ACTIVATION AND THROMBOSIS
Leon C.	-	ABNORMAL MEGAKARYOCYTE MATURATION WITH IMPAIRED PROPLATELET FORMATION IN A MOUSE MODEL OF BERNARD-SOULIER SYNDROME
	-	MEGAKARYOCYTE-RESTRICTED MYH9 INACTIVATION DRAMATICALLY AFFECTS HAEMOSTASIS WHILE PRESERVING PLATELET AGGREGATION AND SECRETION RESPONSES
Leon L.I.R.	-	PLASMA INCOAGULABILITY INDUCED BY LONOMIA OBLIQUA BRISTLE EXTRACT IS ASSOCIATED WITH THE ABUNDANT PRESENCE OF LIPOCALINS
Leon C.	-	MEGAKARYOCYTE-RESTRICTED MHY9 INACTIVATION LEADS TO MEGAKARYOCYTE AND PLATELET ULTRASTRUCTURAL ABNORMALITIES
Leonardi C.	-	ANKLE REPLACEMENT IN SEVERE BLEEDING DISORDERS: RETROSPECTIVE STUDY ON 17 CASES
Leone M.	-	LABORATORY DIAGNOSIS AND MONITORING OF DDAVP TREATMENT OF VON WILLEBRAND DISEASE BY FLOW CYTOMETRY
Leong T.	-	HOMOCYSTEINE AND ITS THIOLACTONE DERIVATIVE ACTIVATE THE PLATELET INTEGRIN ALPHA IIB BETA 3
Leonhard J.	-	HIT II-INDUCED CRITICAL LIMB ISCHAEMIA TREATED WITH UROKINASE AND ARGATROBAN
Lepage L.	-	INCREASED PLASMA MARKERS OF PLATELET AND PROTHROMBIN ACTIVATION IN PATIENTS WITH THORACIC ASCENDING AORTIC ANEURYSM
Lepatan L.P.	-	CRYOPRECIPITATE-REMOVED PLASMA AS A SOURCE OF FACTOR IX IN THE TREATMENT OF HEMOPHILIA B
Leprince T.	-	INCIDENCE OF ANTITHROMBIN LEVEL ON "HEMOFILTER CIRCUIT" THROMBOSIS DURING EARLY CONTINUOUS VENOVENOUS HEMOFILTRATION IN POST CARDIOPULMONARY BYPASS PATIENTS
Lequerrec A.	-	INFLUENCE OF THE SOURCE OF PHOSPHOLIPIDS FOR APTT-BASED FIX ASSAYS AND POTENTIAL CONSEQUENCES FOR THE DIAGNOSIS OF MILD/MODERATE HAEMOPHILIA B
Lerner R.G.	-	A CASE OF NORMAL PLATELET COUNT HEPARIN INDUCED THROMBOCYTOPENIA (HIT)
Leroith D.	-	NATURALLY OCCURRING TF VARIANTS ARE PRESENT IN BLOOD OF FVB/N MICE: THE MKR MODEL OF TYPE 2 DIABETES IS WELL SUITED FOR DEVELOPMENT OF A TF-BASED MODEL OF DIABETIC THROMBOPHILIA
Lerolle N.	-	DECREASED ADAMTS-13 IS ASSOCIATED WITH A POOR PROGNOSIS IN SEPSIS-INDUCED ORGAN FAILURE
Leroux D.	-	IS THE RISK OF VENOUS THROMBOEMBOLISM HIGHER WITH CYPROTERONE CONTRACEPTIVES?
Leroyer C.	-	RISK OF VENOUS THROMBOEMBOLISM (VTE) IN FIRST DEGREE RELATIVES (FDRS) OF PATIENTS WITH UNPROVOKED VTE WHO DO NOT HAVE FACTOR V LEIDEN (FVL) OR THE G20210A PROTHROMBIN GENE MUTATION (PGM)
	-	DETECTING PROTHROMBOTIC STATES USING A THROMBIN GENERATION TEST IN RELATIVES OF PATIENTS WITH VENOUS THROMBOEMBOLISM AND FACTOR V LEIDEN
Leroy-Matheron C.	-	CLASSIFICATION OF FACTOR V-LEIDEN CARRIERS BY QUANTITATIVELY MEASURING ITS PROCOAGULANT ACTIVITY COMPARATIVELY TO THAT OF FACTOR V
Leschnik B.	-	THROMBIN GENERATION IN OBESE CHILDREN AFTER WEIGHT REDUCTION
	-	THROMBIN GENERATION IN NORMAL UNCOMPLICATED PREGNANCY
Leslie B.A.	-	BIVALENT BINDING OF THROMBIN TO GAMMA'-FIBRIN ENHANCES PROTECTION FROM INHIBITION BY ANTITHROMBIN-HEPARIN
	-	ZINC PROMOTES FORMATION OF TERNARY THROMBIN-FIBRIN-HEPARIN COMPLEXES BY ENHANCING HEPARIN-FIBRIN AFFINITY
Lester W.	-	RATE OF DE NOVO VWF MUTATIONS IN PATIENTS HISTORICALLY DIAGNOSED WITH TYPE 1 VWD IN THE EUROPEAN STUDY, MOLECULAR AND CLINICAL MARKERS FOR THE DIAGNOSIS AND MANAGEMENT OF TYPE 1 VWD (MCMDM-1VWD)
Lester Z.	-	VENOUS THROMBOSIS (VTE) HAS AN ADVERSE IMPACT ON THE SURVIVAL IN PATIENTS WITH MALIGNANCY
Lesteven E.	-	AN ABNORMAL MRNA SPLICING IS ASSOCIATED WITH THE A3 HAPLOTYPE OF THE EPCR GENE PROCR: A POSSIBLE NEW CONTRIBUTOR TO PLASMA SOLUBLE EPCR LEVELS
Letellier T.	-	THE RAPID PROCOAGULANT MEMBRANE SCRAMBLING INDUCED BY CALCIUM IONOPHORES IN PLATELETS AND LYMPHOCYTES IS DIFFERENT FROM THAT INDUCED BY THAPSIGARGIN IN PLATELETS: DEMONSTRATION WITH CYCLOSPORIN A
Lethagen S.	-	THE VON WILLEBRAND FACTOR (VWF) AND FACTOR VIII ACTIVITIES VERSUS VWF ANTIGEN RATIOS IN PATIENTS WITH VON WILLEBRAND DISEASE TYPE 1: RESULTS FROM THE EUROPEAN MULTICENTER MCMDM-1VWD STUDY
	-	EVALUATION OF THROMBOELASTOGRAPHY (TEG) ASSAYS FOR MONITORING EX VIVO EFFECT OF RFVIIA (NOVOSEVEN) IN HAEMOPHILIA A AND B PATIENTS
	-	RATE OF DE NOVO VWF MUTATIONS IN PATIENTS HISTORICALLY DIAGNOSED WITH TYPE 1 VWD IN THE EUROPEAN STUDY, MOLECULAR AND CLINICAL MARKERS FOR THE DIAGNOSIS AND MANAGEMENT OF TYPE 1 VWD (MCMDM-1VWD)
	-	MUTATED POSITION OF NMHC-A PREDICTS THE NATURAL HISTORY OF MYH9-RELATED DISEASE
	-	BLEEDING SCORE IS INCREASED IN AFFECTED RELATIVES WITH TYPE 1 VON WILLEBRAND DISEASE AND ABNORMAL MULTIMERIC PATTERN IDENTIFIED IN THE EU MCMDM-1 VWD STUDY
Letowska M.	-	"IMPACT R" - A NEW SCREENING TOOL FOR VON WILLEBRAND DISEASE?
Leung R.	-	INHIBITION OF AMINOPHOSPHOLIPID TRANSLOCASE ACTIVITY IN PHOSPHATIDYLSERINE-EXPOSING HUMAN PLATELETS IS INDEPENDENT OF CALPAIN ACTIVITY
Leung L.L.K.	-	POLYPHOSPHATE INTERACTS WITH THROMBIN EXOSITE II WITH HIGH AFFINITY
Leus B.	-	DIAGNOSTIC ACCURACY OF THE TRIAGE D-DIMER TEST FOR EXCLUSION OF VENOUS THROMBOEMBOLISM IN OUTPATIENTS
Levalle O.A.	-	4G/5G POLYMORPHISM IN THE PLASMINOGEN ACTIVATOR INHIBITOR-1 GENE IN OBESE HISPANIC ADULTS
Levashov M.Y.	-	MODULATION OF STAPHYLOKINASE-DEPENDENT PLASMINOGEN ACTIVATION BY OMEGA-AMINE ACIDS
	-	INHIBITION OF PLASMINOGEN/PLASMINOGEN ACTIVATOR SYSTEM BY ANGIOSTATIN-LIKE PLASMINOGEN FRAGMENTS IS INVOLVED IN MECHANISM OF ANTIANGIOGENESIS
Leversuch W.K.	-	THE EFFECT OF THE SUGARBAKER PROCEDURE ON HAEMOSTASIS
Levesque H.	-	IGG ANTIBODIES WITH HYDROLYTIC ACTIVITY TOWARDS ENDOGENOUS FVIII IN A FRENCH COHORT OF PATIENTS WITH ACQUIRED HEMOPHILIA
	-	EPIDEMIOLOGY AND ONE-YEAR OUTCOMES IN PATIENTS WITH ACQUIRED HEMOPHILIA A (AH) IN FRANCE: THE SACHA PROSPECTIVE STUDY
Lévesque H.	-	RISK FACTOR FOR ORAL ANTICOAGULANT TREATMENT OVERDOSE: A CASE CONTROL STUDY IN AN EMERGENCY UNIT
Levi M.M.	-	ENDOGENOUS PROTEIN C INHIBITS PULMONARY COAGULATION BUT FACILITATES BACTERIAL DISSEMINATION IN THE EARLY PHASE OF PNEUMOCOCCAL PNEUMONIA IN MICE
Leviel F.	-	BASAL EXPRESSION OF ENDOTHELIAL CELL PROTEIN C RECEPTOR IS REGULATED BY ENDOGENOUS ALDOSTERONE, PRODUCED VIA ALDOSTERONE SYNTHASE
Levigne S.	-	ROLE OF THE ALPHA-HELIX 163-170 IN FACTOR XA CATALYTIC ACTIVITY
Levine M.	-	EVALUATION OF THE ACCURACY OF A 99MTC-LABELLED MONOCLONAL ANTIBODY SPECIFIC FOR D-DIMER IN PATIENTS WITH SUSPECTED DEEP VEIN THROMBOSIS (DVT)
	-	RENAL IMPAIRMENT ESTIMATES TO PREDICT THE HAEMORRHAGE RISK IN 2170 PATIENTS TREATED BY HEPARIN. COCKCROFT-GAULT OR SIMPLIFIED MDRD?
Levinson A.J.	-	EFFICACY OF TEACHING CLINICAL CLERKS AND RESIDENTS ABOUT MANAGEMENT OF BLEEDING AND COAGULATION DISORDERS USING E-LEARNING
Levy C.	-	SPECIFIC MULTI-RULE EXPERT SYSTEM FOR ELDERLY INPATIENT ANTICOAGULANT CONTROL
Levy J.H.	-	HEMOSTATIC RESPONSES TO RECOMBINANT ACTIVATED FACTOR VII IN THE PRESENCE OF ANTITHROMBIN DEFICIENCY
Levy M.D.	-	RNAPC2, A NOVEL INHIBITOR OF TISSUE FACTOR/FACTOR VIIA COMPLEX, SYNERGIZES WITH 5-FU OR BEVACIZUMAB IN A MOUSE MODEL OF COLORECTAL CANCER
	-	PHARMACOKINETIC/PHARMACODYNAMIC PROFILE OF A NOVEL APTAMER DIRECT THROMBIN INHIBITOR IN CYNOMOLGUS MONKEYS AND YORKSHIRE PIGS FOLLOWING A SINGLE IV BOLUS ADMINISTRATION
	-	RNAPC2, A NOVEL INHIBITOR OF TISSUE FACTOR/FACTOR VIIA COMPLEX, SUPPRESSES LIVER AND LUNG METASTASES IN MOUSE MODELS OF COLORECTAL CANCER
Levy-Adam F.	-	HEPARANASE INDUCES TFPI EXPRESSION AND EXTRACELLULAR ACCUMULATION IN ENDOTHELIAL AND TUMOR CELLS
Levy-Shraga Y.	-	ISRAELI PEDIATRIC ONCOLOGY REGISTRY ON CENTRAL VENOUS LINE RELATED COMPLICATIONS
Lewandowska M.A.	-	U1SNRNP-MEDIATED RESCUE OF MRNA PROCESSING IMPAIRED BY SPLICING MUTATIONS IN SEVERE FACTOR VII DEFICIENCY
Lewis H.	-	IMMUNE-TOLERANCE IN HAEMOPHILIA A USING PLASMA-DERIVED FACTOR VIII CONCENTRATE FANHDI
Lewis S.	-	PHARMACOKINETIC/PHARMACODYNAMIC PROFILE OF A NOVEL APTAMER DIRECT THROMBIN INHIBITOR IN CYNOMOLGUS MONKEYS AND YORKSHIRE PIGS FOLLOWING A SINGLE IV BOLUS ADMINISTRATION
Lewis S.D.	-	AN ANTI-VON WILLEBRAND'S FACTOR A1 DOMAIN APTAMER INHIBITS ARTERIAL THROMBOSIS INDUCED BY ELECTRICAL INJURY IN CYNOMOLGUS MACAQUES
Lewis B.E.	-	DOWN REGULATION OF THROMBOTIC AND INFLAMMATORY MEDIATORS IN PATIENTS WITH ACUTE CORONARY SYNDROME TREATED WITH CLOPIDOGREL. RELEVANCE TO THE OBSERVED CLINICAL EFFECTS
Lewis S.D.	-	DISCOVERY AND CHARACTERIZATION OF A POTENT NEUTRALIZING ANTI-VWF A1 DOMAIN SPECIFIC APTAMER
Lewis S.	-	PHARMACOKINETIC PROFILES AND PHARMACOKINETIC AND PHARMACODYNAMIC RELATIONSHIP OF A VWF INHIBITORY APTAMER IN THE CYNOMOLGUS MONKEY
Lewis S.D.	-	DISCOVERY OF A POTENT, DIRECT THROMBIN INHIBITING APTAMER
Lewkowicz E.	-	PLATELET MICROPARTICLES LEVELS AND PREVALENCE OF ANTIPROTHROMBIN AND ANTI-BETA-2-GLYCOPROTEIN I ANTIBODIES IN THROMBOANGIITIS OBLITERANS (BUERGER'S DISEASE)
Leya F.	-	NITRIC OXIDE LEVELS ARE INCREASED FOLLOWING BRACHYTHERAPY COMPARED TO STENTING. IMPLICATIONS IN CORONARY RESTENOTIC COMPLICATIONS
Leyte A.	-	PERIOPERATIVE PROPHYLACTIC DOSING OF TINZAPARIN IN MORBID OBESE PATIENTS
	-	COAGULATION PARAMETERS OF THE ISTH OVERT DIC SCORE: FIRST, THEIR DISTRIBUTION
Leytin V.	-	PLATELET ACTIVATION RESPONSE IS MORE SENSITIVE TO THROMBIN STIMULATION THAN IS PLATELET APOPTOSIS
Li N.	-	INCREASED PLATELET PROCOAGULANT ACTIVITY IN TYPE 2 DIABETIC PATIENTS: INHIBITION BY GPIIB/IIIA BLOCKADE
Li L.Z.	-	CORRECTION OF TH1 DOMINANT CYTOKINE PROFILES BY HIGH DOSE DEXAMETHASONE IN PATIENTS WITH CHRONIC IDIOPATHIC THROMBOCYTOPENIC PURPURA
Li X.	-	THROMBIN INDUCES ACTIVATION OF MATURED DENDRITIC CELLS VIA RHO/ERK PATHWAYS
Li Q.	-	OPTIMIZATION OF COAGULATION FACTOR ASSAYS FOR IMPROVED ACCURACY OVER AN EXTENDED LINEAR RANGE
Li L.Z.	-	THE CONSTRUCTION OF A HUMANIZED PHAGE ANTIBODY LIBRARY OF ANTI-PLATELET GPIIB/IIIA SINGLE CHAIN FV
Li L.Y.	-	EXPOSURE-CLINICAL OUTCOME MODELING AND SIMULATION TO FACILITATE DOSE SELECTION OF APIXABAN IN SUBJECTS UNDERGOING ELECTIVE TOTAL KNEE REPLACEMENT SURGERY
Li W.	-	STRUCTURE OF NATIVE PROTEIN C INHIBITOR PROVIDES INSIGHT INTO ITS MULTIPLE FUNCTIONS
Li N.	-	EFFECT OF CLOPIDOGREL TREATMENT ON STRESS-INDUCED PLATELET ACTIVATION AND MYOCARDIAL ISCHEMIA IN ASPIRIN-TREATED PATIENTS WITH STABLE CORONARY ARTERY DISEASE
Li H.	-	CHANGES OF TISSUE FACTOR PATHWAY IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION
Li L.	-	CHANGES OF TISSUE FACTOR PATHWAY IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION
Li N.	-	PLATELETS AND SUBENDOTHELIAL MATRIX PROTEINS DIFFERENTIALLY SUPPORT ADHESION OF LYMPHOCYTE SUBPOPULATIONS UNDER ARTERIAL SHEAR STRESS
Li B.	-	SIGNAL TRANSDUCTION PATHWAYS OF INTERLEUKIN-6 INDUCING TISSUE FACTOR EXPRESSION IN VASCULAR ENDOTHELIAL CELLS
Li Q.	-	PLASMIN INDUCES PROINFLAMMATORY STIMULATION OF HUMAN MACROPHAGES VIA THE ANNEXIN A2 HETEROTETRAMER
Li C.	-	THE ABILITY OF TF TO PROMOTE TUMOUR CELL IMMUNE EVASION, MEDIATED VIA SURFACE VCAM-1
Li Y.G.	-	INDIVIDUAL AND COMBINED EFFECTS OF ASPIRIN AND THIENOPYRIDINES IN ATTENUATION OF PLATELET AGGREGATION INDUCED BY COLLAGEN AND OTHER AGONISTS
Li C.	-	DIFFERENTIAL EXPRESSION OF TF IN CARDIAC HYPERTROPHY AND ITS INVOLVEMENT IN THE PROGRESSION OF THE DISEASE
Li B.	-	EFFECT OF TETRAMETHYLPYRAZINE ON THE EXPRESSION OF TISSUE FACTOR INDUCED BY THROMBIN AND ITS MECHANISM
Li J.	-	TALIN HEAD-ROD INTERACTION MODULATES INTEGRIN BINDING TO THE TALIN HEAD DOMAIN
Li J.L.	-	EFFECTS AND MECHANISMS OF BUYANG HUANWU DECOCTION ON THE CELL VIABILITY AND TF EXPRESSION INDUCED BY ANG? IN ENDOTHELIAL CELLS
Li Y.	-	CYSTIC FIBROSIS HETEROZYGOTES DO NOT HAVE INCREASED PLATELET ACTIVATION
Li H.	-	MURINE GPVI ANTIBODY DOES NOT INDUCE GPVI-DEPLETION BUT REDUCES IN VIVO THROMBOSIS WITH MINIMAL BLEEDING RISK IN RATS
Li Y.G.	-	EFFECT OF PRASUGREL AND HIGH DOSE CLOPIDOGREL ON PLATELET FUNCTION AS ASSESSED BY POINT OF CARE AND OPTICAL AGGREGOMETRY
Li C.	-	THE INFLUENCE OF TISSUE FACTOR ON OESTROGEN RECEPTOR ALPHA EXPRESSION AND CELL INVASION IN BREAST CANCER CELLS
Li Thiao Te V.	-	SERIOUS BLEEDS IN HAEMOPHILIAC A CHILDREN AND CONTINUOUS INFUSION (CI)
Liang Y.	-	INTERLEUKINS GENES TAG-SNP HAPLOTYPES AND RISK OF MYOCARDIAL INFARCTION: A POPULATION BASED CASE-CONTROL STUDY
Liao P.	-	COVALENT ANTITHROMBIN-HEPARIN COMPLEX REDUCES BRAIN EMBOLI DURING HYPOTHERMIC CARDIOPULMONARY BYPASS IN PIGS
Liao C.	-	THE NEGATIVE EFFECT OF LEVOBUPIVACAINE ON COLLAGEN-INDUCED PLATELET AGGREGATION
Liao C.H.	-	SIRTINOL INHIBITS HUMAN PLATELETS AGGREGATION AND Ca2+ RELEASE
	-	A NATURAL EXTRACT FROM PIPER PHILIPPINUM (2R,3R)-2-(3',4'-DEHYDROXYBENZYL)-3-(3"-4"-DIMETHOXYBENZYL)BUTYROLACTONE (PP-6) SUPPRESS FMLP-INDUCED SUPDROXIDE PRODUCTION BY INHIBITION FMLP-RECEPTOR BINDING IN HUMAN NEUTORPHIS
Liao C.	-	THE RGD-CONTAINING PEPTIDE DERIVED FROM PLATELET DISABLED-2 INHIBITS DU145 PROSTATE CANCER CELL-INDUCED PLATELET AGGREGATION
Liaw P.	-	NOVEL REGULATORY FUNCTIONS OF ACTIVATED PROTEIN C: UPREGULATION OF INTERLEUKIN-10 AND INHIBITION OF TISSUE FACTOR IN BLOOD MONOCYTES
Liaw P.C.	-	EFFECTS OF CHEMOTHERAPY AGENTS ON ENDOTHELIAL AND MONOCYTE HEMOSTASIS
Libersa C.	-	EFFECT OF TWO DOSES OF ORAL OESTROGEN REPLACEMENT THERAPY ON THE PROTEIN C SYSTEM IN POSTMENOPAUSAL WOMEN. A RANDOMISED DOUBLE BLIND PLACEBO-CONTROLLED STUDY
Licastro G.	-	IMMUNOGLOBULINE ANTI-D (WINRHO) IN CRHONIC CHILDOOD IDIOPATHIC THROMBOCYTOPENIC PURPURA (ITP), ANALYSIS OF "IMMATURE PLATELET FRACTION (I.P.F.)" AND ASYMPTOMATIC THROMBOCYTOPENIA
Liddington R.C.	-	GENETIC MODIFICATION OF A SPECIES-DIVERGENT BOND IN VWF-A1 PEMITS HUMAN PLATELET THROMBUS FORMATION IN MICE
Liebaers I.	-	IDENTIFICATION OF TWO DE NOVO ANTITHROMBIN TYPE I MUTATIONS
Lieber E.A.	-	ANTICOAGULANT RESPONSES IN PATIENTS RECEIVING LOW MOLECULAR WEIGHT HEPARIN COMPARED TO UNFRACTIONATED HEPARIN FOR TEE GUIDED CARDIOVERSION OF ATRIAL FIBRILLATION: RESULTS FROM THE ASSESSMENT OF CARDIOVERSION USING TRANSESOPHAGEAL ECHOCARDIOGRAPHY (ACUTE
Lieberman J.	-	DABIGATRAN ETEXILATE VERSUS ENOXAPARIN IN PREVENTING VENOUS THROMBOEMBOLISM FOLLOWING TOTAL KNEE ARTHROPLASTY
Lieberman J.R.	-	LATE BREAKING CLINICAL TRIAL: RIVAROXABAN AN ORAL, DIRECT FACTOR XA INHIBITOR FOR THE PREVENTION OF VENOUS THROMBOEMBOLISM IN TOTAL KNEE REPLACEMENT SURGERY: RESULTS OF THE RECORD 3 STUDY - LATE BREAKING
Liebetrau C.	-	HEAT SHOCK PROTEIN 70 (HSP 70) LEVELS AS PROGNOSTIC MARKER OF SEPTIC PATIENTS
Liebman H.A.	-	CANCER-ASSOCIATED THROMBOSIS: TISSUE FACTOR-BEARING MICROPARTICLES ARE ASSOCIATED WITH AN INCREASED RISK OF VENOUS THROMBOEMBOLIC EVENTS IN CANCER PATIENTS
Lien J.C.	-	ANTIPLATELET AND ANTITHROMBOTIC ACTIVITY OF NP-313, 2-ACETYLAMINO-3-CHLORO-1,4-NAPHTHOQUINONE, A NOVEL CPLA2 AND CYTOSOLIC CA 2 + MOBILIZATION INHIBITOR
Lien T.	-	EXPRESSION OF THE TFPI V264M MUTANT IN VASCULAR CELL CULTURES INVOLVES STABILITY OF MRNA
Lien Y.	-	THE REGULATION OF THROMBOMODULIN DISTRIBUTION IN ENDOTHELIAL CELLS
Lienhart A.	-	MONITORING OF RECOMBINANT FVIIA BY THROMBIN GENERATION TEST
Liersch R.	-	CIRCULATING ANGIOPOIETIN-2 IS A STRONG PROGNOSTIC FACTOR IN ACUTE MYELOID LEUKEMIA
Liesner R.	-	PLATELET FUNCTION TESTING IN CHILDREN UNDER 1 YEAR
	-	ADAMTS 13 IN NON-THROMBOTIC THROMBOCYTOPENIC PURPURA CONDITIONS
	-	A COMPARATIVE EVALUATION OF THE CS-2000I COAGULATION ANALYSER USING CLOTTING, AMIDOLYTIC AND IMMUNO-TURBIDOMETRIC ASSAYS
	-	TREATMENT OF IDIOPATHIC THROMBOTIC THROMBOCYTOPENIC PURPURA WITH MABTHERA (RITUXIMAB)
	-	SOUTH EAST ENGLAND THROMBOTIC THROMBOCYTOPENIC PURPURA REGISTRY
Liestøl S.	-	DIFFERENTIAL EFFECTS OF CONVENTIONAL AND LOW DOSE ORAL HORMONE THERAPY, TIBOLONE AND RALOXIFENE ON FUNCTIONALITY OF THE ACTIVATED PROTEIN C SYSTEM
Lieu H.D.	-	INITIAL INTRAVENOUS EXPERIENCE WITH PRT060128 (PRT128), AN ORALLY-AVAILABLE, DIRECT-ACTING, AND REVERSIBLE P2Y12 INHIBITOR
Lijfering W.M.	-	THROMBOPHILIC RISK FACTORS FOR FIRST VENOUS THROMBOEMBOLISM, RECURRENCE AND ITS IMPLICATIONS: RESULTS FROM A LARGE RETROSPECTIVE FAMILY COHORT STUDY
	-	DOES THE PRESENCE OF MULTIPLE INHERITED THROMBOPHILIC DEFECTS EXPLAIN THE INCREASED RISK OF ARTERIAL THROMBOTIC EVENTS IN PATIENTS WITH PRIOR VENOUS THROMBOEMBOLISM?
	-	CYTOMEGALOVIRUS AND HIGH RISK OF (RECURRENT) VENOUS THROMBOSIS AFTER RENAL TRANSPLANTATION
	-	HYPERHOMOCYSTEINEMIA IS NOT A RISK FACTOR FOR VENOUS AND ARTERIAL THROMBOSIS, BUT AN EPIPHENOMENON: RESULTS FROM A LARGE RETROSPECTIVE FAMILY COHORT STUDY
Lijnen R.H.	-	DEFICIENCY OF PLASMINOGEN ACTIVATOR INHIBITOR-2 IMPAIRS NUTRITIONALLY INDUCED MURINE ADIPOSE TISSUE DEVELOPMENT
Lijnen R.	-	NUTRITIONALLY INDUCED OBESITY REDUCES THE ARTERIAL THROMBOTIC TENDENCY OF FACTOR V LEIDEN MICE
Lijnen R.H.	-	INHIBITION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR TYROSINE KINASES IMPAIRS ADIPOSE TISSUE DEVELOPMENT IN MOUSE MODELS OF OBESITY
Lijnen R.	-	CORTICAL NEURONS AGGREGATE IN RESPONSE TO PLASMIN FORMED AT THEIR SURFACE BY TPA
Likhacheva E.	-	TRANSITION TO STANDARD HAEMOSTATIC THERAPY SCHEMES OF HEMOPHILIA IN RUSSIA (THE NATIONAL TREATMENT PROTOCOL FOR HEMOPHILIA PATIENTS)
Likhanov I.D.	-	PEPTIDE MECHANISMS REGULATION OF HEMOSTASIS IN PURULENT SURGICAL INFECTION
Lilley K.S.	-	PHOSPHOPROTEIN PROFILING OF COLLAGEN PEPTIDE ACTIVATED PLATELETS: A FOCUS ON SERINE AND THREONINE PHOSPHORYLATION EVENTS
Lilley P.	-	THROMBIN GENERATION TEST (TGT) AND ROTATIONAL THROMBOELASTOGRAPHY (ROTEM) AND ITS USE IN ASSESSING SEVERE HAEMOPHILIA A PHENOTYPE
Lillicrap D.	-	THE PREVALENCE OF SYMPTOMATIC VON WILLEBRAND DISEASE (VWD) IN PRIMARY CARE PRACTICE
	-	INFLUENCE OF A GT REPEAT ELEMENT ON SHEAR STRESS-RESPONSIVENESS OF THE VWF GENE PROMOTER
	-	THE INFLUENCE OF INTRON 1 SEQUENCE VARIATIONS IN MUTATION- NEGATIVE TYPE 1 VON WILLEBRAND DISEASE PATIENTS
	-	IMMUNOGLOBULIN ISOTYPES AND FUNCTIONAL ANTI-FVIII ANTIBODIES IN RESPONSE TO FVIII TREATMENT IN TWO STRAINS OF HEMOPHILIA A MICE
	-	SAFE AND LONG-TERM EXPRESSION OF FVIII FOLLOWING SUBCUTANEOUS IMPLANTATION OF GENETICALLY-MODIFIED ENDOTHELIAL PROGENITORS IN HEMOPHILIA A MICE
	-	THE SPLENIC MICRO-ENVIRONMENT AND FVIII-VWF INTERACTION ARE DETERMINANTS OF THE IMMUNOGENIC PRESENTATION OF FVIII BY DENDRITIC CELLS
	-	THE ISTH SSC VON WILLEBRAND FACTOR (VWF) ONLINE DATABASE
	-	CHALLENGES IN DEFINING TYPE 2M VON WILLEBRAND DISEASE: RESULTS FROM A CANADIAN COHORT STUDY
	-	DIAGNOSTIC EFFICACY OF SYSTEMATIC INVESTIGATION OF NON-VON WILLEBRAND BLEEDERS: RESULTS OF A PROSPECTIVE STUDY
	-	IMMUNE TOLERANCE INDUCTION TO FVIII IN HEMOPHILIA A MICE USING SUBCUTANEOUSLY IMPLANTED FVIII GENE-MODIFIED ENDOTHELIAL PROGENITOR CELLS
Lillicrap D.P.	-	POLYMORPHIC AND MUTAGENIC SEQUENCE CHANGES IN THE A1 AND A2 DOMAINS OF VON WILLEBRAND FACTOR (VWF) RESULT IN ALTERATIONS TO ADAMTS13 CLEAVAGE EFFICIENCY
Lillicrap D.	-	PRECLINICAL PHARMACOLOGY OF AV513 INCLUDING ORAL EFFICACY IN SEVERE HEMOPHILIA A DOGS
	-	THE EFFECT OF EXERCISE ON INDIVIDUALS WITH TYPE 1 AND TYPE 2B VON WILLEBRAND DISEASE (VWD)
	-	ENHANCED TOLEROGENIC PRESENTATION OF FVIII BY ANDROGRAPHOLIDE-TREATED IMMATURE DENDRITIC CELLS
	-	ANTI-CD3 IN COMBINATION WITH NASAL FVIII-A2 DOMAIN DECREASES FVIII INHIBITORS
	-	PLATELET TYPE VON WILLEBRAND DISEASE: AN UNDERDIAGNOSED CAUSE OF EXCESSIVE MUCOCUTANEOUS BLEEDING
	-	REPORT OF THE SC-VWF WORKING PARTY ON VWF ASSAYS IN VWD DIAGNOSES
	-	EXERCISE IMPROVES THE GLOBAL HEMOSTATIC EFFICACY IN SEVERE HEMOPHILIA A DOGS, AS DETERMINED BY THROMBELASTOGRAPHY
Lim Y.	-	OBOVATOL INHIBITS VASCULAR SMOOTH MUSCLE CELL PROLIFERATION AND NEOINTIMAL FORMATION AFTER CAROTID INJURY IN RATS
	-	ANTIPLATELET ACTIVITY OF FENOFIBRATE, A PPARALPHA AGONIST, WAS MEDIATED BY BLOCKING OF CYTOSOLIC CALCIUM MOBILIZATION AND THROMBOXANE A2 RECEPTOR
	-	EMODIN INHIBITS PDGF-BB-STIMULATED VASCULAR SMOOTH MUSCLE CELL PROLIFERATION BY BLOCKING OF PDGF BETA-RECEPTOR PHOSPHORYLATION
Lim W.	-	LOW-MOLECULAR-WEIGHT HEPARIN IN THE ELDERLY WITH IMPAIRED RENAL FUNCTION
Lim B.B.	-	DE NOVO ATOMIC FORCE MICROSCOPY OF INTRACORONARY THROMBUS: NEW INSIGHTS INTO FIBRIN CLOT ARCHITECTURE AND IMPLICATIONS FOR FIBRINOLYSIS
Lim Y.	-	CERAMIDE KINASE/CERAMIDE 1-PHOSPHATE IS AN IMPORTANT REGULATOR ON AORTIC VASCULAR SMOOTH MUSCLE CELL PROLIFERATION
Lim W.	-	LOW MOLECULAR WEIGHT HEPARIN IN PATIENTS WITH RENAL INSUFFICIENCY: ANALYSIS OF ANTI-XA LEVELS AND CREATININE CLEARANCE
Lim Y.	-	EPOTHILONE B INHIBITS NEOINTIMAL FORMATION AFTER RAT CAROTID INJURY THROUGH THE REGULATION OF CELL CYCLE-RELATED PROTEINS
Lim B.B.	-	SINGLE MOLECULE FORCE SPECTROSCOPY OF FIBRINOGEN
Lim J.	-	SELECTIVE SIGNALLING ROLE FOR PI 3-KINASE P110BETA IN THROMBIN-INDUCED CLOT RETRACTION
Lima L.M.	-	LIPOPROTEIN(A) IN PATIENTS WITH CORONARY ARTERY DISEASE (CAD), ISCHEMIC STROKE (IS) AND PERIPHERAL ARTERIAL OBSTRUCTIVE DISEASE (PAOD)
	-	PREVALENCE OF APOLIPOPROTEIN E ALLELES AND ITS ASSOCIATION WITH SERUM LIPID LEVELS IN BRAZILIAN PATIENTS WITH ISCHEMIC STROKE AND PERIPHERAL ARTERIAL DISEASE
	-	PLASMINOGEN ACTIVATOR INHIBITOR-1 4G/5G POLYMORPHISM IN CORONARY ARTERY DISEASE AND ITS ASSOCIATION WITH PLASMA PAI-1 LEVELS
	-	TISSUE FACTOR AND TOTAL TISSUE FACTOR PATHWAY INHIBITOR LEVELS IN CORONARY ARTERY DISEASE: CORRELATION WITH THE SEVERITY OF ATHEROMATOSIS
	-	CORONARY ARTERY DISEASE (CAD): LACK OF ASSOCIATION BETWEEN APOB/APOA-I RATIO AND ATHEROMATOSIS EXTENT
	-	RISK FACTORS ASSOCIATED TO THE DEVELOPMENT OF PERIPHERAL ARTERIAL OBSTRUCTIVE DISEASE (PAOD)
	-	SERUM C-REACTIVE PROTEIN PLASMA LEVELS IN PATIENTS WITH ARTERIAL THROMBOSIS
	-	APOB/APOA-I RATIO IN PATIENTS WITH ISCHEMIC STROKE (IS) AND PERIPHERAL ARTERIAL DISEASE
	-	PLASMINOGEN ACTIVATOR INHIBITOR -1 (PAI-1) PLASMA LEVELS AND 4G/5G AND G844A PAI-1 PROMOTER POLYMORFISMS IN BRAZILIAN PATIENTS WITH ISQUEMIC STROKE AND PERIPHERAL ARTERIAL DISEASE
	-	SECRETORY PHOSPHOLIPASE A2 AND HIGH-SENSITIVITY C-REACTIVE PROTEIN IN CORONARY ARTERY DISEASE
	-	HOMOCYSTEINE PLASMA LEVELS AND MTHFR C677T MUTATION IN PATIENTS WITH CORONARY ARTERIAL DISEASE, ISCHEMIC STROKE AND PERIPHERAL ARTERIAL OBSTRUCTIVE DISEASE
	-	ASSOCIATION OF OXIDIZED LDL AND LP(A) LIPOPROTEIN WITH EXTENT OF CORONARY ARTERY DISEASE BY ANGIOGRAPHY
	-	LACK OF ASSOCIATION BETWEEN APOLIPOPROTEIN E POLYMORPHISM AND ATHEROMATOSIS EXTENT IN PATIENTS UNDERGOING CORONARY ANGIOGRAPHY
	-	LIPID ALTERATIONS IN PERIPHERAL ARTERIAL OBSTRUCTIVE DISEASE (PAOD)
Limburg V.	-	THE FACTOR VIII C1 DOMAIN CONTRIBUTES TO EFFICIENT LRP/LDL RECEPTOR BINDING
	-	LYSINE RESIDUES 2065 AND 2092 OF THE FACTOR VIII C1 DOMAIN CONTRIBUTE TO BINDING LRP AND LDL RECEPTOR, BUT ARE NOT INVOLVED IN BINDING FACTOR IXA
Limousin L.	-	ORIENTIA TSUTSUGAMUSHI INFECTION (SCRUB TYPHUS) IS ASSOCIATED WITH AN INFRACLINICAL ACTIVATION OF THE COAGULATION SYSTEM BUT NOT WITH AN ACTIVATION OF ENDOTHELIAL CELLS
Lin P.C.	-	VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) IN TRANSFUSION-DEPENDENT THALASSEMIC PATIENTS: RELATION TO BLOOD TRANSFUSION
Lin K.S.	-	VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) IN TRANSFUSION-DEPENDENT THALASSEMIC PATIENTS: RELATION TO BLOOD TRANSFUSION
Lin T.	-	THE INFLUENCE OF THE HEMODIALYSIS PROCEDURES ON PLATELET AND HEMOSTATIC FUNCTIONS
Lin K.T.	-	THE INTERACTION OF KERATINOCYTES AND FIBROBLASTS WITH INTEGRIN ALPHA2BETA1 AGONIST, AGGRETIN, AND ITS REGULATION BETWEEN EPITHELIAL/MESENCHYMAL COMMUNICATION
Lin S.	-	CHARACTERIZATION OF VASCULAR ENDOTHELIAL CELLS WITH NULL THROMBOXANE A2 SYNTHASE
	-	CHARACTERIZATION OF VASCULAR ENDOTHELIAL CELLS WITH NULL THROMBOXANE A2 SYNTHASE
Lin T.	-	IMPAIRED RESPONSIVENESS OF PLATELETS TO EPINEPHRINE IN CHINESE RELATED TO A2A ADRENOCEPTOR POLYMORPHISMS
Lin J.	-	IMPAIRED RESPONSIVENESS OF PLATELETS TO EPINEPHRINE IN CHINESE RELATED TO A2A ADRENOCEPTOR POLYMORPHISMS
Lin B.D.	-	NOVEL MUTATIONS IN THE FACTOR V GENE OF TAIWANESE FACTOR V DEFICIENCY PATIENTS
Lin H.Y.	-	NOVEL MUTATIONS IN THE FACTOR V GENE OF TAIWANESE FACTOR V DEFICIENCY PATIENTS
Lin J.S.	-	NOVEL MUTATIONS IN THE FACTOR V GENE OF TAIWANESE FACTOR V DEFICIENCY PATIENTS
Lin J.N.	-	EFFECTS ON PLATELET AND LEUCOCYTE FUNCTION BY INTRAVENOUS CHINESE MEDICINE WIDELY USED FOR PATIENTS WITH ISCHAEMIC DISEASE IN CHINA
Lin L.	-	IDENTIFICATION OF POTENT CYCLIC PEPTIDES THAT BIND TO PLATELET GLYCOPROTEIN IB ALPHA AND SELECTIVELY INHIBIT VON WILLEBRAND FACTOR DEPENDENT HIGH-SHEAR PLATELET AGGREGATION
Lin Y.	-	THE NEGATIVE EFFECT OF LEVOBUPIVACAINE ON COLLAGEN-INDUCED PLATELET AGGREGATION
Lin J.	-	REFERENCE RANGE OF PLATELET FUNCTION ANALYZER-100 CLOSURE TIMES IN HEALTHY CHINESE
Lin H.Y.	-	SUPERWARFARIN INTOXIFICATION: HEMATURIA IS A MAJOR CLINICAL MANIFESTATION
	-	SEVERE HEMOPHILIA A AND FACTOR VIII INHIBITOR OCCURS IN A YOUNG GIRL WHO HAS A CARRIER MOTHER, TURNER SYNDROME AND CHROMOSOMAL STRUCTURAL ABNORMALITIES WITH 45,X(22)/46,X,IDIC(X)(Q21)(8)
Lin C.	-	KNOCKOUT OF THE THROMBOXANE SYNTHASE CAUSES REDUCTION OF VASCULAR SMOOTH MUSCLE CELL PROLIFERATION AND MIGRATION IN AN ARTERY INJURY MODEL
Lin S.	-	KNOCKOUT OF THE THROMBOXANE SYNTHASE CAUSES REDUCTION OF VASCULAR SMOOTH MUSCLE CELL PROLIFERATION AND MIGRATION IN AN ARTERY INJURY MODEL
Lin T.	-	IMPROVING PATIENT SAFETY WHEN STARTING WARFARIN IN THE HOSPITAL: THE WARFDOCS STUDY
Linari S.	-	EARLY VIRAL KINETICS PORTENDS THE LONG-TERM OUTCOME OF COMBINED THERAPY WITH PEGYLATED INTERFERON (PEG-IFN) PLUS RIBAVIRIN IN HEMOPHILIACS WITH HCV/HIV COINFECTION
Lincz L.	-	PREANALYTICAL VARIABLES IN THE FLOW CYTOMETRIC ANALYSIS OF MICROPARTICLES
Lind V.	-	EFFECT OF RFVIIA AND NN1731 (RFVIIA ANALOGUE) ON THROMBOELASTOGRAPHY (TEG) IN WHOLE BLOOD OBTAINED FROM HAEMOPHILIA A DOGS
	-	EVALUATION OF THROMBOELASTOGRAPHY (TEG) ASSAYS FOR MONITORING EX VIVO EFFECT OF RFVIIA (NOVOSEVEN) IN HAEMOPHILIA A AND B PATIENTS
Lindahl T.	-	PLASMA S/R RATIO OF WARFARIN CO-VARIES WITH VKORC1 HAPLOTYPE
Lindahl T.L.	-	DIFFERENCES BETWEEN FIBRINOGEN BINDING AND RECEPTOR ACTIVATION MEASURED BY FLOW CYTOMETRY INDICATE THE EXISTENCE OF A TRANSITION STATE IN GPIIB/IIIA, RECOGNISED BY PAC-1 BUT NOT BINDING FIBRINOGEN
	-	THE PLASMA SAMPLE DILUTION IMPROVES THE CORRELATION BETWEEN REAGENTS FOR PT-METHODS
Lindahl A.	-	BENEFICIAL EFFECT OF 1-YEAR OPTIMAL MEDICAL TREATMENT, INDEPENDENT OF ADDITIONAL PTA, ON INFLAMMATION IN PATIENTS WITH PERIPHERAL ARTERIAL DISEASE (PAD)
Lindahl T.L.	-	SNAPSHOT OF WARFARIN TREATMENT IN DIFFERENT SETTINGS: A CROSS SECTION STUDY IN SWEDISH PRIMARY HEALTH CARE CENTERS VS ANTICOAGULATION CLINICS
	-	THE PERIODONTAL PATHOGEN PORPHYROMONAS GINGIVALIS INDUCES BLOOD COAGULATION THROUGH ACTIVATION OF FACTOR XI BY GINGIPAIN R
	-	IMAGING OF BLOOD PLASMA COAGULATION AND ITS PROPAGATION AT SURFACES
	-	DOES THROMBIN GENERATION OR D-DIMER VALUES AT TIME OF AN ACUTE EVENT OF VENOUS THROMBO-EMBOLISM PREDICT RECURRENCES?
	-	PLATELET ACTIVATION VIA THROMBIN RECEPTOR PAR4 IS INVOLVED IN THE INITIATION OF THROMBIN GENERATION AND COAGULATION AND IN CLOT ELASTICITY DEVELOPMENT
Linden M.D.	-	TARGETED INHIBITION OF THE SEROTONIN 5-HT2A RECEPTOR ATTENUATES RECURRENT PLATELET-MEDIATED THROMBOSIS IN AN IN VIVO MODEL MIMICKING UNSTABLE ANGINA
	-	CYSTIC FIBROSIS HETEROZYGOTES DO NOT HAVE INCREASED PLATELET ACTIVATION
Lindenmann S.	-	PLATELETS, INFLAMMATION AND ATHEROSCLEROSIS
Lindhoff-Last E.	-	ETIOLOGY, CLINICAL COURSE AND TREATMENT OUTCOME OF PATIENTS WITH INFERIOR VENA CAVA THROMBOSIS
	-	CUTANEOUS DELAYED-TYPE IV-HYPERSENSITIVITY REACTION (DTH) TO HEPARIN AND HEPARIN-INDUCED THROMBOCYTOPENIA TYPE II (HIT) IS THERE AN ASSOCIATION ?
	-	ASSOCIATION OF ADAMDEC1 HAPLOTYPE WITH HIGH FACTOR VIII LEVELS IN VENOUS THROMBOEMBOLISM
	-	ALTERNATIVE ANTICOAGULATION WITH DANAPAROID IN TWO PREGNANCIES IN A PATIENT WITH FORMER HIT, THROMBOPHILIA, A HISTORY OF VENOUS THROMBOSIS AND RECURRENT PREGNANCY LOSSES
	-	NON-RESPONSE TO CLOPIDOGREL IN PATIENTS WITH PERIPHERAL ARTERIAL OCCLUSIVE DISEASE (PAOD); A PROSPECTIVE STUDY
	-	IMPACT OF THE VITAMIN K EPOXIDE REDUCTASE COMPLEX SUBUNIT 1 (VKORC1) POLYMORPHISM C.-1639GA UPON PHENPROCOUMON THERAPY
	-	ALTERNATIVE ANTICOAGULATION WITH FONDAPARINUX IN PREGNANT PATIENTS WITH HEPARIN-INTOLERANCE
	-	MALE GENDER INCREASES RISK OF VTE RECURRENCE AFTER SPONTANEOUS AND RISK-ASSOCIATED FIRST VENOUS THROMBOEMBOLISM
	-	DETERMINATION OF CLOPIDOGREL MAIN METABOLITE IN PLASMA USEFUL TOOL FOR THERAPY MONITORING ?
	-	COMPARISON OF A HEPARIN-PLATELET FACTOR 4 (PF4)-ELISA FOR IGG, IGM AND IGA AND THE HEPARIN-INDUCED PLATELET ACTIVATION ASSAY (HIPA) WITH A HEPARIN-PF4-ELISA FOR IGG
	-	USE OF FONDAPARINUX IN PATIENTS WITH HEPARIN-INDUCED THROMBOCYTOPENIA TYPE II
	-	PHARMACOGENETICS OF ORAL ANTICOAGULATION - VKORC1-HAPLOTYPES DETERMINE THE INTER-INDIVIDUAL VARIABILITY
	-	ARE PATIENTS WITH THROMBOPHILIA AND A HISTORY OF VENOUS THROMBOEMBOLISM AT HIGHER RISK TO ARTERIAL THROMBOTIC EVENTS?
	-	SEVEN NOVEL MISSENSE MUTATIONS IN THE VITAMIN K EPOXIDE REDUCTASE COMPLEX SUBUNIT 1 (VKORC1) CAUSE HEREDITARY COUMARIN RESISTANCE
	-	NON-RESPONSE TO ASPIRIN (ASA) IN PATIENTS WITH PERIPHERAL ARTERIAL OCCLUSIVE DISEASE (PAOD); A PROSPECTIVE STUDY
Lindhout T.	-	INHIBITION OF PROTEASE-ACTIVATED RECEPTOR (PAR)-4 PROTECTS FROM MULTI-ORGAN FAILURE IN A MURINE MODEL OF DISSEMINATED INTRAVASCULAR COAGULATION (DIC)
Lindner E.	-	A NOVEL RECOMBINANT B-DOMAIN-DELETED FACTOR VIII EXPRESSED IN A HUMAN CELL LINE
Lindqvist P.G.	-	FACTOR V LEIDEN AND PLACENTAL PATHOLOGY
Lindstrom E.G.	-	REACTIVE OXYGEN SPECIES DERIVED FROM PLATELETS REDUCE THE ACTION OF NITRIC OXIDE
Lindstrom K.	-	ASSESSMENT OF PLATELET FUNCTION IN NORMAL ADULTS: RISTOCETIN-INDUCED PLATELET AGGREGATION (RIPA)
Lineberger R.	-	LACK OF ASSOCIATION OF ANTIPHOSPHOLIPID ANTIBODIES WITH CORONARY ATHEROSCLEROSIS IN PATIENTS UNDERGOING CORONARY ANGIOGRAPHY
Linné R.	-	EARLY HOME THERAPY AND OUTCOME AMONG 675 PATIENTS WITH PULMONARY EMBOLISM
Linnemann B.	-	NON-RESPONSE TO ASPIRIN (ASA) IN PATIENTS WITH PERIPHERAL ARTERIAL OCCLUSIVE DISEASE (PAOD); A PROSPECTIVE STUDY
	-	ARE PATIENTS WITH THROMBOPHILIA AND A HISTORY OF VENOUS THROMBOEMBOLISM AT HIGHER RISK TO ARTERIAL THROMBOTIC EVENTS?
	-	DETERMINATION OF CLOPIDOGREL MAIN METABOLITE IN PLASMA USEFUL TOOL FOR THERAPY MONITORING ?
	-	MALE GENDER INCREASES RISK OF VTE RECURRENCE AFTER SPONTANEOUS AND RISK-ASSOCIATED FIRST VENOUS THROMBOEMBOLISM
	-	ETIOLOGY, CLINICAL COURSE AND TREATMENT OUTCOME OF PATIENTS WITH INFERIOR VENA CAVA THROMBOSIS
	-	NON-RESPONSE TO CLOPIDOGREL IN PATIENTS WITH PERIPHERAL ARTERIAL OCCLUSIVE DISEASE (PAOD); A PROSPECTIVE STUDY
	-	ALTERNATIVE ANTICOAGULATION WITH DANAPAROID IN TWO PREGNANCIES IN A PATIENT WITH FORMER HIT, THROMBOPHILIA, A HISTORY OF VENOUS THROMBOSIS AND RECURRENT PREGNANCY LOSSES
Lins P.E.	-	FIBRIN GEL POROSITY: COMPARISON OF TWO LABORATORY ASSAYS
	-	FIBRIN GEL POROSITY RELATES TO GLYCOSYLATED HAEMOGLOBIN IN PATIENTS WITH TYPE 1 DIABETES
Liotier J.	-	A DECISION SUPPORT TOOL ON HANDELD COMPUTERS TO IMPROVE DIAGNOSTIC STRATEGIES OF PULMONARY EMBOLISM IN EMERGENCY DEPARTMENTS (SPEED STUDY)
Liou J.T.	-	SIRTINOL INHIBITS HUMAN PLATELETS AGGREGATION AND Ca2+ RELEASE
Lip G.	-	CARDIOVASCULAR RISK FACTORS ARE ASSOCIATED WITH PLASMA MARKERS OF PRO-ATHEROGENIC PROCESSES IN RHEUMATOID ARTHRITIS
	-	ANGIOGENESIS IN RHEUMATOID ARTHRITIS: IS IT RELATED TO ENDOTHELIAL PERTURBATION AND/OR INFLAMMATION?
	-	INFLUENCE OF FACTOR VII 323 DEL/INS POLYMORPHISM IN THE PROTHROMBOTIC STATE AND ISCHAEMIC STROKE RISK IN ATRIAL FIBRILLATION
	-	RAISED CIRCULATING ENDOTHELIAL CELLS IN RHEUMATOID AND EARLY ARTHRITIS
Lisboa L.	-	DELAYED ONSET OF LOW MOLECULAR WEIGHT HEPARIN INDUCED THROMBOCYTOPENIA TYPE II IN A CARDIAC PATIENT
Lischetzki G.	-	PERCUTANEOUS CATHETER EXTRACTION OF A RUPTURED PORT-A-CATH IN A SMALL CHILD WITH HAEMOPHILIA A AND F VIII INHIBITOR USING CONTINUOUS INFUSION OF RFVIIA
	-	INFLUENCE OF STORAGE CONDITIONS ON THROMBIN GENERATION IN PLATELET POOR PLASMA
Lisi F.	-	OBSERVATIONAL STUDY OF 150 WOMEN WITH INHERITED THROMBOPHILIA AND RECURRENT PREGNANCY LOSS
Lisiak K.M.	-	TAFI ACTIVATION IN MODEL THROMBI
Lisman T.	-	GLYCOPROTEIN IB-ALPHA CONTRIBUTES TO TISSUE FACTOR-INDEPENDENT THROMBIN GENERATION BY RECOMBINANT FACTOR VIIA ON THE ACTIVATED PLATELET SURFACE
	-	HYPOFIBRINOLYSIS AS A RISK FACTOR FOR MYOCARDIAL INFARCTION IN MEN
	-	SYNERGISTIC EFFECTS OF HYPOFIBRINOLYSIS AND GENETIC AND ACQUIRED RISK FACTORS IN VENOUS THROMBOSIS
Lissalde-Lavigne G.	-	SIMPLE COAGULATION TESTS IMPROVE EARLY MORTALITY PREDICTION IN ICU PATIENTS WITH SEPTIC SHOCK
	-	THE RISK OF UNEXPLAINED FOETAL LOSS IS DOSE-DEPENDENTLY RELATED TO THE EXPRESSION OF THE GLY219 VARIANT OF THE ENTOTHELIAL PROTEIN C RECEPTOR BY THE MOTHER, BY THE FATHER AND BY THE COUPLE
	-	PROSPECTIVE EVALUATION OF A SIMPLIFIED SCORE FOR THE PREDICTION OF DISSEMINATED INTRAVASCULAR COAGULATION IN SEPSIS
	-	ASYMPTOMATIC CARRIAGE OF THE JAK2V617F MUTATION IS ASSOCIATED WITH UNEXPLAINED EMBRYONIC AND FOETAL LOSS DURING THE FIRST PREGNANCY
Lissens W.	-	IDENTIFICATION OF TWO DE NOVO ANTITHROMBIN TYPE I MUTATIONS
Litauszky K.	-	A PILOT STUDY WITH AUTOLOGOUS BONE MARROW-DERIVED STEM CELL TRANSPLANTATION (ABSCT) IN PATIENTS WITH SEVERE PERIPHERAL ARTERIAL DISORDER (SPAD)
Litvinov R.I.	-	DO B:b INTERACTIONS HAVE A ROLE IN FIBRIN POLYMERIZATION?
	-	DIRECT EVIDENCE OF SPECIFIC INTERACTIONS OF FIBRINOGEN ALPHA C REGIONS WITH THE CENTRAL E REGION AND WITH EACH OTHER
Liu Y.	-	HIGH PREVALENCE OF IRON DEFICIENCY AMONG PATIENTS REFERRED FOR EVALUATION OF A BLEEDING DISORDER
Liu X.	-	SPERM MEDIATED HUMAN COAGULATION FACTOR VIII GENE TRANSFER AND EXPRESSION IN TRANSGENIC MICE
Liu R.	-	THE F11 RECEPTOR (F11R, JAM-A) IN ATHEROTHROMBOSIS: OVEREXPRESSION OF F11R IN ATHEROSCLEROTIC PLAQUES
Liu C.Z.	-	A NEW CONVENIENT METHOD FOR FIBRINOGEN PURIFICATION BASED ON THE AFFINITY OF STAPHYLOCOCCUS AUREUS CLUMPING FACTOR A TO FIBRINOGEN
Liu W.	-	THE VISCOELASTIC PROPERTIES OF SINGLE, CROSSLINKED AND UNCROSSLINKED FIBRIN FIBERS
Liu S.	-	REMOVAL OF PORCINE PARVOVIRUS SPIKED INTO SAMPLES OF HUMAN RECOMBINANT FACTOR VIII
Liu Y.	-	GLOBAL ASSAYS OF PLATELET FUNCTION IN DIAGNOSTIC TESTING
Liu F.C.	-	SIRTINOL INHIBITS HUMAN PLATELETS AGGREGATION AND Ca2+ RELEASE
Liu Y.	-	MURINE GPVI ANTIBODY DOES NOT INDUCE GPVI-DEPLETION BUT REDUCES IN VIVO THROMBOSIS WITH MINIMAL BLEEDING RISK IN RATS
Liu F.	-	FUNCTIONAL IN VITRO CHARACTERIZATION OF A NOVEL ADAMTS13 MUTATION (R1095W) AND POLYMORPHISM (S903L)
Liu L.	-	A SURVEY ON THE PREVALENCE OF VENOUS THROMBOEMBOLIC DISEASES IN GUANGZHOU OF CHINA
Liu Y.S.	-	IMPAIRED 'OUTSIDE-IN' INTEGRIN ALPHAIIBBETA3 SIGNALING AND THROMBUS STABILITY IN CD151 AND TSSC6-DEFICIENT MICE
Liu J.W.	-	A COMPARATIVE ANALYSIS OF THE RESPONSE TO INFLAMMATORY STIMULI OF BLOOD- AND MESENCHYMAL STEM CELLDERIVED ENDOTHELIAL PROGENITOR CELLS
Liu X.	-	THE TRANSCRIPTION FACTOR EGR-1 PLAYS A CRITICAL ROLE IN ANTIPHOSPHOLIPID ANTIBODY-MEDIATED THROMBOSIS
Liu J.	-	NOVEL MODELS OF THROMBOPHILIA RESULT IN SPONTANEOUS PERIPHERAL THROMBOSIS AND PREGNANCY-RELATED COMPLICATIONS
Liu T.	-	EVALUATION OF PEG-FVIII MOLECULES WITH PROLONGED HALF-LIVES IN A MURINE FVIII-DEPENDENT BLEEDING MODEL
Liu S.	-	RECOMBINANT HUMAN THROMBOMODULIN PROMOTES SMOOTH MUSCLE CELL MIGRATION
	-	DEXTROMETHORPHAN REDUCES ATHEROSCLEROSIS AND NEOINTIMA FORMATION IN MICE
Livnat T.	-	ALPHA V SUPPRESSION BY SIRNA AUGMENTS OR INHIBITS VEGF AND VEGFR-2 EXPRESSION DEPENDING ON THE ORIGIN OF ENDOTHELIAL CELLS
	-	CAN THROMBIN GENERATION (TG) BE USED TO MONITOR RFVIIA TREATMENT: IN VIVO "MINI-PK" STUDY IN HEMOPHILIA A PATIENTS
	-	A RECOMBINANT FACTOR VIIA ANALOGUE WITH ENHANCED POTENCY, EXPRESSED BY THROMBIN GENERATION, AND PHOSPHOLIPIDS DEPENDENCY: AN IN VITRO STUDY
	-	The contribution of phospholipids (PL) to thrombin generation (TG) induced by factor eight inhibitor bypassing activity (FEIBA) and recombinant factor VIIa (rFVIIa)
Ljung R.	-	ANTI-PROTEIN S ANTIBODIES IN CHILDREN WITH PURPURA FULMINANS AND IN HEALTHY CHILDREN FOLLOWING VARICELLA AS WELL AS IN CHILDREN WITH THROMBOSIS
Ljung R.C.R.	-	STUDIES OF mRNA IN PATIENTS WITH UNDETECTABLE MUTATIONS IN GENOMIC DNA
	-	FEMALE HEMOPHILIA A - TWO UNUSUAL CASES DUE TO SKEWED X-INACTIVATION
Llamas P.	-	FIVE PROTHROMBOTIC POLYMORHISMS AND VENOUS THROMBOEMBOLISM
	-	THALIDOMIDE AND THROMBOPROPHYLAXIS: TO WHOM AND WHEN
	-	CLINICAL, GENETIC, FUNCTIONAL AND CONFORMATIONAL HETEROGENEITY OF CONGENITAL ANTITHROMBIN DEFICIENCY. RESULTS FROM 27 UNRELATED CASES
	-	THE T ALLELE OF THE FXII 46C/T GENE POLYMORPHISM IS RISK FACTOR FOR ICD IN SPANISH POPULATION
	-	RISK FACTOR PROFILE ASSOCIATED WITH ICD IN SPANISH POPULATION
Lloyd J.V.	-	EVALUATION OF A PRE-TEST CLINICAL SCORE FOR THE DIAGNOSIS OF HIT
	-	LABORATORY DIAGNOSIS OF THE DISCREPANT PHENOTYPE OF MILD HAEMOPHILIA A USING A MODIFIED CHROMOGENIC FACTOR VIII ASSAY
Llugalio B.	-	THE TYPE OF MANIFESTATION OF THE ANTIPHOSPHOLIPID SYNDROME IN RELATION TO THE AGE OF THE PATIENTS
Lo H.	-	GENETIC MODIFICATION OF A SPECIES-DIVERGENT BOND IN VWF-A1 PEMITS HUMAN PLATELET THROMBUS FORMATION IN MICE
Lo Coco L.	-	PERIOPERATIVE BRIDGING THERAPY WITH LOW MOLECULAR WEIGH HEPARIN IN PATIENTS REQUIRING INTERRUPTION OF LONG-TERM ORAL ANTICOAGULANT THERAPY
	-	ENDOGENOUS THROMBIN POTENTIAL IN PATIENTS WITH IDIOPATHIC VENOUS THROMBOSIS
	-	THE PERSISTANCE OF RESIDUAL VEIN THROMBOSIS, AFTER AN EPISODE OF DEEP VEIN THROMBOSIS, AND THE RISK OF NEW OVERT CANCER AND CARDIOVASCULAR DISEASE
Lobacheva G.	-	USE OF RECOMBINANT FACTOR VIIA IN CARDIOSURGERY PATIENTS, INCLUDING NEONATES AND INFANTS UNDER 1 YEAR OF AGE
Lobanova E.S.	-	BLOOD FLOW SUPPRESSES FEEDBACK ACTIVATION OF EXTRINSIC TENASE BY FACTOR XA AND PREVENTS CLOTTING
Locatelli F.	-	CONGENITAL AMEGAKARYOCYTIC THROMBOCYTOPENIA (CAMT): CLINICAL AND BIOLOGICAL CHARACTERIZATION OF FIVE NEW MUTATIONS
Locatelli N.	-	ALTERNATIVE SPLICING AND NONSENSE-MEDIATED DECAY IN THE F5 GENE
Lockyer S.	-	AN ULTRA SENSITIVE ASSAY FOR THE QUANTIFICATION OF GPVI SHEDDING IN HUMAN PLASMA
	-	MURINE GPVI ANTIBODY DOES NOT INDUCE GPVI-DEPLETION BUT REDUCES IN VIVO THROMBOSIS WITH MINIMAL BLEEDING RISK IN RATS
Loeffler C.	-	MECHANISM OF PARADOXICAL PLATELET ACTIVATION INDUCED BY GPIIB/IIIA ANTAGONISTS
Loesel A.	-	INFLUENCE OF DESMOPRESSIN ON HEMOSTASIS IN CHILDREN WITH BLEEDING DISORDERS
Loffredo L.	-	OXIDATIVE STRESS-MEDIATED PLATELET CD40 LIGAND UPREGULATION IN PATIENTS WITH HYPERCHOLESTEROLEMIA. EFFECT OF ATORVASTATIN
Loffredo M.	-	ACQUIRED AND INHERITED PREDISPOSING CONDITIONS IN PATIENTS WITH RETINAL VEIN OCCLUSION
Loffredo L.	-	EARLY INCREASE OF OXIDATIVE STRESS AND SOLUBLE CD40L IN CHILDREN
Lofts F.	-	CHEMOANTICOAGULATION VERSUS CHEMOTHERAPY IN ADVANCED PANCREATIC CANCER (APC): RESULTS OF THE INTERIM ANALYSIS OF THE FRAGEM TRIAL
Loganath A.	-	HUMAN TISSUE KALLIKREINS, HK6 AND HK10 AS NOVEL BIOMARKERS FOR EPITHELIAL OVARIAN CANCER
Loisance D.	-	A NEW ANTITHROMBOTIC STRATEGY FOR PATIENTS WITH LONG TERM MECHANICAL CIRCULATORY SUPPORT (MCS)
Lok C.A.R.	-	CELL-DERIVED MICROPARTICLES AND COMPLEMENT ACTIVATION IN PREECLAMPSIA VERSUS NORMAL PREGNANCY
Lokajczyk A.	-	COMPARISON OF ENDOTHELIAL CELL PROTEIN C RECEPTOR (EPCR) MRNA FORMS IN MONOCYTES AND HUVEC
	-	AN ABNORMAL MRNA SPLICING IS ASSOCIATED WITH THE A3 HAPLOTYPE OF THE EPCR GENE PROCR: A POSSIBLE NEW CONTRIBUTOR TO PLASMA SOLUBLE EPCR LEVELS
	-	RECOMBINATION IN ENDOTHELIAL CELL PROTEIN C RECEPTOR GENE PROCR. INFERENCE FOR THROMBOPHILIC PATIENTS SCREENING
Lokare A.	-	VENOUS THROMBOSIS (VTE) HAS AN ADVERSE IMPACT ON THE SURVIVAL IN PATIENTS WITH MALIGNANCY
Lokhorst H.	-	ELEVATED PLASMIN-ALPHA2-ANTIPLASMIN LEVELS IN SYSTEMIC AMYLOIDOSIS INDICATE ACTIVATION OF THE FIBRINOLYTIC SYSTEM
Lollar P.	-	IMPROVED THERAPEUTIC AGENTS FOR HEMOPHILIA
	-	COMPARISON OF HUMAN RFVIII AND MURINE RFVIII IN A STANDARDIZED FVIII DEPENDENT BLEED MODEL IN FVIII -/- MICE
	-	NEUTRALIZING ANTI-FVIII ANTIBODIES HAVE A DIFFERENT IMPACT IN INHIBITING THROMBIN GENERATION
	-	FUNCTIONAL CHARACTERIZATION OF STRUCTURAL EPITOPES IN THE C2 DOMAIN OF FACTOR VIII
Lomax C.	-	IVIG-SPARING TREATMENT OF PEDIATRIC ITP: DESIGNING A PROTOCOL IN THE SETTING OF THE LARGE CHILDREN'S HOSPITAL
	-	IMPLEMENTATION OF A TREATMENT PROTOCOL FOR PEDIATRIC ITP IN A LARGE CHILDREN'S HOSPITAL
Lombardi G.	-	INSULIN-DEPENDENT CHANGES IN PAI-1 AND T-PA LEVELS AFTER A 6-MO TREATMENT WITH R-HGH IN GROWTH HORMONE DEFICIENT (GHD) ADULTS
Lombardi A.	-	THREE NEW MUTATIONS IN FXII DEFICIENCY
Lombardi G.	-	LOW INSULIN-LIKE GROWTH FACTOR (IGF) I, IGF BINDING PROTEIN-3 AND ACID LABILE SUBUNIT (ALS) LEVELS IN YOUNG ISCHEMIC STROKE: A PROSPECTIVE CASE-CONTROL STUDY
Lombardi A.	-	THROMBOTIC THROMBOCYTOPENIC PURPURA IN PATIENT WITH LOW ADAMTS-13 ACTIVITY LEVELS BUT NO INHIBITORY AUTOANTIBODIES
Lombardi R.	-	PLATELET ADAMTS13 AND IN VITRO EXPRESSION STUDY OF A PATIENT AFFECTED BY CONGENITAL TTP
Lombardo D.	-	BSDL INTERACTS WITH THE PLATELET CXCR4 AND MODULATES THROMBUS FORMATION
Lonati L.	-	ANTIPHOSPHOLIPID ANTIBODIES AND EX-VIVO ENDOTHELIAL PERTURBATION
London F.	-	IN VITRO STUDY OF THE EFFECT OF EXPOSURE OF HUMAN BLOOD TO ADDED INSULIN AND GLUCOSE OVER 24 HOURS AT 20 DEGREES C AND ITS MODULATION BY WORTMANNIN (W)
Longair I.	-	ACCEPTABILITY AND EFFICACY OF PATIENT SELF-TESTING IN PATIENTS NEW TO THE ANTICOAGULATION CLINIC
Longhurst C.M.	-	TETRASPANIN CD9 MODULATES VASCULAR SMOOTH MUSCLE CELL MIGRATION AND PROLIFERATION IN VITRO AND NEOINTIMA FORMATION IN VIVO
Longo V.V.L.	-	A B3 ASP217VAL SUBSTITUTION IN A PATIENT WITH VARIANT GLANZMANN THROMBATHENIA SEVERELY AFFECTS INTEGRIN AIIBB3 FUNCTIONS
Longoni R.	-	CARDIOVASCULAR DISEASE, HYPERHOMOCYSTEINEMIA AND ATHEROTHROMBOTIC RISK FACTORS IN PSORIATIC PATIENTS
	-	EFFICACY AND SAFETY OF HIGH DOSES OF FEIBA FOR MAJOR SURGERY IN A PATIENT WITH HAEMOPHILIA A AND HIGH-TITRE INHIBITOR
	-	THROMBOTIC MARKERS AND MITRAL VALVE PROLAPSE IN MIGRAINE WITH AND WITHOUT AURA AT CHILDHOOD ONSET
Longstaff C.	-	TISSUE PLASMINOGEN ACTIVATOR AND PLASMINOGEN DOMAINS REGULATING THE POTENCY OF THERAPEUTIC THROMBOLYSIS
	-	THE KINETICS OF TPA ACTIVACTION AND INHIBTION BY PAI-1 IN FIBRIN
Lonn E.	-	BRAIN NATRIURETIC PEPTIDE AS A PRECLINICAL MARKER OF CHRONIC PULMONARY HYPERTENSION IN PATIENTS WITH PULMONARY EMBOLISM
Loof A.H.	-	THE DUAL ROLE OF INTRINSIC GENERATED PLASMIN IN THE REGULATION OF THE HEMOSTATIC BALANCE
	-	IN VIVO AND IN VITRO EFFECTS OF RECOMBINANT ACTIVATED FACTOR VII ON THE PLATELET PROTEOME
Loof A.	-	THE NIJMEGEN HAEMOSTASIS ASSAY (NHA) IN THE VITRO-STUDY: RELATION WITH HOMOCYSTEINE, B-VITAMIN TREATMENT AND RECURRENCE RISK
	-	APOLIPOPROTEIN A1 AS A PREDICTOR OF RECURRENT VENOUS THROMBOSIS. RESULTS OF A PLASMA PROTEOMICS APPROACH
Loots D.	-	THE EFFECT OF FIBRINOGEN GLYCATION ON FIBRIN NETWORK STRUCTURE OF TYPE II DIABETIC SUBJECTS
Lopatina E.	-	TRANSITION TO STANDARD HAEMOSTATIC THERAPY SCHEMES OF HEMOPHILIA IN RUSSIA (THE NATIONAL TREATMENT PROTOCOL FOR HEMOPHILIA PATIENTS)
Lopez J.J.	-	REACTIVE OXYGEN SPECIES GENERATION IS REQUIRED FOR THROMBIN-INDUCED PLATELET APOPTOSIS
Lopez L.R.	-	ARE ANTIPHOSPHOLIPID ANTIBODIES RISK FACTORS FOR CORONARY ARTERY DISEASE?
	-	ASSOCIATION OF IGG ANTI-OXLDL/B2GPI AND B2GPI-DEPENDENT ANTI-CARDIOLIPIN (ACL) ANTIBODIES WITH VASCULAR THROMBOSIS IN PATIENTS WITH ANTIPHOSPHOLIPID SYNDROME (APS)
Lopez J.	-	NATIONAL STUDY OF INHIBITOR KINETICS AND TREATMENT RESPONSE IN HEMOPHILIA A AND B MEXICAN PATIENTS
Lopez J.A.	-	MEASURING MICROPARTICLES: PITFALLS AND MODIFICATIONS
Lopez M.	-	PHARMACOKINETICS OF DIPETARUDIN AND PEG-DIPETARUDIN IN PIGS
López F.M.	-	CLINICAL, GENETIC, FUNCTIONAL AND CONFORMATIONAL HETEROGENEITY OF CONGENITAL ANTITHROMBIN DEFICIENCY. RESULTS FROM 27 UNRELATED CASES
Lopez L.R.	-	REDUCTION OF DIABETES-RELATED LIPID OXIDATIVE STRESS BY STATIN THERAPY AS MONITORED BY SERUM OXIDIZED LDL/B2GPI COMPLEX LEVELS
Lopez J.A.	-	DEVELOPING ANTIDOTE CONTROLLED ANTIPLATELET THERAPIES BY TARGETING THE VWF - GP IB-IX-V INTERACTION
Lopez Fernandez M.	-	SPANISH REGISTRY OF HEPARIN-INDUCED THROMBOCYTOPENIA (RETIH). PRELIMINARY DATA
	-	RECOMBINANT ACTIVATED FACTOR VII (RFVIIA) IN THE TREATMENT OF CRITICAL HAEMORRHAGE. A SINGLE CENTRE EXPERIENCE
	-	"PRIMARY" PROPHYLACTIC TREATMENT WITH RECOMBINANT ACTIVATED FACTOR VII (RFVIIA) DURING INMUNE TOLERANCE IN A HAEMOPHILIC CHILD
Lopez Lorenzo J.L.	-	THALIDOMIDE AND THROMBOPROPHYLAXIS: TO WHOM AND WHEN
Lopez-Cabarcos C.	-	RADIOSYNOVIORTHESIS IS NECESSARY IN HEMOPHILIC PATIENTS DESPITE PROHYLAXIS
Lopez-Franco O.	-	HEPATIC TARGETING OF ADENOVIRUS MEDIATED BY COAGULATION FACTOR X
Lopez-Vilchez I.	-	SEROTONIN ENHANCES THE PROCOAGULANT PROPERTIES AND PLATELET ACTIVATION INDUCED DURING PLATELET UP TAKE OF TISSUE FACTOR
	-	SEROTONERGIC MECHANISMS IN HAEMOSTASIS: A CONNECTION BETWEEN MAJOR DEPRESSION AND THROMBOTIC RISK
Lorand-Metze I.	-	ANALYSIS OF MICROPARTICLES IN DEEP VENOUS THROMBOSIS AND ANTIPHOSPHOLIPID SYNDROME PATIENTS AND CARRIERS OF LEIDEN FACTOR V
Lord S.T.	-	THE VISCOELASTIC PROPERTIES OF SINGLE, CROSSLINKED AND UNCROSSLINKED FIBRIN FIBERS
	-	DO B:b INTERACTIONS HAVE A ROLE IN FIBRIN POLYMERIZATION?
	-	ANALYSIS OF AFFINITY OF KNOB-HOLE INTERACTIONS RESPONSIBLE FOR FIBRIN POLYMERIZATION
	-	FIBRINOGEN VARIANT BD432A: NEW INSIGHTS ON THE ROLE OF "B:b" INTERACTIONS IN FIBRIN POLYMERIZATION
Lorenz M.	-	PLATELETS RECRUIT BONE MARROW-DERIVED PROGENITOR CELLS TO ARTERIAL THROMBI IN VIVO
	-	PROTEIN DISULFIDE ISOMERASE (PDI) UNCOVERS TISSUE FACTOR (TF)-DEPENDENT FIBRIN FORMATION AFTER VESSEL INJURY
Lorenzet R.	-	WHOLE BLOOD PROCOAGULANT ACTIVITY: A POSSIBILE CELLULAR MARKER OF CARDIOVASCULAR RISK?
	-	INTERLEUKIN-1B GENE HAPLOTYPES AND INFLAMMATORY/PROCOAGULANT RESPONSE OF HUMAN MONONUCLEAR CELLS
	-	TISSUE FACTOR GENE TAG-SNPS AND HAPLOTYPES AND THE RISK OF MYOCARDIAL INFARCTION
	-	LEPTIN INDUCES TISSUE FACTOR EXPRESSION IN HUMAN MONOCYTES
Loreth R.M.	-	UNEXPLAINED PROLONGED PLATELET FUNCTION ANALYZER (PFA-100) CLOSURE TIME INDUCED BY SAMPLE ANTICOAGULANT
Loreth R.	-	PSEUDO-HOMOZYGOUS APC RESISTANCE DUE TO COINHERITANCE OF HETEROZYGOUS FACTOR V-R506Q AND FV TYPE I DEFICIENCY
Lorga A.R.	-	FACTOR V LEIDEN AS A THROMBOPHILIA'S MARKER IN LIVER TRANSPLANTATION - AN EVALUATION
Lösche W.	-	BENEFICIAL EFFECTS OF ANTIPLATELET DRUGS IN SEPSIS: FIRST DATA FROM A CLINICAL AND ANIMAL STUDY
	-	THE VALUE OF ROTEM THROMBOLELASTOMETRY TO DETECT DISTURBED HAEMOSTASIS AND BLEEDING RISK IN ON-PUMP CARDIAC SURGERY
	-	EXPRESSION AND SECRETION OF ADAMTS13 IS INHIBITED BY PROINFLAMMATORY STIMULATION
	-	EXCESS THROMBIN GENERATION IN PATIENTS AFTER ON-PUMP CARDIAC SURGERY
Losonczy H.	-	THE EFFECT OF ADP RECEPTOR ANTAGONISTS AND ASPIRIN ON WHOLE BLOOD PLATELET AGGREGATION MEASURED BY MULTIPLE ELECTRODE AGGREGOMETRY
Losordo D.W.	-	AUTOLOGOUS CD34+ CELL TRANSPLANT FOR ISCHEMIC TISSUE REPAIR
Lotfi A.	-	MORPHOLOGIC EVIDENCE OF INTRAVASCULAR PLATELET ACTIVATION WITH GENERATION OF PLATELET MICROPARTICLES & EXOSOMES IN MURINE HEPATIC SCHISTOSOMIASIS AND ITS MODULATION BY PENTOXIFYLLINE TREATMENT
Lotter K.	-	BLEEDING COMPLICATIONS IN SURGICAL PATIENTS WITH VON WILLEBRAND'S DISEASE
Lotti L.	-	EVIDENCE OF ASPIRIN EXCRETION FROM PLATELET BY MRP4 TRANSPORT RESPONSIBLE FOR REDUCED DRUG ACTIVITY IN PATIENTS AT 5 DAYS CABS
Loubele S.T.B.G.	-	ACTIVE SITE INHIBITED FACTOR VIIA HAS A PROTECTIVE ROLE IN RENAL ISCHEMIA/REPERFUSION INJURY VIA ANTI-INFLAMMATORY MECHANISMS
	-	ACTIVE SITE INHIBITED FACTOR VIIA REDUCES MYOCARDIAL INFARCT SIZE AFTER ISCHEMIA/REPERFUSION INJURY IN MICE VIA TISSUE FACTOR/NFKAPPAB-MEDIATED MECHANISMS
Loughman A.	-	STAPHYLOCOCCUS AUREUS FIBRONECTIN BINDING PROTEINS DO NOT PLAY A ROLE IN THROMBUS FORMATION
Lounes K.C.	-	RECOMBINANT HUMAN PLASMIN PRODUCED IN LEMNA MINOR
Louw S.	-	A STUDY OF THE UTILITY OF THROMBOELASTOGRAPHY IN THE MONITORING OF ASPIRIN THERAPY
Louzada M.L.	-	PSYCHOLOGICAL IMPACTS OF GENETIC TESTING FOR THROMBOPHILIA ON FIRST DEGREE RELATIVES OF PATIENTS WITH VENOUS THROMBOEMBOLISM AND A THROMBOPHILIA A PILOT STUDY
	-	A PILOT STUDY TO ASSESS THE FEASIBILITY OF A MULTICENTER TRIAL FOR THE MANAGEMENT OF ASYMPTOMATIC PERSONS WITH A THROMBOPHILIA
	-	IMPACTS OF GENETIC TESTING FOR THROMBOPHILIA ON FIRST DEGREE RELATIVES OF PATIENTS WITH VENOUS THROMBOEMBOLISM AND A THROMBOPHILIA - A CROSS-SECTIONAL SURVEY
Lova P.	-	VON WILLEBRAND FACTOR AND GPIB-IX-V REGULATE PROPLATELETS FORMATION BY HUMAN MEGAKARYOCYTES
	-	MODULATION OF PLATELET FUNCTION BY THE ENDOCANNABINOID 2-ARACHIDONOYLGLYCEROL
	-	EVIDENCE FOR THROMBIN-INDUCED PLATELET ACTIVATION INDEPENDENT OF PAR1, PAR4, AND GPIB-IX-V
Lovegrove J.A.	-	STRUCTURE-FUNCTION RELATIONSHIPS OF POLYPHENOLS AND THE MODULATION OF PLATELET FUNCTION AND SIGNALLING
Lovejoy A.E.	-	A NOVEL MUTATION IN EXON 10 OF FACTOR XIII SUBUNIT B
Lovell T.	-	ELEVATED PLASMA LEVELS OF FACTOR VIIA-ANTITHROMBIN COMPLEXES IN PATIENTS WITH ANTIPHOSPHOLIPID ANTIBODIES
Low J.	-	COMBINING 4T'S PRE-TEST CLINICAL SCORE AND ID-PAGIA HEPARIN/PF4 TEST TO EXCLUDE HEPARIN INDUCED THROMBOCYTOPENIA (HIT)
	-	A NOVEL 'FIBRINOGEN-SPIKED' INR METHOD TO MONITOR WARFARIN IN A PATIENT WITH HYPO/DYSFIBRINOGENAEMIA (FIBRINOGEN DARLINGHURST)
Lowe G.D.O.	-	COMPARISON OF THE ASSOCIATIONS BETWEEN HAEMOSTATIC AND INFLAMMATORY VARIABLES AND CHD RISK: FLETCHER CHALLENGE STUDY
Lowe G.D.	-	LOW ADAMTS13 LEVELS INCREASE THE RISK OF MYOCARDIAL INFARCTION (MI) INDEPENDENTLY OF VON WILLEBRAND FACTOR: GLASGOW MI STUDY
Lowe G.D.O.	-	COST-EFFECTIVENESS OF COMPUTER-ASSISTED ANTICOAGULANT DOSAGE CLINICAL STUDY
	-	COST-EFFECTIVENESS OF COMPUTER-ASSISTED ANTICOAGULANT DOSAGE
	-	PREDICTING RISK OF RECURRENT VENOUS THROMBOSIS USING A 5-POINT SCORING SYSTEM INCLUDING FIBRIN D-DIMER
Lowell J.	-	EFFECTS OF ORAL (OC) AND TRANSDERMAL (TC) HORMONAL CONTRACEPTION ON COAGULATION FACTORS AND ACTIVATED PROTEIN C RESISTANCE: IMPLICATIONS FOR THROMBOSIS RISK
Lowry P.J.	-	TACHYKININS AND THE NEUROKININ RECEPTOR 1 ARE REQUIRED FOR PLATELET THROMBUS FORMATION
Loyau S.	-	EX VIVO ANTITHROMBOTIC EFFECTS OF ANTI GPVI FAB FRAGMENT IN NON-HUMAN PRIMATES WITHOUT MODIFICATION OF GPVI EXPRESSION
	-	COORDINATED ACTION OF GPVI AND FCRGAMMA CYTOPLASMIC DOMAINS IN SIGNALLING
	-	GENERATION AND CHARACTERIZATION OF A RECOMBINANT BLOCKING ANTI-GLYCOPROTEIN VI SINGLE CHAIN ANTIBODY FRAGMENT
Lozano M.	-	FLAVONOIDS INHIBIT PLATELET ADHESION AND AGGREGATION UNDER FLOW: BLOCKADE OF TXA2 RECEPTORS IN PLATELET RICH PLASMA
Lozano M.L.	-	JAK2 V617F MUTATION IS ASSOCIATED WITH THE LEUKOCYTE COUNT AND BONE MARROW CD34+ CELLS IN PATIENTS WITH ESSENTIAL THROMBOCYTHEMIA
Lozano M.	-	ATS-13 ACTIVITY AS A COMMON MARKER OF THE ENDOTHELIAL DYSFUNCTION DEVELOPING IN THROMBOTIC MICROANGIOPATHIES OF DIFFERENT ORIGIN
Lozano M.L.	-	INFLUENCE OF JAK2 V617F AND OTHER GENETIC RISK FACTORS IN THROMBOSIS AND HEMORRHAGE IN PHILADELPHIA NEGATIVE MYELOPROLIFERATIVE DISORDERS [PH(-) MPD]
Lozano M.	-	BETA1-TUBULIN Q43P POLYMORPHISM IS ASSOCIATED WITH A HIGHER INTRACEREBRAL HAEMORRHAGE OCCURRENCE IN MEN
Lozano M.L.	-	PLATELET FUNCTION (PFA-100) AND ACTIVATION IN PATIENTS WITH CHRONIC PHILADELPHIA NEGATIVE MYELOPROLIFERATIVE DISORDERS: ROLE OF THE JAK2 V617F MUTATION
Lu D.	-	RGD-CONTAINING DENDROASPIN, RGD PEPTIDE AND DDM PEPTIDE INDUCE APOPTOSIS OF JURKAT CELLS
Lu X.	-	RGD-CONTAINING DENDROASPIN, RGD PEPTIDE AND DDM PEPTIDE INDUCE APOPTOSIS OF JURKAT CELLS
Lu S.	-	CD72 POLYMORPHISM ASSOCIATED WITH SUSCEPTIBILITY TO IDIOPATHIC THROMBOCYTOPENIA PURPURA IN CHINESE PATIENTS
Lu X.	-	DETERMINATION OF THE INTEGRIN BINDING PROPERTIES OF THE PUTATIVE INTEGRIN-BINDING MOTIFS OF ADAM PROTEINS USING MUTANTS BASED UPON A DENDROASPIN SCAFFOLD
Lu D.	-	DETERMINATION OF THE INTEGRIN BINDING PROPERTIES OF THE PUTATIVE INTEGRIN-BINDING MOTIFS OF ADAM PROTEINS USING MUTANTS BASED UPON A DENDROASPIN SCAFFOLD
	-	DENDROASPIN, AN RGD-CONTAINING SNAKE VENOM PROTEIN INITIATES ACTIVATION OF CYTOSOLIC PHOSPHOLIPASE A2-ALPHA ACTIVATION
Lu X.	-	DENDROASPIN, AN RGD-CONTAINING SNAKE VENOM PROTEIN INITIATES ACTIVATION OF CYTOSOLIC PHOSPHOLIPASE A2-ALPHA ACTIVATION
Lu Y.	-	COMBINED POLYMORPHISM MARKERS FOR CARRIER AND PRENATAL DIAGNOSIS OF HAEMOPHILIA IN CHINA
	-	RECOMBINATION IN ONE HAEMOPHILIA A FAMILY
	-	HETEROCLITIN D, A COMPONENT OF PLANTS OF THE KADSURA SPECIES INHIBITS PAF-INDUCED PLATELET AGGREGATION, P-SELECTIN EXPRESSION AND PLATELET-LEUCOCYTE CONJUGATE FORMATION
	-	TETRASPANIN CD9 MODULATES VASCULAR SMOOTH MUSCLE CELL MIGRATION AND PROLIFERATION IN VITRO AND NEOINTIMA FORMATION IN VIVO
Lu D.	-	INHIBITION OF AIRWAY SMOOTH MUSCLE CELL ADHESION AND MIGRATION BY THE DISINTEGRIN DOMAIN OF ADAM-15
Lu X.	-	INHIBITION OF AIRWAY SMOOTH MUSCLE CELL ADHESION AND MIGRATION BY THE DISINTEGRIN DOMAIN OF ADAM-15
	-	ALTERATIONS OF HEMOSTATIC PARAMETERS IN PATIENTS RECEIVING HEMATOPOIETIC STEM CELL TRANSPLANTATION
Lu A.	-	CONCURRENT RELEASE OF NATIVE CONFORMATION REACTIVE CENTER LOOP AND HELIX D STRAND 2A STRUCTURAL CONSTRAINTS FULLY ACTIVATES ANTITHROMBIN III IN THE ABSENCE OF HEPARIN
Lu P.	-	SPERM MEDIATED HUMAN COAGULATION FACTOR VIII GENE TRANSFER AND EXPRESSION IN TRANSGENIC MICE
Lu A.	-	THE ANTITHROMBIN III SERINE-380 P14 HYDROXYL MAKES CRITICAL CONTRIBUTIONS TO METASTABILITY OF THE NATIVE CONFORMATION AND TO STABILIZATION OF THE HEPARIN-BOUND ACTIVATED STATE
	-	REMOVAL OF THE POSITIVE CHARGE BUT NOT THE HYDROPHOBIC STEM FROM LYSINE-222 IN ANTITHROMBIN III BETA-SHEET-A REDUCES FACTOR XA INHIBITION RATES AND INCREASES HEPARIN BINDING AFFINITY
	-	ENHANCED HEPARIN BINDING AFFINITIES INCREASE THE EFFICIENCIES AT WHICH THE BETA-ANTITHROMBIN III ISOFORM AND A RECOMBINANT ATIII VARIANT LOAD ONTO PENTASACCHARIDE-BEARING SURFACES UNDER FLOW
Lu D.	-	SELECTIVE BINDING TO INTEGRIN ALPHA-9-INTEGRIN EXPRESSING CELLS OF MUTANTS OF DISINTEGRIN-LIKE DOMAIN OF ADAM-15 CONTAINING THE PUTATIVE INTEGRIN BINDING MOTIF OF ADAM-2, -12 AND -19, RESPECTIVELY
Lu X.	-	SELECTIVE BINDING TO INTEGRIN ALPHA-9-INTEGRIN EXPRESSING CELLS OF MUTANTS OF DISINTEGRIN-LIKE DOMAIN OF ADAM-15 CONTAINING THE PUTATIVE INTEGRIN BINDING MOTIF OF ADAM-2, -12 AND -19, RESPECTIVELY
Lubenow N.	-	HEPARIN-INDUCED THROMBOCYTOPENIA (HIT): A PROSPECTIVE STUDY ON THE INCIDENCE, PLATELET-ACTIVATING CAPACITY AND CLINICAL SIGNIFICANCE OF ANTI-PLATELET FACTOR 4/HEPARIN ANTIBODIES (ANTI-PF4/H ABS) OF THE IGG, IGM, AND IGA CLASS
	-	PROTEOMICS OF CELL-BASED THERAPEUTICS - PROFILING OF ALTERATIONS IN PLATELET PROTEINS DURING STORAGE OF PLATELET CONCENTRATES
Lubetsky A.	-	PERINATAL ISCHEMIC STROKE AND THE INCIDENCE OF MATERNAL AND NEONATAL THROMBOPHILIA
	-	RESPONSIVENESS TO CLOPIDOGREL AND ASPIRIN AMONG PATIENTS WITH ACUTE CORONARY SYNDROME AS ASSESSED BY THE IMPACT-R [CONE AND PLATE(LET) ANALYZER]
	-	THROMBOPHILIA IS ASSOCIATED WITH HEPARIN THROMBOPROPHYLAXIS FAILURE IN PATIENTS WITH ACUTE TRAUMATIC SPINAL CORD INJURY
Lubezki A.	-	COMPARISON OF PEGYLATED LIPOSOMAL FVIII INFUSION RATES IN HEMOPHILIA A
Luboshitz J.	-	COMPARISON OF PEGYLATED LIPOSOMAL FVIII INFUSION RATES IN HEMOPHILIA A
Lubsczyk B.	-	EFFECTS OF RECOMBINANT FACTOR VIIA (NOVOSEVEN) ON RESTORING THROMBIN GENERATION IN PATIENTS WITH HEMOPHILIA A AND ANTIBODIES TO FACTOR VIII
Lucarini L.	-	MUTATION SCREENING ANALYSIS OF TGFBR1 GENE IN PATIENTS WITH MARFAN SYNDROME
	-	RISK OF BLEEDING IN VERY OLD ATRIAL FIBRILLATION PATIENTS ON WARFARIN: RELATIONSHIP WITH AGEING AND CHADS2 SCORE
	-	HOMOCYSTINURIA AND CARDIOVASCULAR MANIFESTATIONS: 5 ITALIAN CASES
	-	B-GROUP VITAMINS' PROFILE AND OCCURRENCE OF CORONARY ARTERY DISEASE: A CASE-CONTROL STUDY
	-	ROLE OF D-DIMER IN COMBINATION WITH F1+2, RVO AND THROMBOPHILIA IN THE RISK OF RECURRENCE OF PATIENTS WITH A FIRST VTE EPISODE AFTER OAT WITHDRAWA
Lucas J.	-	THROMBIN ACTIVATABLE FIBRINOLYSIS INHIBITOR (TAFI) GENE POLYMORPHISM AND RISK FOR VENOUS THROMBOSIS DISEASE (VTD)
Lucic A.M.	-	PROPHYLACTIC APPROACH TO WOMEN WITH THROMBOPHILIA AND REPEATED SPONTANEOUS ABORTIONS
Luddington R.	-	ELEVATED ENDOGENOUS THROMBIN POTENTIAL (ETP) IS ASSOCIATED WITH AN INCREASED RISK OF A FIRST DEEP VENOUS THROMBOSIS BUT NOT WITH RECURRENCE
Luddington R.J.	-	EFFECT OF METHYLENE BLUE (MB) TREATMENT OF FRESH FROZEN PLASMA (FFP) ON CALIBRATED AUTOMATED THROMBOGRAPHY (CAT) AND ROTATIONAL THROMBOELASTOMETRY (ROTEM)
Ludlam C.A.	-	EFFECT OF PRE-ANALYTICAL VARIABLES ON MICROPARTICLE NUMBERS
Ludwig R.J.	-	CUTANEOUS DELAYED-TYPE IV-HYPERSENSITIVITY REACTION (DTH) TO HEPARIN AND HEPARIN-INDUCED THROMBOCYTOPENIA TYPE II (HIT) IS THERE AN ASSOCIATION ?
	-	INTERACTIONS WITH P-SELECTIN AND ANTIMETASTATIC ACTIVITIES OF NADROPARIN AND UFH
Luettgen J.M.	-	INHIBITION OF MEASURED THROMBIN GENERATION IN HUMAN PLASMA BY APIXABAN: A PREDICTIVE MATHEMATICAL MODEL BASED ON EXPERIMENTALLY DETERMINED RATE CONSTANTS
Lugovskaya N.E.	-	A FIBRIN-SPECIFIC MONOCLONAL ANTIBODY WITH EPITOPE LOCALIZED IN FIBRIN FRAGMENT BBETA118-134: ITS APPLICATION TO QUANTIFICATION OF SOLUBLE FIBRIN
Lugovskoy E.V.	-	A FIBRIN-SPECIFIC MONOCLONAL ANTIBODY WITH EPITOPE LOCALIZED IN FIBRIN FRAGMENT BBETA118-134: ITS APPLICATION TO QUANTIFICATION OF SOLUBLE FIBRIN
Lui X.	-	ROLE OF P38 MITOGEN ACTIVATED PROTEIN KINASE IN ANTIPHOSPHOLIPID ANTIBODY-MEDIATED THROMBOSIS AND ENDOTHELIAL CELL ACTIVATION
Luiking Y.C.	-	ARGININE THERAPY TENDS TO REDUCE ENDOTHELIAL DAMAGE IN SEPSIS
Luis S.A.	-	THE ANTITHROMBIN III SERINE-380 P14 HYDROXYL MAKES CRITICAL CONTRIBUTIONS TO METASTABILITY OF THE NATIVE CONFORMATION AND TO STABILIZATION OF THE HEPARIN-BOUND ACTIVATED STATE
	-	REMOVAL OF THE POSITIVE CHARGE BUT NOT THE HYDROPHOBIC STEM FROM LYSINE-222 IN ANTITHROMBIN III BETA-SHEET-A REDUCES FACTOR XA INHIBITION RATES AND INCREASES HEPARIN BINDING AFFINITY
Luken B.	-	THE IMPORTANCE OF DETECTING ANTI-ADAMTS-13 ANTIBODIES IN PATIENTS WITH SEVERE ADAMTS-13 DEFICIENCY
Luken B.M.	-	HUMAN VH1-69 GERMLINE GENE ENCODED ANTI-SPACER DOMAIN ANTIBODIES THAT DEVELOP IN PATIENTS WITH ACQUIRED TTP INTERFERE WITH THE BINDING OF ADAMTS13 TO VWF
Lukes A.S.	-	LABORATORY CHARACTERISTICS OF WOMEN WITH MENORRHAGIA: A MULTI-SITE U.S. STUDY
	-	QUALITY OF LIFE (QOL) EVALUATION IN WOMEN WITH MENORRHAGIA AND ABNORMAL HEMOSTASIS TESTING PARTICIPATING IN A CROSS-OVER STUDY OF INTRANASAL DESMOPRESSIN AND ORAL TRANEXAMIC ACID
	-	THE EFFECT OF INTRANASAL DESMOPRESSIN VS. ORAL TRANEXAMIC ACID ON MENSTRUAL BLOOD LOSS AMONG WOMEN WITH MENORRHAGIA AND ABNORMAL LABORATORY HEMOSTASIS: A MULTICENTER, RANDOMIZED CROSS-OVER STUDY
Lukomski S.	-	NOVEL ROLE FOR TAFI IN THE MODULATION OF HOST RESPONSES BY STREPTOCOCCI?
Lumley T.	-	ESTROGEN USE, VARIANTS IN 24 CLOTTING GENES AND THE RISK OF THROMBOSIS IN POSTMENOPAUSAL WOMEN
Luna H.	-	NATIONAL STUDY OF INHIBITOR KINETICS AND TREATMENT RESPONSE IN HEMOPHILIA A AND B MEXICAN PATIENTS
Lunardi M.	-	SEVERE SPONTANEOUS ARTERIAL THROMBOTIC MANIFESTATIONS IN PATIENTS WITH INHERITED HYPO- AND AFIBRINOGENEMIA
Lundin A.	-	CHARACTERISATION OF THE ACTIVE FORM OF THE NOVEL ORAL DIRECT THROMBIN INHIBITOR AZD0837 IN COAGULATION ASSAYS
Lundtorp L.	-	RENAL ELIMINATION OF TINZAPARIN VERSUS ENOXAPARIN IN NORMAL VERSUS NEPHRECTOMIZED RATS
Luneau S.	-	BIOLOGICAL ASSAY OF ASPIRIN-RESISTANCE: ULTRASTRUCTURE OF PLATELET GLYCOPROTEIN REDISTRIBUTION AFTER ARACHIDONIC ACID ACTIVATION AND ASPIRIN INHIBITION, AND COMPARISON WITH USUAL LABORATORY TESTS
Lunghi B.	-	COAGULATION FACTOR XI LEVELS AND THE LDL RECEPTOR-RELATED PROTEIN (LRP) GENOTYPE
	-	VITAMIN K-INDUCED VARIATION OF COAGULATION PHENOTYPE IN VKORC1 HOMOZYGOUS DEFICIENCY
Luo R.Z.	-	EFFECTS ON PLATELET AND LEUCOCYTE FUNCTION BY INTRAVENOUS CHINESE MEDICINE WIDELY USED FOR PATIENTS WITH ISCHAEMIC DISEASE IN CHINA
Luppi M.	-	PLASMA EXCHANGE AND ASPIRIN PLUS HIGH VERSUS STANDARD DOSE STEROIDS IN IDIOPATHIC THROMBOCYTOPENIC PURPURA (TTP): A PROSPECTIVE, RANDOMIZED STUDY BY THE ITALIAN GROUP FOR PTT
Lupu C.	-	FUNCTIONAL REGULATION OF TFPI IN LIPID RAFTS/CAVEOLAE
Lupu F.	-	FUNCTIONAL REGULATION OF TFPI IN LIPID RAFTS/CAVEOLAE
Lupu C.	-	GENOMIC AND STRUCTURAL ANALYSIS OF THE PROTECTIVE EFFECTS OF ACTIVATED PROTEIN C IN A BABOON MODEL OF E. COLI SEPSIS
Lupu F.	-	GENOMIC AND STRUCTURAL ANALYSIS OF THE PROTECTIVE EFFECTS OF ACTIVATED PROTEIN C IN A BABOON MODEL OF E. COLI SEPSIS
Luqmani A.	-	MAJOR OBSTETRIC HAEMORRHAGE IN LATE TERMINATION OF PREGNANCY
	-	MAJOR OBSTETRIC HAEMORRGHAGE IN LATE TERMINATION OF PREGNANCY
Lusher J.	-	INFLUENCE OF NANOPOLYMERS WITH DIFFERENT END-FUNCTIONALITIES ON PLATELETS AND COAGULATION. AN EX-VIVO STUDY
Lusher J.M.	-	FIBRINOLYTIC PARAMETERS IN CHILDREN WITH NON-CATHETER RELATED DEEP VENOUS THROMBOSIS
Lusher J.	-	TISSUE PLASMINOGEN ACTIVATOR (RTPA) INDUCED FIBRINOLYSIS - STANDARDIZATION OF METHOD ON THROMBELASTOGRAPHY
Lussana F.	-	ENDOTHELIAL PROTEIN C RECEPTOR EXPRESSION IN BREAST CANCER
Lutgens E.	-	VISUALIZATION OF THROMBUS FORMATION ON ACUTELY RUPTURED PLAQUES IN VIVO
Luther T.	-	CLINICAL RELEVANCE AND TUMOR BIOLOGICAL ROLE OF THE UROKINASE RECEPTOR MRNA SPLICE VARIANT UPAR-DEL4/5 IN BREAST CANCER
Luu H.	-	ANTIHEMOPHILIC FACTOR (RECOMBINANT), PLASMA/ALBUMIN-FREE METHOD (RAHF-PFM) EXPERIENCE ASSESSED THROUGH ONGOING POST-AUTHORIZATION SAFETY SURVEILLANCE (PASS)
Luxembourg B.	-	SEVEN NOVEL MISSENSE MUTATIONS IN THE VITAMIN K EPOXIDE REDUCTASE COMPLEX SUBUNIT 1 (VKORC1) CAUSE HEREDITARY COUMARIN RESISTANCE
	-	PHARMACOGENETICS OF ORAL ANTICOAGULATION - VKORC1-HAPLOTYPES DETERMINE THE INTER-INDIVIDUAL VARIABILITY
	-	ARE PATIENTS WITH THROMBOPHILIA AND A HISTORY OF VENOUS THROMBOEMBOLISM AT HIGHER RISK TO ARTERIAL THROMBOTIC EVENTS?
	-	USE OF FONDAPARINUX IN PATIENTS WITH HEPARIN-INDUCED THROMBOCYTOPENIA TYPE II
	-	IMPACT OF THE VITAMIN K EPOXIDE REDUCTASE COMPLEX SUBUNIT 1 (VKORC1) POLYMORPHISM C.-1639GA UPON PHENPROCOUMON THERAPY
	-	COMPARISON OF A HEPARIN-PLATELET FACTOR 4 (PF4)-ELISA FOR IGG, IGM AND IGA AND THE HEPARIN-INDUCED PLATELET ACTIVATION ASSAY (HIPA) WITH A HEPARIN-PF4-ELISA FOR IGG
Lwaleed B.A.	-	PLASMA THROMBOMODULIN IN PRE-ECLAMPSIA
	-	TISSUE FACTOR AND TOTAL TISSUE FACTOR PATHWAY INHIBITOR LEVELS IN CORONARY ARTERY DISEASE: CORRELATION WITH THE SEVERITY OF ATHEROMATOSIS
	-	TFPI PLASMA LEVELS IN WOMEN WITH PRE-ECLAMPSIA
Lyanova K.M.	-	CLINICAL USE OF TEST OF LYMPHOCYTE-PLATELET ADHESION
Lyapin G.Yu.	-	THE PREVENTION OF THROMBFORMATION UNDER INFLUENCE OF A COMPLEX PREPARATION OF PLANT ANTICOAGULANT
Lyapina L.A.	-	ANTITHROMBOTIC EFFECT OF ADENOSINTHREEPHOSPHATE AT INTRODUCTION BY AN ANIMALS WITH DISTURB OF HAEMOSTATIC SYSTEM
Lyberg T.	-	CARDIAC tPA RELEASE DURING SYMPATHETIC NERVE STIMULATION IN PIGS DECREASES BY REPEATED STIMULATIONS
Lyman G.H.	-	DEVELOPMENT AND VALIDATION OF A PREDICTIVE MODEL FOR CHEMOTHERAPY-ASSOCIATED THROMBOSIS
	-	INCREASING RATE OF VENOUS THROMBOEMBOLISM AMONG HOSPITALIZED CANCER PATIENTS
Lynch S.F.	-	EFFECT OF PRE-ANALYTICAL VARIABLES ON MICROPARTICLE NUMBERS
Lynn H.S.	-	ASSOCIATION BETWEEN A HISTORY OF INHIBITORS AND DELAYS IN SKELETAL MATURATION IN ADOLESCENTS WITH HEMOPHILIA
Lyubimov E.	-	PLATELET ACTIVATION RESPONSE IS MORE SENSITIVE TO THROMBIN STIMULATION THAN IS PLATELET APOPTOSIS
Lyutova L.V.	-	HAEMOSTASIS AND FIBRINOLYSIS AFTER EXPERIMENTAL AUDIOGENIC SEIZURES/

| ISTH 2009